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Abstract 
Wound healing in the skin is a complex and well orchestrated process involving the 
interaction of numerous cell types as healing progresses through phases involving 
inflammation, proliferation and remodelling. Impairment to the wound repair process 
can lead to delayed (chronic wounds) or excessive healing (fibroproliferative disorders). 
Because of the loss of function in scarring tissue, the difficulty in healing chronic wounds 
and high cost of wound care, there is considerable interest in the factors involved in the 
regulation of normal healing. Following injury, vascular damage often occurs resulting in 
low oxygen tension (hypoxia). Slight changes in systemic and cellular oxygen 
concentrations induce tightly regulated response pathways that attempt to restore 
oxygen supply to cells and modulate cell function in hypoxic conditions. Most of these 
responses occur through the induction of the transcription factor hypoxia inducible 
factor-1 (HIF-1) which regulates many processes needed to carry out tissue repair 
processes during wound ischaemia. For this reason HIF-1 is viewed as a positive 
regulator of wound healing and a potential regulator of tissue fibrosis. Seven in absentia 
homologue proteins (Siah) are a family of E3 ubiquitin ligases that tag HIF-hydroxylases 
for degradation during hypoxia and thus increase HIF-1α availability. In this context, Siah 
deficient cells are unable to adequately stabilise HIF-1α under hypoxic conditions. We 
hypothesized that Siah would have a regulatory role in early wound healing where 
hypoxic microenvironments are common and that Siah would be important for cell 
functionality in hypoxia. Thus, this thesis aims to address the role of Siah2 in dermal 
wound healing in vivo by examining the effect of Siah2 deficiency using Siah2 knockout 
(transgenic) mice and in vitro through the study of cultured dermal fibroblasts (murine 
Siah2-deficient fibroblasts and human fibroblasts). The results indicate that in the 
absence of Siah2, cutaneous wound repair is significantly impaired, albeit transiently. 
Specifically, macrophage invasion, re-epithelialisation, matrix deposition, fibroblast-
myofibroblast transition, angiogenesis and wound contraction are delayed or reduced in 
Siah2 deficient wound repair. Furthermore, Siah2 knockout fibroblasts showed impaired 
functionality under hypoxic conditions (specifically collagen synthesis, αSMA induction) 
and an impaired response to exogenous TGFβ (delayed cell migration and reduced 
collagen synthesis). Moreover, transient inhibition of Siah in human dermal fibroblasts 
using a transfected Siah1/2 inhibitor (phyllopod, a Drosophila protein) reduced the 
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functionality (VEGF release, collagen induction, cell migration and TGF beta receptor 
type 1 induction) of otherwise healthy dermal cells. The results suggest for the first 
time, a role for Siah proteins as positive regulators of early wound healing through their 
regulation of HIF-1α fate and possibly through HIF-1 independent mechanisms. Aberrant 
wound healing is a concern of epidemic promotions and current strategies are far from 
ideal. In conclusion, this thesis demonstrates that Siah is a positive regulator of wound 
healing and cell functions related to healing and we propose that these findings may 
have important clinical implications for both impaired and over-elaborate forms of 
healing that result in scarring.           
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1.1. Introduction 
Wound healing is a highly orchestrated sequence of complex overlapping events that 
are precisely timed to repair damage, prevent infection and restore function of tissue 
after injury or insult. These events are classically divided into inflammatory, proliferation 
and remodelling phases (Clark, 1996). In postnatal full-thickness wound repair 
regardless of the type of injury be it burns, pathological damage, toxin related, 
autoimmune or physical trauma the inevitable outcome is scarring and some 
subsequent loss of tissue function (Darby and Hewitson, 2007). In contrast, fetal wound 
healing before the third trimester proceeds with little or no scarring (Longaker et al., 
1990). Healing is thought to become more adult like after the third trimester correlating 
with the development of the immune system (Longaker et al., 1990, Frantz et al., 1993). 
Scar free fetal wound healing is the subject of intensive research aimed at unlocking 
strategies that may achieve a similar outcome in adult wound healing (Siebert et al., 
1990).   
 
Wound healing involves a complex series of interactions between cells, chemical signals, 
extracellular matrix proteins and microenvironments collectively termed “dynamic 
reciprocity” (Singer and Clark, 1999). Invasion by inflammatory cells debrides the wound 
of damaged tissue and prevents infection, while releasing soluble factors that help to 
stimulate chemotaxis of fibroblasts and endothelial cells to form the granulation tissue 
(Singer and Clark, 1999). Simultaneously, rapid migration of keratinocytes also helps to 
cover and seal the wound from the external environment to further prevent infection. 
Alteration to the precise nature of these events leads to defective wound healing or 
abnormal scar formation (Clark, 1996).  
 
Abnormal wound healing clinically presents mostly as fibroproliferative disorders 
(keloids and hypertrophic scars) and more commonly chronic wounds (diabetic ulcers, 
pressure sores and venous ulcers). These defects impose a great burden to patients in 
terms of morbidity and quality of life and also place a substantial financial burden on 
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global health care systems (Sen et al., 2009). Fibroproliferative lesions are often painful 
and prone to develop into contractures which can impose severe restrictions to mobility 
and quality of life (Roseborough et al., 2004, Bayat et al., 2003).  Ulcers can be painful, 
may be socially isolating because of appearance or smell and are often prone to 
infection which increases the risk of amputations (Cavanagh and Bus, Barron et al., 
2007).  
 
Sadly, current wound care strategies are still far from ideal, owing mostly to our limited 
understanding of the complex mechanics involved in wound healing. An urgent 
approach to wound healing research must be adopted to further our understanding of 
wound healing and wound care strategies (Sen et al., 2009). In this chapter, the general 
mechanics of wound healing are reviewed with emphasis on the role of hypoxia and its 
signalling pathways on the wound healing milieu. Furthermore, the potential roles of 
hypoxia regulating transcription factor, HIF-1, and its associated proteins including 
prolyhydroxlyases (PHDs) and seven in absentia homologue (Siah) in wound healing are 
discussed in further detail.              
 
1.2. Normal wound healing 
 
After tissue insult, platelet aggregation initiates the coagulation cascade that converts 
fibrinogen to fibrin fibres which then helps to stabilize the plug. This forms a temporary 
barrier and scaffold that acts as a provisional matrix which is critical in providing both a 
transient structure to the wound bed and anchorage for infiltrating cells (Laurens et al., 
2006). Activated platelets release cytokines which accumulate in the provisional matrix 
and create a chemotactic gradient that can be tracked by infiltrating inflammatory and 
mesenchymal cells. These cytokines and growth factors likely act as a pool that can be 
used until autocrine and paracrine secretion of soluble factors take over once 
inflammatory cells have infiltrated the provisional matrix (Laurens et al., 2006). 
Transforming growth factor beta (TGFβ) is an example of a matrix bound latent growth 
Chapter 1 
a 
4 
factor present during the early inflammatory phase and can be enzymatically or 
mechanically activated later (Wipff et al., 2007, Hynes, 2009).   
 
Inflammatory cells (neutrophils and macrophages) infiltrate the provisional matrix in 
large numbers to debride the wound site, removing debris and bacteria. The wound 
sites are often avascular during the inflammatory phase owing to the disruption of 
blood vessels and then rapid infiltration of metabolically demanding cells occurs , thus 
ischaemia develops causing tissue hypoxia (Remensnyder and Majno, 1968). 
Inflammatory cells preferentially accumulate in these hypoxic areas which is critical in 
the restoration of aseptic tissue conditions and in the release of chemotactic factors 
that stimulate re-epithelialisation, and the formation of the granulation tissue (Leibovich 
and Ross, 1975, Knighton et al., 1983, Bosco et al., 2008).  
  
Following the onset of inflammation, keratinocytes from the wound margin migrate 
rapidly over the provisional matrix to re-epithelialise and seal the wound site (Ortonne 
et al., 1981, Takashima and Grinnell, 1985). In response to released factors 
keratinocytes differentiate into a migratory phenotype by down-regulating their 
desmosome and hemi-desmosome integrin links, at the cell-cell and cell-basement 
membrane contact points as well as increasing expression of actin filaments that enable 
mobility (Odland and Ross, 1968, Krawczyk and Wilgram, 1973, Gabbiani et al., 1978). 
This may show as a purse-string arrangement of actin filaments which aid in coordinated 
movement and rapid closure of the epithelial defect adult (Danjo and Gipson, 1998) and 
fetal wound healing (Cowin et al., 2003) .  
 
Replacement of provisional matrix with granulation tissue is critical to restoring tissue 
integrity, architecture and function. As fibroblasts and endothelial cells infiltrate the 
provisional matrix, they lay down extracellular matrix and blood vessels respectively 
which eventually form the granulation tissue. The granulation tissue is later remodelled 
mechanically by contracting fibroblasts, loss in cellularity via apoptosis follows and there 
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is modification to extra-cellular matrix by matrix metalloproteinase (MMPs)(Gabbiani et 
al., 1971, Desmouliere et al., 1995, Darby et al., 2002). Typically in adult mammalian full-
thickness wounds, matrix synthesis exceeds the remodelling attempt resulting in scar 
formation, failure to achieve the original architecture and reduced tensile strength of 
the resulting scar tissue (Clark, 1996). Essential functions of the skin in thermoregulation 
tend to be impaired by scar formation, which may have varying effects depending on 
the size of scar (Wilson et al., 1971). For a schematic representation of wound healing 
phases and cell recruitment refer to Figure 1-1 below.  
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Figure 1-1. Schematic overview of the overlapping phases of wound healing over time 
and the peak of different cells during these phases. Wound healing is classically divided 
into three phases: inflammation (acute or chronic), proliferation (fibrogenesis and 
angiogenesis) and remodelling. Migration of wound repair cells into the wound site is 
sequential and co-ordinated in a time depended manner. Different cells types peak and 
co-exist at different time points allowing for spatio-temporal regulation of different 
wound healing phases. Eventually wound contraction and loss in cellularity through 
apoptosis resolve the granulation tissue and  the matrix fibrillar mass is degraded by 
metalloprotienases. The resulting mature wound is relatively acellular and avascular 
(Adopted from (Greenhalgh, 1998)) 
 
(0 time)  (21 time) 
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1.3. Inflammation 
Inflammation acts as a protective attempt to remove microbes and injurious debris. In 
addition, inflammatory cells in particular macrophages are widely appreciated as 
important regulators of cytokines and growth factors during wound healing (Leibovich 
and Ross, 1975). In adult wound repair, macrophages and their released factors typically 
persist in the wound bed and act as regulators of the following proliferation and 
remodeling phases as part of an overlapping chronic inflammatory phase. This is in 
contrast to scarless fetal wound healing which tends to be characterized by a short 
inflammatory phase and rapid wound resolution (Blakytny et al., 2004, Martin and 
Leibovich, 2005). So although the inflammatory process is thought to be important in 
normal wound healing its prolonged effects may be important for scar formation in 
adult animals (Blakytny et al., 2004).   
 
1.3.1. The coagulation cascade and platelets in wound repair  
The inflammatory phase is typically preceded by the coagulation cascade which is 
considered to be the initiator of the wound healing process (Singer and Clark, 1999). It is 
essential in haemostasis, activation of inflammatory cells and growth factor 
release/activation. The coagulation cascade leads to aggregation of platelets and the 
conversion of fibrinogen to fibrin. Together with fibronectin these events form a stable 
plug (clot) which helps to re-establish haemostasis by preventing further blood loss 
(Laurens et al., 2006). The clot also establishes a provisional matrix that can act as a 
scaffold for infiltrating cells to adhere to through specialised cell matrix receptors called 
integrins (Albelda and Buck, 1990, Clark et al., 1982b, Clark et al., 1982a). In co-
ordination with other cell surface molecule receptors, integrins allow inflammatory and 
mesenchymal cells to migrate and proliferate towards the wound centre along a 
chemotactic gradient of released factors and chemical mediators. Activated platelets 
within the fibrin clot are essential in the release of multiple factors including interleukins 
1 (IL-1), IL-6, platelet-derived growth factor (PDGF), transforming growth factors α 
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(TGFα) and TGFβ (Werner and Grose, 2003). It is well accepted that some growth factors 
are released into the matrix in latent or bound form which provides both storage and an 
additional platform for their regulation. Activation of latent growth factors occurs in 
different ways but mostly through cleavage by proteolytic factors or mechanical force. 
Specific examples are the activation of latent TGFβ1 by platelet released furin-like 
proprotein convertases or by integrin associated matrix metalloproteinase (MMPs) 
(Blakytny et al., 2004, Wipff and Hinz, 2008). Mechanical activation of latent growth 
factors by cells is also possible, for example the activation of latent TGFβ from 
extracellular matrix through myofibroblast contraction (Wipff et al., 2007). 
 
1.3.2. Neutrophil recruitment 
Following the formation of the haemostatic plug, neutrophils (polymorphonuclear 
leukocytes) rapidly accumulate in the damaged tissue acting as the first line of defence 
against local infection. They initialise debridement of damaged tissue and matrix 
components by synthesizing and secreting hydrolases and reactive oxygen 
intermediates (Clark, 1996). Neutrophils typically reach their peak 24 to 48 hours post 
injury, after which their numbers reduce considerably through apoptosis and 
macrophage-induced phagocytosis (Engelhardt et al., 1998, Newman et al., 1982). 
Macrophage-induced phagocytosis of apoptotic neutrophils is an essential stimulant for 
the initial release of TGFβ1 which regulates the function of fibroblasts and endothelial 
cells and their chemotaxis into the wound site (Peters et al., 2005). 
 
The bulk of neutrophils transmigrate to the wound site from the circulatory system 
along a gradient of released soluble factors which increases leukocyte-endothelial 
adherence (Engelhardt et al., 1998, Gillitzer and Goebeler, 2001, Bevilacqua, 1993). 
These cell-cell interactions occur mainly through endothelial selectins (P and E-selectin) 
and neutrophil integrin molecules expressed on the cell surface (Bevilacqua, 1993). The 
expression of these adhesion molecules is regulated by a mixture of non-specific and 
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neutrophil-specific pro-inflammatory factors produced by preceding platelets, 
pathogens and resident inflammatory cells.  
 
During wound healing highly specialised C-X-C chemokines mediate regional specific 
extravasation of neutrophils and precise tissue homing (Engelhardt et al., 1998).  These 
include growth related oncogene–α (GRO-α) and interleukin-8 (IL-8) which bind CXCR1 
and CXCR2 neutrophil cell surface receptors respectively (Baggiolini et al., 1994). 
Following injury, IL8 and GRO-α expression is rapidly up-regulated  and released by local 
macrophages and neutrophils in response to TNFα and IL-1 and expression peaks after 
24 hours, correlating with the influx of neutrophils observed during this period 
(Engelhardt et al., 1998).  
 
In addition to these secreted factors, the tissue ischaemia encountered in healing 
wounds is considered to be stimulatory for the recruitment of neutrophils (Palluy et al., 
1992). Inflammatory cells in general (neutrophils and macrophages) preferentially 
accumulate in regions of ischaemia such as damaged and pathological tissue. Hypoxia 
stimulates the up-regulation of leukocyte-endothelial adhesion molecules, selectin and 
β2-integrin subunit resulting in increased tethering, rolling and diapedesis (Wood et al., 
2000)(Rainger et al., 1995). In addition, hypoxia up-regulates IL8 presentation and 
release by endothelial cells which further enhances neutrophil specific recruitment to 
hypoxic tissue (Wang and Lin, 2010).  
 
1.3.3. Relevance of neutrophils in wound healing  
The relevance of neutrophils in wound healing has been intensely debated over the 
years. Using an anti-neutrophil serum approach, earlier studies on neutrophil-depleted 
wounds showed no significant difference in cutaneous wound healing kinetics when 
compared to control wounds, suggesting that neutrophils were dispensable during 
healing (Simpson and Ross, 1972). Since then depletion studies utilizing CXCR2 and CD-
18 transgenic mice, which both fail to recruit neutrophils, have had phenotypes with 
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delayed or defective wound healing (Devalaraja et al., 2000, Peters et al., 2005). The 
lack of apoptotic neutrophils in CD-18 deficient wounds is thought to deprive 
macrophages of apoptotic neutrophils, their main stimulant to secrete TGFβ1, resulting 
in impaired myofibroblast transformation and reduced wound contraction (Peters et al., 
2005). A similar explanation may also be plausible for the defect in CXCR2 mice which 
display a similar phenotype. Additionally, neutrophil function is impaired in diabetes as 
a result of hyperglycaemia and is restored by insulin treatment and euglycaemia, 
pointing to a possible role for altered neutrophil function in diabetic healing impairment 
(Weringer et al., 1982, Wierusz-Wysocka et al., 1988). This would further support the 
role of neutrophils in normal wound healing. The discrepancy in results from animal 
experiments is surprising given that some of the approaches used in these studies target 
neutrophils specifically. Highly selective and tissue specific deletion models are now 
possible using Cre-lox systems and may better serve to draw a conclusion on the 
relevance of neutrophils in cutaneous wound healing. 
 
1.3.4. Macrophage recruitment  
Macrophages infiltrate the wound site in parallel to neutrophils, initially in smaller 
numbers, and eventually (2-3 days post injury) become the predominant inflammatory 
cell in the wound (Leibovich and Ross, 1975). They remain in wounds until the 
remodelling phase as part of a chronic inflammatory phase of wound repair. Like 
neutrophils, macrophages are essential during host defence and tissue debridement but 
are also necessary regulators of the proliferation and remodelling phases of wound 
repair (Kurihara et al., 1997, Leibovich and Ross, 1975, Mirza et al., 2009).  This largely 
relies on their ability to express and release cytokines into the wound bed that regulate 
fibroblast function and angiogenesis (Leibovich and Ross, 1975, Leibovich and Ross, 
1976, Mirza et al., 2009). These cytokines include platelet-derived growth factor (PDGF), 
transforming growth factor beta (TGF-β) , fibroblast growth factors (FGF) and VEGF (IL-
1)(Werner and Grose, 2003). This cocktail of soluble factors potently stimulate 
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proliferation, migration and differentiation of keratinocytes, fibroblasts and endothelial 
cells thus promoting wound closure, angiogenesis, ECM deposition and remodelling.  
 
Macrophages infiltrate the wound bed mainly from the circulation and to a lesser extent 
from local or adjacent unwounded tissue (Clark, 1996). Successful macrophage 
extravasation requires specific cell-cell adhesion molecules including immunoglobulins 
such as VCAM-1, integrins such as α4β1 and selectins which include  
P and E isoforms (Beekhuizen and van Furth, 1993). Platelet and neutrophil released 
factors increase the expression of these molecules on the cell surface of endothelial 
cells and macrophages which enables increased tethering, rolling and adhesion of 
monocytes on endothelial cells along a chemotactic gradient of specific cytokines and 
growth factors (Beekhuizen and van Furth, 1993). Specific monocyte chemokines bind to 
the C-C motif chemokine family of receptors (Yoshimura et al., 1989a, Yoshimura et al., 
1989b). Most notably, CCL2 (or monocyte chemo-attractant protein -1 (MCP-1)) which 
acts on the C-C receptor 2 (CCR2), is thought to be the most specific cytokine during 
monocyte homing into the wound site. CCL2 is expressed by up to 20% of total cells 
within and around the wounded area in response to TNF-α and IL1 and peaks about 24 
hours post injury (Engelhardt et al., 1998). Other C-C binding chemokines may include 
RANTES (or CCL5) and macrophage inflammatory protein -1 (MIP-1) but appear to be 
dispensable during normal dermal wound repair (Low et al., 2001). The importance of C-
C binding chemokine in wound healing is effectively demonstrated in CCL2-null mice 
which exhibit impaired macrophage invasion and subsequent delays in wound healing 
characterised by aberrant re-epithelialisation, collagen synthesis and revascularisation 
(Low et al., 2001). 
 
1.3.5. Relevance of macrophages in wound healing   
Despite their central role in regulating nearly all phases of wound repair, the relevance 
of macrophages in wound healing in recent years has been intensively debated. In 
particular, the question as to whether infiltrating macrophages impede or promote 
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wound healing has received much attention. Earlier studies had established the 
importance of macrophages and their released factors in early wound healing by 
demonstrating impaired healing and delayed fibroblast infiltration in macrophage 
depleted wounds following anti-macrophage serum and steroid treatment post injury 
(Leibovich and Ross, 1975). However, these findings were challenged by a 
demonstration of complete healing in the absence of macrophages and neutrophils, as 
described in the antibiotic rescued newly born PU null mouse which heal despite the 
lack of multiple macrophage and granulocyte progenitor cell lineages (Martin et al., 
2003).  Wound healing in the PU null mouse follows an embryonic pattern of repair with 
reduced scarring (Martin et al., 2003). However experiments in adult mice have not 
been performed using this transgenic line because PU null mice die 48 hours after birth 
in the absence of antibiotic treatment. Furthermore, wound healing in adult mice and 
humans is associated with prolonged inflammation, including the persistence of 
macrophages through almost all phases of wound healing. Numerous studies have 
continued to describe impaired wound healing in models with defective 
monocyte/macrophage recruitment or function.  Impaired cutaneous wound healing is 
observed in granulocyte/ macrophage colony-stimulating factor knockout mice which 
show reduced neutrophil and macrophage recruitment (Fang et al., 2007). Moreover, 
deletion of macrophage signalling molecule such as MyD88 that enable the release of 
macrophage derived angiogenic growth factors, also cause significant delays in wound 
healing (Macedo et al., 2007). Recently, selective and specific ablation of macrophages 
using Cre-lox transgenic mice with deleted CD11b showed elaborate defects in all 
phases of wound healing (Mirza et al., 2009). Additionally, macrophages from CD11b 
null mice show impaired synthesis of relevant growth factors such as, TGFβ1 and VEGF, 
highlighting the regulatory role of macrophages in the cytokine environment of the 
healing wound (Mirza et al., 2009) .   
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1.3.6. Hypoxia and macrophages    
The impact of local inflammatory cells in wound healing is also heavily influenced by 
micro-environments encountered by these cells such as hypoxia. Macrophages 
preferentially accumulate in hypoxic areas which is characteristic of most lesions 
including tumours, keloids and cutaneous wounds (Bosco et al., 2008). Macrophages 
accumulate in large numbers in such sites and then respond rapidly to the hypoxia 
present with altered gene expression, thought mostly to be mediated through up-
regulation of the transcription factor, hypoxia-inducible factor (HIF)(Cramer et al., 2003). 
Adaptation of macrophages to hypoxia may involve increasing expression of trans-
endothelial adhesion proteins (integrins) and cytokines such as TNF-α and IL1 which 
enhance the ability of macrophages to cross the vascular endothelium and migrate into 
hypoxic lesions (Kalra et al., 1996, Li et al., 1999). Hypoxia also alters the expression of 
some macrophage receptors allowing them to be more responsive to increased 
inflammatory cytokines (Ghezzi et al., 1991, Scannell et al., 1993). For example, the 
increased release of TNF-α and IL-1 by numerous local cells within the wound bed 
including resident fibroblasts, macrophages, endothelial cells and keratinocytes 
immediately after injury. It is plausible that macrophages increase receptors during 
hypoxia making them more sensitive to chemokines and enhances their migration to 
hypoxic sites. Interestingly, wounds are not shown to be hypoxic at day 1 as determined 
immunochemically by hypoxyprobe® staining, a widely used marker of tissue hypoxia 
(Haroon et al., 2000). Although, this may also be due to poor perfusion failing to deliver 
the marker to the wounded tissue.  It is instead suggested that hypoxia increases 
gradually and is detectable at about 3 days post injury, correlating with the maximal 
peak in macrophage infiltration (Haroon et al., 2000). Hypoxia is further sustained until 
day 7 to 10 correlating with a rapid increase of proliferating mesenchymal cells that 
enter the wound (Lokmic et al., 2006, Haroon et al., 2000). The importance of hypoxic 
stimuli in macrophage infiltration during wound healing is demonstrated in 
heterozygous HIF-1α deficient mice which show considerable delays in myeloid cell 
Chapter 1 
a 
14 
infiltration as early as day 2 post injury, a consequence of reduced  hypoxia signalling 
(Zhang et al., 2010b).         
 
As hypoxia in the early wounds increases, macrophage-derived factors are likely to be 
increased and provide additional stimuli for attracting macrophages and mesenchymal 
cells such as fibroblasts and endothelial cells. Described hypoxia-induced macrophage 
derived soluble factors include  TGFα, TGFβ, VEGF, FGF, PDGF, TNF-α, IL-1  and IL-8  
(Jackson et al., 2007, Kuwabara et al., 1995, Albina et al., 1995, Hempel et al., 1996, 
Scannell et al., 1993). This mixture of growth factors and cytokines is likely to have an 
additive effect on early wound healing events such as re-epithelialisation and 
granulation tissue formation.  
 
In addition to enhancing macrophage infiltration and cytokine release, hypoxia through 
HIF-1 also enhances the phagocytic potential of myeloid cells, increasing their ability to 
debride damaged tissue and rid lesions of micro-organism such as bacteria (Cramer et 
al., 2003). In wound healing, phagocytosis of apoptotic neutrophils by macrophages is 
an important event in the release of soluble factors including TGFβ, which plays a major 
role in regulating formation and remodeling of granulation tissue (Peters et al., 2005). 
Overall, the effects of hypoxia on macrophages are therefore likely to be important in 
accelerating wound healing.   
  
1.4. Proliferation: Re-epithelialisation, Angiogenesis and Fibrogenesis 
 
Re-epithelialisation and formation of granulation tissue form the proliferative phase of 
wound repair. It is a complex phase of wound repair which relies on complex 
interactions between inflammatory cells, fibroblasts, keratinocytes and endothelial cells 
as well as the extracellular matrix components and released cytokines. Here, soluble 
factors released into the fibrin clot by inflammatory cells, in particular platelets and 
macrophages, stimulate the simultaneous and cooperative migration, proliferation and 
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differentiation of keratinocytes from the existing uninjured epidermis to close the 
wound as well as fibroblasts and endothelial cells from both resident and circulating 
progenitor lineages to form the granulation tissue (Singer and Clark, 1999). As they 
migrate into the wound site mesenchymal cells interact with each other in an organised 
but complex fashion through the release of specific paracrine and autocrine factors to 
allow successful transition from provisional to a mature granulation tissue.     
 
1.4.1. Re-epithelialisation  
Rapid restoration of the epithelial barrier helps to seal the wounded area from the 
external environment and prevents further infiltration by micro-organisms. Successful 
re-epithelialisation relies on rapid proliferation, differentiation and migration of 
keratinocytes from the edges of the wound to cover a fibronectin rich provisional matrix 
(Clark et al., 1982a). Shortly after injury, keratinocytes undergo significant subcellular 
modifications, from an otherwise predestined terminally differentiated phenotype to 
one that is highly migratory. These modifications include disassembly of hemi-
desmosomal integrin links between epidermis and basement membrane, retraction of 
intracellular tonofilaments and keratin filaments, dissolution of most desmosomes, and 
formation of peripheral cytoplasmic actin filaments which can extend and contract 
creating lamellipodia and filopodia (Santoro and Gaudino, 2005). Regulation of the 
keratinocyte migratory phenotype during wound healing requires cooperative 
responses by multiple factors including integrins, matrix components (fibronectin and 
collagen), cytokines and specific cell-cell interactions (Santoro and Gaudino, 2005). Re-
epithelialisation may also be accelerated by wound microenvironments, such as tissue 
hypoxia, which are encountered as re-epithelialisation progresses over a mostly 
avascular provisional matrix (O'Toole et al., 1997, Ridgway et al., 2005). As the migrating 
edges meet, regeneration of the basement membrane occurs and keratinocytes lose 
their migratory phenotype, returning to a resting state (Santoro and Gaudino, 2005). 
After maturation of the granulation tissue, the wound is remodelled through 
contraction, reassembly of matrix and loss in cellularity through apoptosis (Desmouliere 
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et al., 1995). Keratinocytes terminally differentiate and undergo apoptosis, most likely in 
a TGFβ-mediated manner. (Greenhalgh, 1998, Amendt et al., 2002) 
 
1.4.1.1. Matrix and re-epithelialisation  
Interactions between keratinocytes and matrix components are critical during re-
epithelialisation. In vitro, fibronectin and collagen especially, have profound stimulatory 
effects on keratinocyte migration even in the absence of growth factors, while growth 
factor induced migration remains dependent on the availability of matrix components 
(Li et al., 2004). However in vivo the lack of growth factor stimulation as observed 
following mutation to keratinocyte growth factor receptor (FGFRIIIb) results in delay and 
abnormalities in re-epithelialisation, an indication that growth factors are also 
important in accelerating wound closure (Werner et al., 1994).  
 
The interaction between matrix components and keratinocytes occurs mostly through 
integrins which are heterodimeric cell surface receptors consisting of α and β subunits. 
There are 24 known α/β combinations that can be achieved to specifically recognise 
different matrix proteins through recognition of specific amino acid sequences such as 
RGD sequences (Clark, 1996). Activation of integrin receptors in migrating keratinocytes 
allows for interaction with a variety of matrix proteins interspersed in newly formed 
matrices and pre-existing matrices at the wound margin (Giancotti, 1997). Keratinocytes 
can increase their repertoire and vary their expression of integrins accordingly as matrix 
components change in the maturing wound (Larjava et al., 1993). For example, 
migration of keratinocytes on fibronectin rich provisional matrix requires a different 
profile of integrins to that of keratinocytes migrating on fibrillar collagens present at the 
wound margin and in maturing granulation tissue or on superficial wounds such as 
blisters where the dermis may not be breached (Collo and Pepper, 1999, Putnins et al., 
1999, Dumin et al., 2001)  
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In the unwounded epidermis α6β4 integrins are an essential structural component of 
hemidesmosome anchoring keratinocytes to the basement membrane (Laminin-322), as 
demonstrated in patients with junctional epidermolysis bullosa and α6β4 gene deficient 
mice that are prone to epidermal blistering (Carter et al., 1990a, Vidal et al., 1995). α2β1 
and α3β1 integrins are highly expressed in unwounded and resting epithelium where 
they are proposed to facilitate cell-cell adhesion (Carter et al., 1990a, Carter et al., 
1990b). Furthermore, α2β1 acts as the receptor for type I and II collagen required for 
keratinocyte migration during wound healing (Dumin et al., 2001). High expression of 
α2β1 in quiescent keratinocytes (unwounded tissue) is proposed to be a pre-emptive 
measure to allow attachment and rapid migration of keratinocytes on underlying 
collagen if the basement membrane is breached during injury and inhibition of α2β1 
using neutralising antibodies impairs re-epithelialisation by human keratinocytes (Parks, 
2007, Dumin et al., 2001).  
 
Following injury, the α6β4 integrin subunits are modified by phosphorylation to allow 
keratinocytes to detach and expression of fibronectin and collagen receptors α5β1 and 
α2β1 respectively is increased to allow migration and proliferation at the wound edge 
and onto newly formed matrix (Dans et al., 2001, Larjava et al., 1993). Other integrins 
expressed during re-epithelialisation include fibronectin receptor αVβ1 and vitronectin 
receptors αvβ5 and αvβ6 (Larjava et al., 1993).  The interaction between integrins and 
matrix during migration also requires cleavage of the matrix components by matrix 
metalloproteases (MMPs). MMPs bind to their respective integrins and catalyse a three 
part cycle involving ligation, cleavage and separation which functions as a “motor” to 
maintain keratinocyte movement and directionality (Dans et al., 2001, Parks, 2007). The 
relevance of this mechanism is observed during α2β1-mediated keratinocyte migration, 
which can be halted when the ability of α2β1 to bind to its ligand is blocked, if MMP1 is 
inhibited or its expression reduced, or if cells are plated on collagenase- resistant type-1 
collagen (Dumin et al., 2001). Regulation of integrins and MMP activity during migration 
is extensively influenced by availability of matrix substrates but also by a host of growth 
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factors present in the wound (Gailit et al., 1994, Zambruno et al., 1995, Koria and 
Andreadis, 2007).  
 
1.4.1.2.  Re-epithelialisation and cytokines 
A battery of growth factors produced by inflammatory cells such as platelets and 
macrophages play an important role in stimulating re-epithelialisation. Growth factors 
released into the provisional matrix are often bound to matrix substrates requiring 
activation by proteolysis.  Growth factors that modulate keratinocyte migration include 
TGFα, FGF2, IL8, keratinocyte growth factor (KGF [FGF7]), IL-1α and TGFβ, to mention a 
few (Gailit et al., 1994, Li et al., 2006). In vitro, TGFα shows the highest potency in 
promoting keratinocyte migration and proliferation, showing a similar potency to that of 
complete serum which contains a mixture of factors (Li et al., 2006). However, re-
epithelialisation during wound healing is more likely to involve a co-operative response 
from a cocktail of growth factors and is evident by the lack of wound phenotype in TGFα 
and KGF null mice which show normal re-epithelialisation following injury (Humble et 
al., 1998, Guo et al., 1996). Indeed, during wound healing TGFβ, TGFα and KGF act co-
operatively to promote a balance between proliferation and migration, which is 
important for normal and organised re-epithelialisation to occur. All three growth 
factors, promote keratinocyte migration while TGFα and KGF promote hyper-
proliferation (Gailit et al., 1994, Li et al., 2006). TGFβ has a net inhibitory effect on 
keratinocyte proliferation, an effect that is suggested to keep the re-epithelialisation 
attempt organised by preventing unregulated proliferation (Amendt et al., 2002). 
Consequently, increased proliferation and reduced apoptosis is evident in dominant-
native TGFβ type II receptor (TGFRII) mutant basal keratinocyte transgenic animals and 
mouse lacking Smad3 (Amendt et al., 2002) (Ashcroft et al., 1999), TGFRII and Smad3 
being required for TGFβ signal transduction. 
 
The regulation of integrins by growth factors is important for the detachment, migration 
and proliferation of keratinocytes during re-epithelialisation. Phosphorylation of 
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serine/threonine and tyrosine residues of α6β4 integrin subunit (β4) by macrophage 
stimulation proteins and growth factors such as epidermal growth factor (EGF) induces 
hemidesmosome disassembly which is a critical process in keratinocyte detachment 
from the basement membrane (Santoro and Gaudino, 2005). Following detachment, 
KGF and TGFβ induce the expression of α5, α2 and β1 integrin subunits to increase 
migration on the fibronectin and collagen in the newly formed matrix (Gailit et al., 1994, 
Koria and Andreadis, 2007). Conversely, the release and activation of these factors from 
their matrix bound substrates is also regulated by integrins and MMPs expressed by 
migrating keratinocytes at the leading edge. In keratinocyte and fibroblast cultures, the 
activation of matrix-bound latent TGFβ is shown to be a αvβ6 integrin-dependent 
mechanism (Munger et al., 1999, Annes et al., 2002). The relevance of this is 
demonstrated by reduced TGFβ1 activation on epithelium at the leading edge following 
injury or infection and accelerated wound healing in αvβ6-deficient animal models 
(Annes et al., 2002, Munger et al., 1999, Xie et al., 2009).  
 
1.4.1.3. Re-epithelialisation and hypoxia 
Re-epithelialisation of the wound may also be influenced in part by acute hypoxia as 
migration of keratinocytes proceeds over an avascular provisional matrix. Hypoxia can 
be detected on re-epithelialising sheets during cutaneous wound healing in the early 
proliferative phase of wound healing using pimonidazole adduct staining (hypoxyprobe) 
(Haroon et al., 2000, Lokmic et al., 2006). Alterations in the expression of metabolic 
proteins, adhesion proteins, receptors and released factors are required during hypoxia 
to enhance or continue cell functions such as migration, differentiation and 
proliferation. Cellular adaptations to hypoxia are regulated mostly by HIF-1 mediated 
pathways (Semenza, 1999).  
 
Indeed, basal keratinocytes migrating over the provisional matrix show increased 
expression of HIF-1α and the downstream target Glut-1 on the re-epithelialising sheet 
during cutaneous wound healing (Elson et al., 2000). Increased Glut-1 expression is 
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associated with increased glucose intake into the cell and is necessary for the provision 
of metabolic energy required for increased cell migration and proliferation during 
hypoxia. Furthermore hypoxia up-regulates expression of migratory integrins such as 
αvβ6  and closely associated MMPs (MMP-2 and MMP9) in keratinocyte cultures which 
correlates to their enhanced migration on fibronectin (Ridgway et al., 2005). Increased 
αvβ6 may also correlate to increased activation of latent TGFβ (Munger et al., 1999). 
The expression of paracrine acting factors such as VEGF is also increased in a HIF-1 
dependant manner in keratinocytes and is likely to have a stimulatory effect on 
angiogenesis during tissue hypoxia (Weir et al., 2011). Deficiency of HIF-1, for example 
in aged keratinocytes, reduces TGFβ activity, MMP expression and impairs migration in 
hypoxia (Xia et al., 2001). Furthermore cutaneous wound healing in HIF-1 heterozygous 
null mice is characterised by impaired wound healing and delayed wound closure (Zhang 
et al., 2010b). Overall, hypoxic conditions appear to be important for rapid re-
epithelialisation during wound healing which is essential for restoring aseptic conditions 
and an epithelial barrier. Additionally, hypoxia may also be important for the release or 
activation of keratinocyte derived paracrine factors (including VEFG) that are important 
for stimulating other wound healing events such as angiogenesis. 
 
1.4.2. The formation of the granulation tissue 
Following the inflammatory response, the restoration of tissue integrity and vasculature 
are fundamental functions of granulation tissue formation. Initially, tissue integrity is 
temporarily restored by the provisional matrix which also provides a scaffold for cell 
migration and a reservoir of chemotactic factors released by inflammatory cells. 
Fibroblasts infiltrate the wound and release a variety of extracellular matrix components 
that provide further anchorage for cell adhesion and restore tissue architecture and 
tensile strength (Clark, 1996). Furthermore, fibroblasts synthesize and release a variety 
essential paracrine and autocrine factors required for the successful formation and 
remodelling of the granulation tissue (Denton et al., 2009). As fibroblast numbers 
increase, a shift in regulatory processes controlled by inflammatory cells to processes 
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regulated mostly by fibroblast-derived factors occurs as the wound matures. Eventually 
endothelial cells and smooth muscle cells proliferate and differentiate in the wound bed 
and form new vessels that sprout into the granulation tissue to provide oxygen and 
nutrients for the healing tissue (Singer and Clark, 1999). Then once matured, the 
granulation is remodelled mechanically, enzymatically and cellularity becomes reduced 
(Gabbiani et al., 1971, Desmouliere et al., 1995, Darby et al., 2002, Darby et al., 1990).  
Mechanisms involved in the formation of the granulation tissue are complex due to the 
interplay of signals and interactions between macrophages, fibroblasts and endothelial 
cells in the granulation tissue as well as paracrine factors exchanged between epithelial 
cells overlaying the wound and mesenchymal cells. Moreover, the effects of different 
tissue microenvironments such as hypoxia which can alter cell behaviour and the 
outcome of wound healing are still not well understood.  
 
1.4.3. Angiogenesis:  
Angiogenesis is an essential component of wound healing, morphogenesis and 
pathological processes such as tumour growth and includes the cellular processes of 
adhesion, invasion, migration, proliferation and differentiation of vascular endothelial 
cells to form capillary tubes (Clark, 1996).  Angiogenesis is critical for the provision of 
nutrients and oxygen to growing and regenerating tissue (Niinikoski, 1969, 
Remensnyder and Majno, 1968). During the tissue repair process, endothelial cells from 
surrounding undamaged blood vessels invade, migrate, proliferate and form tube-like 
structures that sprout and split to form new capillaries throughout the newly formed 
granulation tissue. Circulating cells derived from the bone marrow and distant vessel 
walls, for example circulating endothelial progenitor cells, provide an additional source 
of cells that promote angiogenesis. Indeed depletion of endothelial progenitor cells 
impairs wound healing, as demonstrated in experimental models of diabetic wound 
healing (Botusan et al., 2008). Angiogenesis is a complex process involving multiple 
growth factors, cell-matrix interactions, cell to cell interactions most of which are still 
incompletely understood. In addition to this, angiogenesis is greatly stimulated by tissue 
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hypoxia following disruption to the original vasculature and the rapid influx of 
metabolically demanding wound repair cells such as inflammatory cells (Remensnyder 
and Majno, 1968). Increased angiogenic responses in ischaemia are part of tightly 
regulated homeostasis feedback mechanism regulated predominately through HIF 
transcription factors (Semenza, 1998).  
 
During the early phases of wound healing HIF-1 regulates the invasion of circulating 
angiogenic cells, which include a heterogeneous population of cells including endothelial 
progenitor cells, as well as myeloid, mesenchymal and hematopoietic stem cells which 
promote vascular growth and remodelling through the production of angiogenic 
cytokines (Zhang et al., 2010b). Furthermore, HIF-1 up-regulates the expression of 
angiogenic paracrine factors such as VEGF and TGFβ by different cells types including 
macrophages, keratinocytes and fibroblasts (Jeon et al., 2007, Weir et al., 2011, Distler 
et al., 2007). The increased expression of matrix molecules such as fibronectin and 
collagen following stabilisation of HIF-1 in dermal fibroblasts has also been 
demonstrated and is likely to enhance angiogenesis during wound healing (Distler et al., 
2007, Steinbrech et al., 1999). Consequently, ablation or reduction of HIF-1 impairs 
angiogenesis while constitutive expression or up-regulation of HIF-1 improves or 
accelerates granulation tissue formation and improves wound healing (Zhang et al., 
2010b, Botusan et al., 2008).        
 
1.4.3.1. Angiogenic cytokines 
Angiogenesis is regulated by a variety of autocrine and paracrine factors produced by 
cells in and adjacent to the granulation tissue. The most studied and most potent of the 
angiogenic factors is the heparin binding glycoprotein, vascular endothelial growth 
factor (VEGF), which exerts its biological effect through cell surface receptors VEGFR-1 
and VEGFR-2, selectively expressed on endothelial cells (Connolly et al., 1989, de Vries 
et al., 1992). In response to tissue ischaemia and inflammatory cytokines, VEGF 
expression and release is increased by a variety of cells types including neutrophils, 
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macrophages, fibroblasts, keratinocytes and endothelial cells, with the effect to provide 
vasculature for newly formed granulation tissue (Jeon et al., 2007, Berse et al., 1999, 
Ghezzi et al., 1991, Weir et al., 2011, Steinbrech et al., 1999, Nogami et al., 2007).  VEGF 
potently stimulates endothelial cell proliferation, migration and vessel sprouting by 
stimulating the up-regulation of various matrix-binding integrins including αvβ3, α1β1 
and α2β1 involved in enhancing endothelial cell to cell and endothelial cell to matrix 
binding, a process required for proliferation and tube formation (Senger et al., 1997, 
Senger et al., 1996). Furthermore, expression of integrin-associated MMPs is increased 
by VEGF in endothelial cells and vascular smooth muscles cells allowing ligation and 
cleavage of matrix which is necessary for cells to migrate, proliferate and form tubes 
through the matrix (Iwasaka et al., 1996).  
 
Loss or reduction in VEGF expression or binding to its receptors results in defective 
vessel formation which can have a significant impact on tissue formation including that 
seen in development, wound healing as well as tumourogenesis. Loss of VEGF in 
transgenic mice causes severe cardiovascular and vascular abnormalities resulting in 
embryonic lethality (Ferrara et al., 1996). Similarly, inactivation of  VEGFR-1 or VEGFR-2 
in transgenic murine models causes embryonic lethality and impedes the development 
of functional blood vessels (Ferrara et al., 1996). Furthermore, mini-pump mediated 
delivery of VEGF neutralising antibody into subcutaneous wound environments retards 
vascular development and inhibits granulation tissue formation (Howdieshell et al., 
2001). Conversely, VEGF-targeted vascular therapy may be beneficial in controlling the 
outcome of some pathological events associated with VEGF over-expression such as 
fibrosis and cancers (Wang et al., 2008a, Gounant et al., 2009). Anti-VEGF monoclonal 
antibodies are currently in clinical trials for scar prevention post glaucoma related 
surgical interventions (Bochmann et al., 2011, How et al., 2010). Additionally, due to 
underlying microvascular dysfunction associated with diabetes and difficulties in 
forming granulation tissue, application of VEGF has been used to stimulate mobilisation 
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of circulating progenitor endothelial cells and promote angiogenesis in diabetic wound 
healing (Galiano et al., 2004, Kirchner et al., 2003).   
 
Angiopoietin-1 (Ang 1) is a heparin binding glycoprotein from the same family as VEGF 
with potent angiogenic capacity and is important for the maintenance, growth and 
stabilization of new vessels (Werner and Grose, 2003). Ang-1 exerts its effect through 
tyrosine kinase Tie-2 receptors which are unique to endothelial cells and critical during 
development as demonstrated by lethality and severe retardation to vascular integrity 
of Tie-2 deficient mice (Sato et al., 1995). Ang-1 is regulated by Ang-2 which antagonizes 
its effects through competitive ligand binding of the Tie-2 receptor (Sato et al., 1995). 
Consequently, over-expression of Ang-2 in transgenic models results in lethality and 
severe vascular defects in a manner resembling phenotypes in Ang-1- or Tie -2-deficient 
transgenic models (Maisonpierre et al., 1997). In contrast, over-expression of Ang-1 in 
rodent models significantly increases vessel sprouting and similarly, delivery of matrix- 
bound Ang-1 into cutaneous diabetic wounds promotes improved healing through the 
enhancement of angiogenesis, lymphangiogenesis and blood flow (Suri et al., 1998, Cho 
et al., 2006).  Ang-1 and Tie-2 expression are increased in fibroblasts-myofibroblasts and 
endothelial cells during the early phases of wound healing and expression regresses as 
the granulation tissue matures and scar formation occurs (Staton et al.).  
 
FGFs are heparin binding mitogenic proteins suggested to play a role in angiogenesis 
through stimulation of endothelial cell proliferation and migration (Werner and Grose, 
2003). They exert their effect through activation of tyrosine kinase receptors FGFR-1-4 
which are expressed by a variety of cell types (Johnson and Williams, 1993). Expression 
of FGF1, FGF2, FGF5 and FGF7 is found in normal and unwounded skin, and expression 
of these factors is increased after skin injury suggesting a regulatory role during wound 
healing (Werner and Grose, 2003). Furthermore, FGF2 is found in human and porcine 
wound fluid particularly in the early stages after injury (Chen et al., 1992, Breuing et al., 
1997). Angiogenic effects of FGFs have been reported in endothelial cell cultures where 
Chapter 1 
a 
25 
exogenous FGFs promote  cell migration (Montesano et al., 1986). Furthermore, FGFs 
increase the expression of plasminogen activators (which convert plasminogen to 
plasmin) and MMPs which has been shown to enhance endothelial  cell migration on 
matrix (Montesano et al., 1986). FGFs are also mitogenic for other wound healing cells 
such as fibroblasts and keratinocytes in culture, which can in turn produce angiogenic 
factors in vivo. Additionally, the role of FGFs in regulating wound healing responses is 
corroborated by a number of studies where local application of FGF1, FGF2, FGF4, FGF7 
(KGF) and FGF10 stimulated tissue repair (Werner and Grose, 2003). However, 
numerous FGFs appear to be dispensable during angiogenesis, evidenced by the lack of 
an angiogenic phenotype after injury in several FGF null mice, include FGF1, FGF2 and 
FGF7 which show no obvious vascular defects or complications when compared to wild 
type littermates (Miller et al., 2000). That said, delivery of FGF2 neutralising antibodies 
in cutaneous wounds causes a striking reduction in cellularity and vascularization 
compared with the granulation tissue formed in control IgG-treated  wounds (Broadley 
et al., 1989). Cross-reactivity between FGF2 neutralising antibodies with other members 
of the FGF family was not excluded and this is likely to be the reason for the strong 
phenotype observed, given the partial phenotype in the FGF2 null model(Miller et al., 
2000).  
 
TGFβ1 is a broad range cytokine that acts through a heterodimeric serine threonine 
kinase receptor complex consisting of Type I (TGFRI) and II (TGFRII) subunits expressed 
on a multiple cell types (Massague, 1998). TGFβ1 is renowned for its ability to potently 
induce angiogenesis and fibrogenesis during wound healing and pathological fibrosis. 
Roberts et al was the first to show rapid induction of severe fibrogenic and angiogenic 
events following subcutaneous injection of TGFβ1 into normal skin (Roberts et al., 
1986). Following this, subcutaneous neutralization of TGFβ was shown to decrease 
spontaneous vascular growth and collagen deposition in a model of wound healing 
(Fajardo et al., 1996). Moreover, wound healing of TGFβ1 null mice show marked delays 
in angiogenesis and granulation tissue (Crowe et al., 2000). In culture, TGFβ rapidly 
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stimulates endothelial cell migration and differentiation allowing tube formation and 
sprouting in collagen lattices, but inhibits proliferation and migration of endothelial cell 
monolayer cultures implying that TGFβs regulates cell-matrix interactions involved in 
angiogenesis (Iruela-Arispe and Sage, 1993).  Additionally, the regulation of angiogenesis 
-related integrins by TGFβ has been suggested. For example, the increase in expression 
of α2β1 and α5β1 integrins induced by TGFβ provides activated endothelial cells with an 
enhanced capacity to migrate through their underlying basement membrane and invade 
interstitial or newly-formed matrices, and it has been hypothesized that this is an 
essential process during angiogenesis (Enenstein et al., 1992). Furthermore, up-
regulation of matrix proteolytic activity (via MMPs) is required for “motorized” function 
of integrins as endothelial cells invade the extracellular matrix, and this may also be 
regulated by TGFβ to promote angiogenesis. It also well appreciated that TGFβ can 
stimulate neutrophils, macrophages and fibroblasts to up-regulate and release paracrine 
factors in particular VEGF, which can further potentiate stimulation of angiogenesis 
(Jeon et al., 2007).  
 
1.4.3.2. Extracellular matrix and angiogenesis 
Endothelial cell to matrix interactions are vital for successful angiogenesis (Basson et al., 
1992, Madri and Williams, 1983). The extracellular-matrix acts as a vital scaffold, a 
reservoir for growth factors and cytokines as well as a mediator of intracellular signals. 
The relevance of cell to matrix interactions in angiogenesis can simply be demonstrated 
by the contrast in behaviour following growth of endothelial cells in three-dimensional 
type I matrix or basic monolayer cultures. When embedded in matrix endothelial cells 
attach, elongate, proliferate and differentiate to eventually form tubes with a lumen 
resembling capillaries, while monolayer cultures in contrast fail to differentiate (Madri 
and Williams, 1983, Montesano et al., 1983). Consequently, the formation of matrix and 
the interaction of different matrix components with endothelial cells, is thought to be 
critical for successful angiogenesis during wound healing and development and may 
have important implications in angiogenesis in  fibrotic diseases and tumourigenesis.  
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Interactions between matrix proteins and endothelial cells occur predominantly through 
a variety of integrin receptors which can be up-regulated or down-regulated by 
cytokines and other factors as cells encounter overlapping matrix components in the 
healing wound. For example, VEGF selectively increases interactions between dermal 
endothelial cells and provisional matrix by selectively inducing the expression of cell 
surface integrins α1β1, α2β1 and αvβ3 while α5β1 expression can be modulated by 
TGFβ1 (Collo and Pepper, 1999, Senger et al., 1997, Senger et al., 1996). Since ligand 
specificity differs between different integrins, endothelial cell migration, proliferation, 
differentiation and survival differs in both temporal and spatial manner as wound 
healing progresses (Perruzzi et al., 2003). Endothelial cells will initially bind to 
fibronectin in the provisional matrix and later attach to fibroblast-deposited type I 
collagen as the granulation tissue develops. This may be achieved through transiently 
expressing fibronectin specific integrins including αvβ3 and α5β1 which allow 
endothelial cells to adhere to fibronectin and later overlap with expression of α1β1 and 
α2β1 integrins to allow attachment and function on type I and III collagen (Collo and 
Pepper, 1999, Perruzzi et al., 2003). Failure or inhibition of these overlapping integrin 
expression inhibits angiogenesis during wound healing and prevents cell survival despite 
rescue attempts by angiogenic cytokines such VEGF (Perruzzi et al., 2003, Senger et al., 
1997) 
  
Integrins are vital transducers of bidirectional cell signals after ligand (matrix) binding. 
Outside-in signalling informs cells about the matrix environment while inside-out signals 
are important for integrin activation and function (Clark, 1996). Type I collagen–integrin 
(α2β1) dependent activation of intracellular  p44/P42 mitogen activated protein kinases 
(Mapk) pathways is an example of an outside-in signal which induces gene expression 
associated with endothelial cell survival.  Inhibition of p44/42 or α2β1 interrupts 
integrin mediated signalling and subsequently reduces endothelial cell viability and 
response to exogenous VEGF (Perruzzi et al., 2003). The importance of ligand-integrin 
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associated inside-out and outside-in signalling is also reported in integrin β3 mutant 
transgenic mice which fail to form complete capillaries in response to VEGF stimulation 
(outside-in signalling) (Mahabeleshwar et al., 2006). Furthermore, phosphorylation of 
VEGF receptor-2 is significantly reduced in endothelial cells expressing mutant β3 
integrin leading to impaired integrin activation (inside-out signalling) in these cells 
(Mahabeleshwar et al., 2006). Targeting integrin based interactions is viewed as an 
important therapeutic strategy for the future in the treatment of pathologies where 
angiogenesis is a contributing factor including abnormal wound healing, fibrotic 
disorders and cancers.  
 
1.4.3.3. Angiogenesis - cell to cell interactions: 
Irrespective of the physiological process (wound healing or development) or 
pathological condition (fibrosis or cancer), angiogenesis represents a complex multi-step 
process in which capillary endothelial cells sever their normal cell to cell attachments, 
migrate and proliferate in perivascular extracellular matrix in which they eventually 
reform cell to cell associations and create new vessels (Albelda and Buck, 1990). As 
discussed earlier, cellular adhesion between cells and matrix predominately occur with 
through integrin receptors which are vital for angiogenesis (1.4.3.2). Cell-specific cell to 
cell adhesion molecules localized to endothelial cell intercellular junctions are equally 
important for angiogenesis. These intercellular junctions are made up of 
transmembrane proteins anchored to actin cytoskeleton which provide structural and 
functional support during vessel formation. Furthermore, it is increasingly becoming 
evident that endothelial cell to cell interactions play an important role in inducing and 
integrating intracellular signals involved in cell growth and survival as well as matrix and 
cytoskeleton remodelling. Numerous cell junction proteins have been identified and 
extensively reviewed including vascular endothelial (VE) and neural (N) cadherins, 
junction adhesion molecule (JAM), occludins, PECAM-1 and claudins (Liebner et al., 
2006). Loss or inhibition of these cell to cell adhesion molecules impairs functionality of 
blood vessels and blocks endothelial cell tube formation. For example, anti-VE cadherin 
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augments vessel permeability and decreases integrity by disrupting VE-cadherin 
homotypic adhesion and clustering (Corada et al., 1999). Furthermore, loss of VE-
cadherin in transgenic mice causes embryonic lethality characterised by defective 
organization of endothelial cells in large vessels and impairment of angiogenesis (Vittet 
et al., 1997, Gory-Faure et al., 1999). Similarly, neutralisation with monoclonal anti-
PECAM-1 antibodies has been shown to inhibit cytokine-induced angiogenesis in 
subcutaneous implants (DeLisser et al., 1997). In addition, PECAM-1 null mice, although 
viable, show significant defects in subcutaneous impant and tumour-related 
angiogenesis (Cao et al., 2009). Interestingly, anti-PECAM-1 treatment does not alter the 
rate of wound closure or angiogenesis in excisional cutaneous wounds, however, a 
similar result is yet to be confirmed using PECAM-1 null mice (Cao et al., 2009).    
 
Besides providing structural functions, endothelial cell to cell intracellular signalling 
through adhesion molecules has been proposed to be important for sustaining vessel 
integrity and regulating angiogenesis. For example, VE-cadherin clustering and 
complexing with VEGF-receptor 2 is required for VEGF induced activation of 
phosphatidly inositol 3-kinase (PI3), AKT and Bcl2 pathways which promote cell survival 
and inhibit endothelial apoptosis during angiogenesis (Carmeliet et al., 1999). Deficiency 
or truncation of VE-cadherin induces endothelial apoptosis and abolishes VEGF induced 
survival signals (AKT kinase and Bcl2) via reduced complex formation with VEGF 
receptor-2, beta-catenin and phosphoinositide 3 (PI3)-kinase, causing impaired vascular 
remodelling and maturation (Carmeliet et al., 1999).   
 
1.4.3.4. Hypoxia and angiogenesis 
Blood vessels function as conduits for the delivery of oxygen and nutrients in all 
physiological and pathological states. Following full-thickness cutaneous injury, vessel 
function is compromised leading to acute tissue hypoxia and the hypoxic state is 
sustained further due to rapid influx of inflammatory and mesenchymal cells with a high 
metabolic demand for oxygen (Remensnyder and Majno, 1968). Local relative hypoxia 
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has been observed in wounds by direct measurement of local oxygen pressure and its 
necessity in maintaining good angiogenesis during wound healing has been well-defined 
(Knighton et al., 1981). Hypoxia is well known to induce the up-regulation of major 
angiogenic factors (VEGF, Ang-1, TGFβ1 and FGF-2), the recruitment of inflammatory 
and progenitor endothelial cells as well as inducing the migration of fibroblasts and 
keratinocytes which coordinate the angiogenic effort (Steinbrech et al., 1999, Cramer et 
al., 2003, Berse et al., 1999, Weir et al., 2011, Albina et al., 1995, Jeon et al., 2007, 
Harmey et al., 1998, Kuwabara et al., 1995, Zhang et al., 2010b). Cellular adaptive 
responses to hypoxia are mediated by HIF-1, which induces transcriptional responses 
that include expression of angiogenic factors by hypoxic cells and expression of cognate 
receptors for these ligands by vascular cells and their progenitors (Semenza, 2010). 
Expression of virtually all critical angiogenic growth factors required for local activation 
of vascular cells during angiogenesis is induced by HIF-1, including VEGF, stromal 
derived factor 1 (SDF-1), Ang 2, PDGF and TGFβ (Forsythe et al., 1996, Loh et al., 2009, 
Distler et al., 2007, Semenza, 2010).  Although TGFβ expression and responsiveness is 
increased during hypoxia and impaired in HIF-1 deficient cells, it is not known whether 
HIF-1 is a direct or indirect activator of TGFβ gene expression (Distler et al., 2007). The 
released factors also serve as homing signals for mobilization and recruitment of 
circulating angiogenic cells (CACs) (progenitor endothelial cells and bone marrow 
derived myeloid cells) from distant sites such as bone marrow and vessels from other 
adjacent tissue (Botusan et al., 2008).  
 
Impairment of HIF-1-dependent responses to hypoxia is a major factor contributing to 
the impaired vascular responses seen in wound ischaemia. For example, defective HIF-1 
signalling has been identified in ageing- and diabetes-related impaired angiogenesis 
during wound healing, and correction by constitutive expression or stabilization of HIF-1 
significantly improves the angiogenic defect and accelerates wound healing (Botusan et 
al., 2008, Liu et al., 2008). Conversely, prolonged hypoxia and over stimulation of HIF-1 
associated responses are viewed as an important mechanism of elaborate angiogenesis 
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in pathological conditions. High levels of HIF-1 and its downstream targets (such as 
VEGF) are reported in a variety of pathological conditions including keloid scars, system 
sclerosis and liver cirrhosis (Zhang et al., 2006, Distler et al., 2004, Bozova and Elpek, 
2007). Consequently, inhibition or ablation of HIF-1 signalling is shown to reduce 
angiogenesis and collagen deposition in some fibrotic models (Distler et al., 2007, 
Bozova and Elpek, 2007, Moon et al., 2009). Furthermore, impaired angiogenesis, 
reduced mobilisation of endothelial progenitor cells and delayed wound healing  has 
recently been demonstrated in HIF-1 heterozygous null mice (Partial HIF-1 
deletion)(Zhang et al., 2010b). These studies confirm at a molecular level that acute 
hypoxia responses mediated through HIF-1 are required for good angiogenic responses 
during wound healing, but may also contribute to abnormal angiogenesis that drive 
pathological forms of tissue repair.  
 
1.4.4. Fibrogenesis: Fibroblasts and myofibroblasts in wound repair 
Fibroblast functions are critical in formation of granulation tissue which restores 
integrity to damaged tissue, and its eventual remodelling to form mature scar tissue 
(Gabbiani et al., 1971). Furthermore, it is generally accepted that defective 
reconstruction of connective tissue by fibroblasts/myofibroblasts in pathological states 
leads to tissue deformation that characterises many pathological fibroses (Hinz and 
Gabbiani, 2003a). In addition, due to loss of tissue functionality associated with scar 
formation and fibrosis, concerted efforts are being made to understand mechanisms 
that regulate fibroblast functions and might be targets for anti-fibrotic treatments 
(Wilson et al., 1971, Darby and Hewitson, 2007). The involvement of several autocrine 
and paracrine factors, matrix interactions, mechanical stimuli (tension) and cell to cell 
interactions in fibroblast function have been defined over the years, with particular 
focus on their involvement of fibroblast to myofibroblast differentiation which is 
appreciated as a major event in scar formation and fibrosis.  
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Fibroblasts are embryologically of mesenchymal origin and display a spectrum of 
phenotypes including non-contractile fibroblasts, semi-contractile proto-myofibroblasts 
and contractile myofibroblasts (Tomasek et al., 2002). The contractile phenotypes are 
mostly evident following activation by cytokines, extracellular matrix (splice variant 
fibronectin) and mechanical stimuli present in different physiological and pathological 
states including wound healing, fibrosis and tumourigenesis (Hinz et al., 2007, 
Desmouliere et al., 1993, Darby et al., 1990, Schmid et al., 1998, Serini et al., 1998, 
Tomasek et al., 1992). In addition to the contractile features of activated fibroblasts, 
prototypical myofibroblasts are further distinguished by their expression of contractile 
actin stress fibres, these are composed of alpha smooth muscle actin (αSMA), linked in a 
linear fashion through transmembrane fibronexus junctions to protruding filamentous 
fibronectin fibres (Singer et al., 1985, Desmouliere et al., 1993). Myofibroblasts are 
further distinguished from smooth muscle cells predominantly by their lack of 
expression of smooth muscle cell markers including desmin and smooth muscle cell 
heavy chain myosin. Specific fibroblast markers are problematic but may include 
fibroblast specific protein-1 (FSP-1) first suggested by the Neilson group (Strutz et al., 
1995) 
 
Following tissue insult, fibroblasts infiltrate the provisional matrix from local 
mesenchymal connective tissue and bone marrow derived circulating progenitor 
lineages in response to released inflammatory factors (Leibovich and Ross, 1975, Abe et 
al., 2001). Furthermore, epithelial mesenchymal transition (EMT), a well-defined origin 
of fibroblasts from differentiated epithelial cells in non cutaneous tissue repair, has 
been proposed as a source of fibroblasts in cutaneous wound repair. Briefly, EMT 
requires the organised dedifferentiation of epithelial cells through loss of polarity, 
adherence to underlying basement membrane and tight junctions (Clark, 1996).  Recent 
reports described EMT in human skin wound healing by induction of bone morphogenic 
protein-2 (BMP-2) through addition of exogenous TNFα to grafted explants (Yan et al., 
2010). However, whether this occurs in vivo and how much EMT contributes to the 
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fibroblast/myofibroblast population in wound healing and fibrosis in human skin 
remains contentious.  
 
To repopulate the damaged tissue, quiescent fibroblasts from local and circulatory 
origins become activated in response to matrix substrates (fibronectin) and growth 
factors deposited in the wound by inflammatory and resident cells, acquiring a 
migratory phenotype with cytoplasmic actin but only partial contractile ability (photo-
myofibroblast) (Hinz and Gabbiani, 2003b). Fibroblast adhesion to and migration on 
matrix also requires expression of appropriate integrin receptors for the variety of 
substrates encountered in the evolving matrix including fibronectin and type I collagen 
(Hakkinen et al., 1994, Saalbach et al., 1997).  As fibroblasts migrate to the wound 
centre they replace provisional matrix with granulation tissue matrix (mostly type I and 
III collagen) whilst simultaneously releasing proteolytic factors and their inhibitors which 
ensures an organised formation of granulation tissue through deposit and remodelling 
(Clark, 1996). Furthermore, autocrine and paracrine factors released by activated 
fibroblasts take over from overlapping inflammatory-derived factors becoming the 
central regulators of subsequent proliferation and tissue remodelling events (Denton et 
al., 2009). With increasing mechanical tension generated by tissue remodelling, 
mechano-perception via cell-matrix junctions (fibronexis and focal adhesions) become 
activated causing protomyofibroblasts to further differentiate into myofibroblasts 
characterized by expression of α-SMA (Tomasek et al., 1992, Singer et al., 1985, Hinz et 
al., 2003). In addition to tension, the joint actions of TGFβ1 and fibronectin splice variant 
ED-A are also required for this phenotypic change (Serini et al., 1998, Desmouliere et al., 
1993).  
 
Importantly, the presence of myofibroblasts in most physiological and pathological 
states of wound repair is accompanied by excessive production of collagenous 
extracellular matrix (Hinz et al., 2007). An exception to this is fetal wound healing which 
proceeds while maintaining a tight balance between matrix production and remodelling 
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by fibroblasts leading to complete matrix resolution and “scarless healing” (Rolfe et al., 
2005).  The over stimulation and persistence of myofibroblast in response to cytokines 
and growth factors is accepted as a key mechanism by which the balance between 
matrix synthesis and degradation is lost leading to the development of scar tissue and 
ongoing, often irreversible fibrotic disease (Schmid et al., 1998).  
 
Cutaneous wound healing involves transient expression of αSMA  and contraction by 
tissue myofibroblasts which later disappear through massive apoptosis resulting in a loss 
of cellularity, formation of mature scar tissue and some loss to tissue functionality 
(Desmouliere et al., 1995, Darby et al., 2002, Darby et al., 1990). However, in extensive 
burn wound repair, myofibroblast activity persists and leads to hypertrophic scarring 
and tissue deformation, characterized by excessive matrix bundles and fibrotic tissue 
contractures (Ehrlich et al., 1994). Detrimental loss of tissue function is characteristic of 
fibrosis affecting vital organs where myofibroblast-generated contractures and over 
production of collagenous matrix is evident; examples include idiopathic lung fibrosis, 
various forms of liver fibrosis including cirrhosis and renal (interstitial) fibrosis (Phan, 
2002, Lan, 2003, Desmouliere et al., 2003).          
 
1.4.4.1.  Growth factors and fibroblast-myofibroblast function 
Fibroblast activity during wound repair is initially regulated by matrix composition and a 
range of growth factors and cytokines mostly released into provisional matrix by 
preceding inflammatory as well as resident mesenchymal cells (Leibovich and Ross, 
1975, Leibovich and Ross, 1976, Mirza et al., 2009). Active growth factors initiate the 
chemotaxis of fibroblasts from local mesenchyme and progenitor cell sites, while latent 
factors sequestered in the new matrix can be activated later to regulate fibroblast 
function as they populate the wound tissue (Clark, 1996, Blakytny et al., 2004, Wipff et 
al., 2007, Murphy-Ullrich and Poczatek, 2000, Munger et al., 1999). Furthermore, as 
fibroblasts become activated they begin to release soluble factors in an autocrine and 
paracrine fashion allowing regulation of their own functions as well as those of other 
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wound repair cells such as vascular endothelial cells and keratinocytes (Clark, 1996, 
Denton et al., 2009). Eventually, fibroblast-derived factors take over from inflammatory 
cytokines in the regulation of granulation tissue formation and its subsequent 
remodelling. Over the years a variety of growth factors and their cognate receptors, 
with specific and overlapping effects on fibroblasts function and wound repair have 
been identified. The most well-defined include growth factors belonging to the family of 
PDGFs, FGFs, and TGFβs. Furthermore, growth factors from the connective tissue 
growth factor/cysteine-rich 61/nephroblastoma over-expressed (CNN) family as well 
pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumour necrosis factor alpha 
(TNF-α) have gained increasing importance in the regulation of fibroblast function.  
 
PDGFs comprise of a family of homodimeric or heterodimeric growth factors including 
PDGF-AA, PDGF-AB, PDGF-BB, PDGF-CC and PDGF-DD which exert their effect through 
tyrosine kinase receptors comprised of homo or heterodimers of α- and β-chains 
(Werner and Grose, 2003). The α-chain displays high affinity for all PDGF isoforms while 
the β has a high affinity for PDGF BB (Heldin and Westermark, 1999). PDGF is one of the 
first growth factors deposited by degranulating platelets and is proposed to be a key 
factor in granulation tissue formation (Senior et al., 1983). PDGF receptors are 
expressed in many wound cell types and it is suggested that it mostly operates in a 
paracrine fashion (Singer and Clark, 1999). Dermal fibroblasts are one of the major 
target cells of PDGF in the initiation and propagation of wound healing in the skin 
(Senior et al., 1983). Migration of dermal fibroblast is significantly enhanced by addition 
of exogenous PDGF-BB and to a lesser extent by the PDGF AB isoform in vitro (Siegbahn 
et al., 1990). Furthermore, application of PDGF-BB in cutaneous wound healing induces 
the influx of inflammatory cells and fibroblasts, stimulates fibroblast proliferation and 
granulation tissue formation (Pierce et al., 1989)(Pierce et al., 1991).  
 
Deletion of PDGFR-β gene retards key dermal fibroblast functions including migration, 
proliferation and survival (Gao et al., 2005). Lethality in PDGF-BB and PDGFR-β 
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homozygous mice has restricted a full determination of the role of endogenous PDGF on 
fibroblast function in a wound healing scenario (Sariano p 1994 and Leveen P, 1994). 
However, mice generated from the blastocyst chimeras that contain both wild type and 
PDGFR-β null cells show a significant reduction in the contribution of PDGFR-β null 
dermal fibroblasts in the formation of the granulation tissue following subcutaneous 
injury (Crosby et al., 1999).  
 
Importantly, augmented PDGF levels have been linked with a variety of wound healing 
disorders.  PDGF ligand and receptor expression is reduced in age- and diabetes-related 
forms of impaired healing which further supports its role in fibroblast function and 
granulation tissue formation in normal healing (Beer et al., 1997, Ashcroft et al., 1997). 
Consequently, treatment of impaired wound healing defects with PDGF has had 
beneficial effects in clinical trials and its use is now approved for the treatment of 
human diabetic ulcers (Nagai and Embil, 2002). In contrast, augmented PDGF 
production might also be involved in the pathogenesis of various fibroproliferative 
disorders. Examples of this include hypertrophic and keloid scars, which both show 
elevated levels of PDGF expression, which may be a contributing factor in the over-
stimulation of fibroblast proliferation and production of collagenous matrix in these 
disorders (Haisa et al., 1994, Niessen et al., 2001).      
      
As mentioned earlier, FGFs are heparin binding mitogenic proteins suggested to play an 
important role in angiogenesis (see section 1.4.2.1). In addition to their angiogenic and 
re-epithelialising stimulatory effects, the importance of FGFs in the chemotaxis and 
regulation of fibroblast function including matrix production and remodelling during 
wound repair is demonstrated through a variety of models. For example, constitutive 
release of anti-FGF2 neutralising antibodies from subcutaneously implanted polyvinyl 
alcohol sponges showed a striking reduction in cellularity, vascularization of granulation 
tissue and collagen levels in normal wound healing, suggesting that endogenous FGF2 
plays an important role in wound healing (Broadley et al., 1989). Furthermore, 
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exogenous application of FGF2 accelerates granulation tissue formation in impaired 
wound disorders such as ischaemic and diabetic wounds, by increasing fibroblast 
proliferation and collagen accumulation independently as well as synergistically with 
TGFβ (Uhl et al., 1993, Tsuboi and Rifkin, 1990, Broadley et al., 1988).  
 
In addition to promoting granulation formation by fibroblasts FGF2 appears to be a 
negative regulator of the myofibroblast phenotype. Single application of FGF2 on 
cutaneous wounds antagonises fibroblast to myofibroblast transition, accelerates 
granulation tissue remodelling, restores tensile strength and improves scar outcome 
(Spyrou and Naylor, 2002). Furthermore, artificial dermal transplants lined with FGF2 
showed reduced α-SMA-positive cells and increased myofibroblast apoptosis (Akasaka 
et al., 2007). Moreover, administration of FGF2 induces down-regulation of α-SMA and 
accelerates myofibroblast apoptosis in open skin wounds (Ishiguro et al., 2009).  
 
Surprisingly, while most FGFs seem to be increased following injury and their 
applications appear to modulate different fibroblast functions associated with wound 
healing such collagen synthesis and remodelling, they appear to be mostly dispensable, 
as evidenced by a lack of wound phenotype in a number of FGF null wound healing 
models, including FGF1 and FGF7(aka KGF) which are thought to be important in wound 
healing (Miller et al., 2000, Guo et al., 1996). Moreover, FGF2 null mice show a partial 
but significant delay in wound healing characterised by reduced production of 
collagenous matrix and delayed wound contraction (Miller et al., 2000). Functional 
redundancies and structural similarities between FGF family members have been 
implicated in the lack of phenotype following single gene deletions. Consequently, it is 
not surprising that mutation of FGFR2IIIb, a receptor for several FGF isoforms causes a 
severe impairment to wounding healing (Werner et al., 1994).  
 
Interleukin 6 (IL-6) is an important pro-inflammatory cytokine and its expression is 
strongly increased during the inflammatory phase of dermal wound healing (Grellner et 
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al., 2000). IL-6 is detected in wound fluid and its expression is detected in a variety of 
cell types within cutaneous wounds including neutrophils, macrophages and fibroblasts 
(Peteiro-Cartelle and Alvarez-Jorge, 1999, Gillitzer and Goebeler, 2001). Although the 
role of IL-6 during wound healing is mostly to induce leukocyte infiltration, there is a 
growing body of evidence that suggests that it might also directly and indirectly regulate 
some fibroblast functions. For example, in culture recombinant IL-6 induces pro-
collagen gene expression and directly induces collagen production in adult human 
dermal fibroblasts (Duncan and Berman, 1991). Furthermore, IL-6 knockout mouse 
wounds show reduced TGFβ-1 gene expression which correlates to delayed deposition 
of collagenous matrix implying an indirect effect of IL-6 on fibroblast function through 
the induction of TGFβ1 (Gallucci et al., 2000). In addition, IL-6 can directly induce and 
inhibit α-SMA expression in dermal fibroblast cultures in a dose-dependant manner 
(Gallucci et al., 2006). Surprisingly however, IL-6 knockout mice show reduced wound 
contraction despite early augmentation of α-SMA expression in comparison to wild type 
littermates (Gallucci et al., 2000). The mechanism underlying dysregulated expression of 
α-SMA in this phenotype is still not clear but suggests that IL-6 might be important in 
preventing early differentiation of fibroblasts during wound healing. It is plausible that 
reduced TGFβ1 and reduced mechanical tension due to reduced cellularity and reduced 
granulation tissue formation are a contributing factor in delayed wound contraction of 
IL-6 knockout mice , despite their elevated expression of α-SMA. Overall these studies 
demonstrate that IL-6 can regulate important fibroblast functions including collagen 
production and α-SMA expression which are highly relevant in both wound healing and 
fibrotic diseases. Further characterisation of IL-6 in functional assays such as matrix 
contraction studies might also be useful in defining its effects on myofibroblast 
phenotypic  modulation.                        
 
CTGF is a matricellular protein that contains 38 conserved cysteine residues that is 
characteristic of members belonging to the CNN family (Werner and Grose, 2003). CNN 
members are involved in embryonic development and gene deletion or global 
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inactivation of CTGF leads to defective endochondral bone formation, respiratory failure 
and perinatal lethality (Kawaki et al., 2008). In addition to its developmental roles, CTGF 
has emerged as an important regulator of cell proliferation, migration, differentiation, 
angiogenesis, matrix production and cell adhesion during physiological conditions such 
as wound repair as well as pathological states such as fibrosis and tumourigenesis. 
 
 In the unwounded dermis, CTGF expression is undetectable and only induced following 
insult (Igarashi et al., 1993). In normal cutaneous wound healing, CTGF is markedly 
increased by TGFβ-activated fibroblasts in the granulation tissue, where it is suggested 
to regulate proliferation and extracellular matrix production (Igarashi et al., 1993). 
Furthermore, CTGF is an important downstream inducer of TGFβ-mediated effects. In 
mice, subcutaneous injection of TGFβ1 results in increased CTGF expression in dermal 
fibroblasts and induces fibrosis at the site of injection (Frazier et al., 1996).  Comparable 
effects can be observed after subcutaneous injection of CTGF (Frazier et al., 1996).  
 
Importantly, over-expression of CTGF is observed in a variety of chronic fibrotic 
disorders affecting multiple organs including skin, liver and kidney.  In skin, persistent 
over-expression of CTGF is observed in biopsies of keloid scars and hypertrophic lesions 
(Igarashi et al., 1996). While in culture, dermal fibroblasts derived from keloids and 
hypertrophic lesions show increased basal expression of CTGF as well as augmented 
CTGF expression in response to TGFβ (Shi-wen et al., 2000, Colwell et al., 2005) 
 
The role of CTGF in cutaneous wound healing and fibrosis has also been tested using 
inhibition and depletion studies. In vitro CTGF induces matrix contraction of TGFβ1 
primed fibroblasts in the presence of mechanical tension through up-regulation of α-
SMA and attachment through increased MMP expression while inhibition of CTGF 
reduces these responses and subsequently reduces contraction (Daniels et al., 2003, 
Garrett et al., 2004). Furthermore in vivo, antisense inhibition of CTGF mRNA limits 
hypertrophy, reduces scarring and reduces myofibroblast persistence in the later phase 
Chapter 1 
a 
40 
of rabbit cutaneous wound healing (Sisco et al., 2008). Surprisingly, it does this without 
hampering or delaying early events such as re-epithelialisation and initial granulation 
tissue formation (Sisco et al., 2008). Taken together, this data suggests CTGF is likely to 
be an important inducer of mid to late phase fibroblast functions in wound healing 
including myofibroblast differentiation, enhanced matrix production and wound 
contraction.  
 
TGF-β1 is released in large amounts by platelets and macrophages during the acute 
inflammatory phase of healing and is undoubtedly the most important regulator of 
fibroblast function during wound healing. In particular, its role in inducing production of 
collagenous matrix and growth factors, fibroblast to myofibroblast transition and 
granulation tissue remodelling have been convincingly demonstrated over the years 
through addition and depletion studies. 
 
TGFβ1 is pivotal to chemotaxis, collagen production and subsequent formation of 
granulation tissue by fibroblasts. This was first demonstrated by application of TGFβ1 to 
normal skin and its induction of rapid fibrosis with massive invasion by inflammatory 
cells, endothelial cells and fibroblasts with excessive collagenous matrix production in 
vivo and in vitro (Roberts et al., 1986). Furthermore, healing of rodent cutaneous 
incisional wounds is accelerated by TGFβ1 in a dose dependant manner and is evident 
through increased infiltration of macrophages and fibroblasts, increased tensile strength 
and increased collagen deposition (Mustoe et al., 1987). Exogenous TGFβ has also been 
used  to augment healing in impaired wound disorders such as diabetic wounds by 
restoring collagen content of granulation tissue and improving tensile strength of the 
tissue (Broadley et al., 1988).  
 
It is generally accepted that fibroblast to myofibroblast transformation is a key event in 
the physiological reconstruction of collagenous matrix after injury and it is also 
implicated in the generation of deformations that characterise fibrosis (Gabbiani, 2003). 
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In normal cutaneous wound healing, transient expression of αSMA correlates to 
fibroblast-myofibroblast transition and wound contraction (Darby et al., 1990). However 
in fibrotic disorders αSMA expressing myofibroblasts persistent for long periods and are 
associated with increased fibrosis and detrimental tissue contractures (Schmid et al., 
1998). TGFβ1 is central to the myofibroblast phenotype through its ability to induce de 
novo expression of αSMA in granulation tissue fibroblasts and quiescent fibroblasts both 
in vivo and in vitro (Desmouliere et al., 1993, Serini and Gabbiana, 1996, Montesano and 
Orci, 1988). These findings implicate TGFβ1 in wound contraction and retractile 
phenomena observed during fibrotic diseases.  
    
The importance of endogenous TGFβ1 in fibroblast function during wound healing has 
been demonstrated in several inhibition and deletion studies. For example, 
neutralisation of endogenous TGFβ1 with antibodies in rodent cutaneous incisional 
wounds has been shown to reduce granulation tissue formation and overall scarring 
(Shah et al., 1995). Paradoxically in this incisional model, healing is not delayed and 
tensile strength remained unaffected implying that the net effect of endogenous TGFβ1 
was on scar formation and not the rate of healing. In contrast, marked delays in 
granulation tissue formation and wound contraction are observed in immunodeficient 
TGF-β1 null mice excisional wound models (Crowe et al., 2000) . Additionally, selective 
deletion of TGFRII in dermal fibroblasts results severe abnormalities during wounding 
with diminished fibrillar collagen and granulation matrix deposition, impaired 
myofibroblasts transition and reduced contraction (Denton et al., 2009). While in culture 
TGFβRII null mouse fibroblasts fail to migrate, contract lattices or express de-novo α-
SMA following addition of exogenous TGFβ (Denton et al., 2009). Inhibiting TGFβ and its 
signalling cascade is viewed as an important strategy for treatment of fibrotic disorders. 
For example, limiting of TGFβ receptor binding  though retroviral delivery of a dominant 
negative TGFRII has been shown to reduce scar hypertrophy in scarring rodent models  
(Reid et al., 2007). Furthermore, temporal neutralisation of TGFβ1 and 2 with their 
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cognate monoclonal antibodies has been shown to reduce hypertrophic scarring in a 
rabbit ear cutaneous model (Lu et al., 2005) 
 
It is also well accepted that TGFβ augments the direct and indirect expression of 
fibroblast-derived paracrine and autocrine factors as well as their cognate receptors on 
different cell types to regulate a variety of wound healing events including angiogenesis 
and re-epithelialisation. For example, activation or over-expression of SMAD3, a 
downstream effector of TGFβ signalling, in dermal fibroblasts has been shown to up-
regulate the release of VEGF and augment expression of FGF-2 receptors in vitro and to 
accelerate wound healing in dermal ulcer models by increasing angiogenesis and re-
epithelialisation (Sumiyoshi et al., 2004). Furthermore, TGFβ1 up-regulates VEGF release 
by dermal fibroblasts in temporal micro-environments such as hypoxia, which in vivo is 
likely to have an additive effect on angiogenesis during wound repair and also in fibrotic 
diseases where hypoxia is common (Berse et al., 1999).  In addition to VEGF, TGFβ1 
induces the expression and release of autocrine CTGF in fibroblasts which augments 
their proliferation and their extracellular matrix synthesis, a process that has been 
linked to several fibrotic disorders as well as having a role in normal wound healing 
(Frazier et al., 1996).  Importantly, TGFβ1 induces further expression of TGFβ1 and its 
cognate receptors in dermal fibroblasts resulting in an autocrine loop, a mechanism that 
extends and amplifies its action during the repair process (Van Obberghen-Schilling et 
al., 1988). In normal wound healing TGFβ auto induction may be useful in enhancing 
angiogenesis and granulation tissue formation while later, in scar resolution, there is 
loss of TGFβ over-expressing fibroblasts through apoptosis (Desmouliere et al., 1995, 
Schmid et al., 1998). In contrast, augmented TGFβ receptor expression and persistent 
autocrine induction of TGFβ1 is viewed as an important mechanism by which 
myofibroblast survival and activity is prolonged in fibrotic lesions, including hypertrophic 
scars, where excessive production of collagenous matrix and poor resolution of 
granulation tissue is  observed (Schmid et al., 1998). Additionally, impaired forms of 
wound healing, such as chronic wounds, show aberrant TGFβ signalling, decreased TGFβ 
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receptor expression in fibroblasts and impaired granulation tissue formation, implying 
that reduced auto-induction by TGFβ is a possible mechanism in the pathogenesis of 
impaired healing (Kim et al., 2003, Wu et al., 1999).   
 
1.4.4.2. Fibroblasts, integrins and the extracellular matrix  
The function of fibroblasts during wound healing and fibrosis is critically influenced by 
their ability to interact with the extracellular matrix, a process mediated through cell-
surface expressed matrix receptors (integrins)(Clark, 1996). Integrins are transducers of 
signals from outside into the cells and vice versa that regulate cell adhesion, migration, 
proliferation and differentiation as well as extracellular matrix remodelling (Thannickal 
et al., 2003, Clark, 1996), as discussed above in sections on re-epithelialisation and 
angiogenesis. Integrins can modulate the signalling cascade elicited by several growth 
factors through activation of intracellular pathways and influence cell function 
(Thannickal et al., 2003). Furthermore, integrins play a critical role in the activation of 
latent growth factors sequestered in the extracellular matrix as well as the activation of 
some growth factor receptors (Asano et al., 2005b, Wipff et al., 2007, Margadant and 
Sonnenberg, 2010). The role of integrins during myofibroblast differentiation and 
activation of latent TGFβ during wound healing and fibrosis has been especially studied 
over the years.         
 
Granulation tissue fibroblasts differentially express integrins depending on the matrix 
substrate present as the wound heals (Saalbach et al., 1997). Following injury, the 
events of the coagulation cascade result in a provisional matrix rich in fibronectin which 
provides the initial anchorage for infiltrating wound repair cells (Clark et al., 1982a, 
Laurens et al., 2006). Adhesion and migration of fibroblasts on fibronectin during the 
early phase of wound healing is mediated through increased expression of fibronectin 
receptor α5β1 (Saalbach et al., 1997). As healing proceeds, collagen becomes the 
predominant substrate and  granulation tissue fibroblasts show reduced functionality of 
α5β1 integrins and weakened interactions with fibronectin (Hakkinen et al., 1994).  
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Granulation tissue fibroblasts increase their expression of collagen binding receptors 
α1β1 and α2β1 integrins to establish collagen contacts (Saalbach A, 1997).  
 
As tension in the granulation tissue develops, with increasing fibroblasts matrix 
deposition and remodelling, fibroblasts differentiate into myofibroblasts through 
expression of de novo α-SMA and the granulation tissue contracts (Darby et al., 1990). 
Integrins play a critical role in mechano-perception by acting as link between 
extracellular matrix and focal contacts (Hinz et al., 2003). Mechanical forces act on focal 
contacts and together with TGFβ and ED-A fibronectin splice variant, lead to expression 
and incorporation of α-SMA (Desmouliere et al., 1993, Serini et al., 1998, Serini and 
Gabbiana, 1996). Loss or inhibition of integrins impairs tension induced activation of the 
myofibroblast. For example, blockade of α2 and β1 subunits with respective antibodies 
abrogates TGFβ1 induced α-SMA expression in fibroblasts seeded under tension (Arora 
et al., 1999). Furthermore, mice with fibroblast-specific deletion of integrin β1 subunit 
show delayed cutaneous wound closure, less granulation tissue formation and reduced 
fibroblast to myofibroblast differentiation (Liu et al., 2010). 
 
In addition to cell to matrix interactions, integrins play an important role in the 
activation of latent growth factors. In wound healing and fibrosis activation of latent 
TGFβ by fibroblast and myofibroblast integrins occurs through both a protease 
dependant and protease independent manner (Wipff and Hinz, 2008, Margadant and 
Sonnenberg, 2010). Integrin-dependant protease activation of TGFβ involves association 
of αV containing integrins with TGFβ latency complex and recruitment of MMPs (MMP2 
and MMP9) to release TGFβ through proteolytic cleavage (Wipff and Hinz, 2008). In 
fibrotic disorders such as scleroderma, high amounts of active TGFβ are apparent and 
fibroblasts show increased integrin expression and enhanced cell surface proteolytic 
activity through MMPs (Asano et al., 2005a). Inhibition of integrins including αVβ3 
reduces MMP expression and levels of active TGFβ (Asano et al., 2005b) while antibody 
antagonists of αVβ3 specifically inhibited granulation tissue formation in a transient 
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manner in porcine cutaneous wound healing (Clark et al., 1996). Integrin related 
protease independent activation of TGFβ can occur mechanically via integrin-mediated 
cell contraction. In vitro, the force generated by contracting myofibroblasts can exert 
conformation changes on the latent TGFβ complex bound by integrins (αVβ5, α8β1 and 
αVβ3) and cause mechanical release of active TGFβ (Wipff P, 2007). Conversely,  
inhibition of these integrins or loss of tension reduces TGFβ activation (Wipff P, 2007).  
 
The relevance of integrin-dependent activation of TGFβ has been demonstrated in αV 
and β1 subunit null mice. Mice lacking αVβ6 and αVβ8 mirror abnormalities  
characteristic of TGFβ 1, 3 null mice including cleft palates, severe autoimmunity 
syndrome and loss of Langerhans cells (Aluwihare et al., 2009).  Targeted deletion of β1 
subunit in fibroblasts using Cre-lox systems caused significant reduction in activation of 
latent TGFβ1 by fibroblasts causing delayed closure and reduced granulation tissue 
formation in cutaneous wound healing in mice (Liu et al., 2010).  
 
1.4.4.3. Hypoxia modulates fibroblast function 
Tissue hypoxia is considered to be a major signal that initiates and regulates angiogenic 
responses in physiological and pathological conditions including normal and abnormal 
wound healing. Cellular adaptive responses to hypoxia are mediated mostly by HIF-1, 
which induces transcriptional responses that include expression of a variety of proteins 
that enable survival and function of hypoxic cells (Semenza, 2010). Response to hypoxia 
and activation of HIF-1 pathways by wound repair cells is critical for normal wound 
healing, so much so that failure to do so, contributes to impaired wound healing 
(Botusan et al., 2008, Zhang et al., 2010b). Additionally, sustained HIF-1 accumulation in 
fibroblastic cells represents an important mechanism in the pathogenesis of several 
fibrotic disorders. Over the years the role of HIF-1 and hypoxia on fibroblast function has 
been partially defined, particularly in the context of fibroblast cell migration, 
collagenous matrix production, fibroblast to myofibroblast differentiation and the 
release of paracrine and autocrine factors.   
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Acute hypoxia in the early phase of healing has been determined through direct PO2 
measurement and immunochemical assay (pimonidazole) in normal wound healing and 
correlates to an increase in expression of HIF-1 and downstream targets such as the  
glucose transporter -1 (Elson et al., 2000, Lokmic et al., 2006, Remensnyder and Majno, 
1968). In culture acute hypoxia (0 to 72 hrs) enhances several fibroblast functions 
including migration, proliferation and production of collagenous matrix through up-
regulation of TGFβ1 responses (Falanga and Kirsner, 1993, Falanga et al., 2002, Siddiqui 
et al., 1996, Steinbrech et al., 1999). Accumulating evidence point to a strong correlation 
between HIF-1 stabilisation and TGFβ signalling during enhanced fibroblast function in 
hypoxic tissue. Indeed increased HIF-1 signalling enhances fibroblast expression of 
matrix proteins (collagens and fibronectin), growth factors (TGFβ, CTGF, and VEGF) and 
TGFβ1 activating factors (thrombospondin-1) (Distler et al., 2007, Higgins et al., 2004). 
The relevance of HIF-1 in the regulation of these factors during hypoxia has been 
convincingly tested using HIF-1 depleted or inhibited fibroblasts (Distler et al., 2007, 
Higgins et al., 2004). The evidence suggests that HIF-1 is important in the regulation of 
dermal fibroblast function during angiogenesis and granulation tissue formation, events 
that occur under relatively hypoxic conditions. Indeed, recent studies of cutaneous burn 
wound healing in HIF1α heterozygous null mice showed a significant reduction in wound 
vascularization, perfusion and granulation tissue contraction (Zhang et al., 2010b).  
 
In contrast to acute hypoxia, chronic ischaemia (not anoxia) has a net inhibitory effect 
on some pivotal fibroblast functions in the skin. In a cutaneous wound in an ischaemic 
limb model, persistent hypoxia was shown to reduce production of collagenous matrix 
and retard granulation tissue formation as well as impair αSMA expression and reduce 
contraction (Alizadeh et al., 2007). In culture, persistent hypoxia reduces collagen 
synthesis, αSMA expression, contractile ability and increases cell survival, which are 
pivotal elements required for effective wound healing and remodeling (Modarressi et 
al., 2010, Siddiqui et al., 1996). Re-oxygenation is shown to reverse the effects of 
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chronic hypoxia and restore αSMA expression and matrix production in vitro 
(Modarressi et al., 2010, Siddiqui et al., 1996). This adds support to the use of 
hyperbaric oxygen in the treatment of some ischaemic wounds. Impaired TGFβ 
signalling is proposed as one of the mechanisms behind these hypoxia-induced defects 
(Modarressi et al., 2010). Indeed, fibroblasts from chronic ischaemic wounds show 
reduced TGFβ signalling, decreased TGFRII expression and unresponsiveness to stimuli 
from TGFβ1 (Kim et al., 2003). Ischaemia has also been suggested to reduce peptide 
growth factor receptor binding (Falanga et al., 1994). That said, it is still unclear how 
TGFβ signalling is impaired by persistent hypoxia, in the absence of complications 
associated with age and diabetes, and where hypoxic conditions cause HIF-1α 
stabilisation. It is conceivable that severe hypoxic conditions, such as chronic hypoxia 
and anoxia, induce HIF-1α stabilisation but repress HIF-1 transcription activity (Schmid 
et al., 2004). It is therefore tempting to speculate that the reduced fibroblast activity 
during chronic hypoxia is also in part due to HIF-1 transcriptional repression.  
 
Impaired healing in aged and diabetes-associated wounds has been linked with 
defective responses to hypoxia. Briefly, dermal fibroblasts from aged patients show 
delayed migration in hypoxia and impaired TGFβ signalling in comparison to fibroblasts 
from young patients (Mogford et al., 2002). Furthermore, TGFβ1 shows a failure to 
stimulate healing in aged mice but stimulates healing in young mice with chronic 
ischaemic wounds (Wu et al., 1999). Growing research now indicates that impaired 
healing in aged and diabetic ischaemic wounds is partly caused by defective HIF-1 
signalling and a reduced ability to respond to local tissue hypoxia (Botusan et al., 2008). 
Indeed, hyperglycaemia has been shown to impair HIF-1 stability and cellular function in 
primary dermal fibroblasts and endothelial cells (Catrina et al., 2004). Additionally, HIF-
1α gene transcription is impaired in dermal fibroblasts of aged mice resulting in delayed 
angiogenic responses in ischaemic wounds (Loh et al., 2009). Defective granulation 
tissue formation and delayed dermal regeneration in diabetic mice wound models were 
also improved by preventing hydroxylation and thus increasing stabilisation of HIF-1α 
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(Botusan et al., 2008). Lastly, constitutive expression of HIF-1 through gene therapy has 
been shown to improve wound healing in aged diabetic mice (Liu et al., 2008). 
 
Fibrotic disorders characteristically develop chronic tissue hypoxia due to microvascular 
occlusion and high oxygen consumption (Kischer et al., 1982, Ichioka et al., 2008). In 
skin, this is observed in scarring disorders including keloids, hypertrophic lesions and 
scleroderma (Kischer CW, 1982)(Silverstein Jl, 1988). The persistence of myofibroblasts, 
augmented expression of growth factors (TGFβ1 and VEGF), their cognate receptors 
(TGFβRI / II and VEGFR) and excessive production of collagen matrix and tissue inhibitor 
of metalloproteinase (TIMP-1) are key features of skin fibrotic disorders. Increasing 
evidence now demonstrates that hypoxia through HIF-1 induction may be a contributing 
factor in the pathogenesis of certain fibrotic disorders. For example, accumulation of 
HIF-1 protein is observed in biopsies and cells from keloid scars and scleroderma 
suggesting a possible link between hypoxia and unregulated behaviour of fibroblastic 
cells in fibrotic disorders (Distler, 2007) (Zhang, 2003). In keloids persistent hypoxia up-
regulates plasminogen activator inhibitor-1 (PAI-1) in a HIF-1-dependent manner in vitro 
and in vivo, correlating to excessive production of matrix by dermal fibroblasts (Zhang, 
2003). Using fibroblasts from scleroderma patients and mice treated with long-term 
hypoxia, HIF-1 is shown to up-regulate expression of collagenous matrix and TGFβ1 
while abrogation of HIF-1 or TGFβ1 inhibits the hypoxia-induced expression of 
extracellular matrix (Distler, 2007). The role for HIF-1 in the pathogenesis of fibrotic 
disease has been further supported by the discovery HIF-1α gene polymorphisms in 
systemic sclerosis cases of a French European Caucasian population (Wipff J, 2009). 
Additionally, chronic hypoxia and augmented HIF-1 accumulation in fibroblasts of non-
cutaneous organs is considered to be an important mechanism in the pathogenesis of 
fibrosis including liver cirrhosis and kidney fibrosis. Furthermore, selective and tissue 
specific deletion of HIF-1α in liver using a Cre-lox system has been shown to reduce liver 
fibrosis through reduced myofibroblast transformation, reduced expression of PDGF and 
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PAI-1 and reduced production of collagenous matrix following bile duct ligation (Moon 
et al., 2009).    
 
Overall, local relative hypoxic gradients and HIF-1 in normal healing are likely to be 
important for maintaining good angiogenic responses and granulation tissue formation 
by potentiating several fibroblast functions such as migration, proliferation, survival, 
growth factor release and matrix synthesis in the early phases of healing. Failure to 
respond to hypoxic stimuli, due to HIF deficiency, (as seen in age- and diabetes-related 
wounds) plausibly propagates chronic hypoxia, which appears to be detrimental to 
some dermal fibroblast functions such TGFβ signalling, matrix production and 
myofibroblast transformation. In contrast, chronic hypoxia and consistent HIF 
accumulation in fibrotic disease appears to potentiate the actions of fibroblasts causing 
increased myofibroblast differentiation and excessive matrix production. The 
susceptibility to fibrotic disease may also be higher in populations with an increased 
frequency of HIF-1α polymorphisms. Based on all the above, it would seem that 
targeting HIF-1 has several important clinical implications to tissue repair conditions 
where HIF-1 is impaired, deficient or over-expressed by fibroblastic cells.  
 
1.5. Remodelling and scar formation  
Once the granulation tissue has spread evenly across the wound site, the remodelling 
phase of wound repair begins. Remodelling is characterised by contraction of the 
granulation tissue, degradation of collagen and a significant loss in cellularity in the 
wound bed, the net result of which is a scar (Darby et al., 2002, Gabbiani et al., 1971, 
Desmouliere et al., 1995). Myofibroblasts expressing contractile actin (αSMA) align 
parallel to the direction of mechanical tension by adhering to collagen through focal 
adhesion proteins and integrins (Darby et al., 1990, Tomasek et al., 2002, Tomasek et 
al., 1992, Hinz et al., 2003). Myofibroblasts also make fibronexus connections to each 
other(Singer et al., 1985) .  TGFβ1 in combination with fibronectin splice variant ED-A FN 
and mechanical stress, stimulate contraction of αSMA bundles which significantly 
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reduces the granulation area (Desmouliere et al., 1993, Serini et al., 1998). Following 
contraction αSMA positive myofibroblasts and vascular cell numbers in the granulation 
tissue are reduced by the induction of apoptosis(Desmouliere et al., 1995). An up-
regulation of iNOS (inducible nitric oxide synthase) which increases the production of 
free radicals in the granulation tissue may be one trigger for apoptosis (Darby et al., 
2002). Additionally, increased collagen degradation due to increased expression of 
MMPs coupled with reduced expression of TGFβ1 and metalloproteinase inhibitors 
(TIMP-1) is thought to further promote remodelling (Darby et al., 2002) and may induce 
apoptosis through loss of growth factor signalling and changes in cell adhesion. 
However, despite all the efforts in remodelling, adult mammalian full thickness wounds 
inevitably produce a scar.  
1.6. Abnormal wound repair 
Injurious events that create tissue loss give rise to the healing process that eventually 
leads to restoration of tissue integrity, albeit with some loss in function due to scar 
formation. Tissue repair is a highly orchestrated series of complex events which may be 
subject to several abnormalities.  These abnormalities can occur at different phases of 
wound repair and lead to different types of abnormal wounds. Clinically, abnormal 
wound healing manifests mostly as fibroproliferative disorders (keloid and hypertrophic 
scars) and chronic wounds (ulcers) (Clark, 1996). Fibroproliferative disorders are the 
result of an excessive or continual fibrogenesis response that outstrips the remodelling 
attempt (Craig, 1975). Fibroproliferative lesions are often painful, itchy and prone to 
develop into contractures (hypertrophic scar) which can impose severe restrictions to 
mobility and quality of life as well as social and psychological burdens. (Roseborough et 
al., 2004, Bayat et al., 2003). Chronic wounds are characterized by persistent 
inflammation, lacking a proliferative phase and increased proteolytic activity that 
prevents sufficient deposition of matrix components (Wilkinson et al., 1993, Palolahti et 
al., 1993). Chronic wounds can be painful, may smell and are often prone to infection 
which increases the risk of amputations (Cavanagh and Bus, Barron et al., 2007).  
 
Chapter 1 
a 
51 
Abnormal wounds are difficult to treat and often impose a significant financial load on 
global healthcare system mostly due to the massive amount of hours required for 
wound care (Sen et al., 2009). In developed countries alone, it has been estimated that 
1 to 2% of the population will experience a chronic wound during their lifetime, and 
with an aging population and increasing incidence of diabetes and obesity world wide, 
this figures are likely to increase sharply (Sen et al., 2009). In the US alone, the 
estimated costs cost of chronic wounding is in excess of 25 billion dollars (US) per 
annum. While in Australia chronic wounds are conservatively estimated to cost the 
healthcare system 500 to 600 million dollars per annum (Leach, 2004). In the US alone, 
the cost of anti-scarring drugs was conservatively estimated to be a 12 billion dollar (US) 
market (Sen et al., 2009). The cost of wound healing in general is only sure to rise with 
the increase global population and the rising cost of healthcare. Please refer to Figure 1-
2 for typical gross images of abnormal wounds.  
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a. b.
c. d.
e. f.
 
Figure 1-2. Representative gross images and histological images of typical abnormal 
wounds. (a.) Typical hypertrophic and (c.) keloid scars and (b.)(d.) their histology 
showing excessive amounts of disorganized collagen. (e.) Typical foot ulcer and (f.) 
histology showing poorly formed granulation tissue. Images were adopted from 
(a.)(b.)(Kokoska, 2010, Roseborough et al., 2004), (c.)(d.)(Berman, 2008, Sperling, 2010) 
and (e.)(f.)(Hichand, 2010, Moretti et al., 2009)    
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1.6.1. Hypertrophic and Keloids scars 
Hypertrophic and Keloid scars are defined as raised skin scars characterised by a 
constitutively active proliferation phase of wound healing with a structural makeup that 
is highly vascular, with excessive deposition, mostly of type I collagen (Craig, 1975, 
Rudolph, 1987, Bayat et al., 2003, Aarabi et al., 2007). There are clear histological and 
immunochemical differences between the two fibroproliferative lesions. Hypertrophic 
scars contain distinct collagen bundles and high cellular density of myofibroblasts, an 
important feature in provoking contractures around areas prone to mechanical stress 
such as joints (Ehrlich et al., 1994). Keloids deposit large amounts of thick disorganised 
collagen fibres and seldom contain α-SMA expressing fibroblasts or provoke contracture 
(Ehrlich et al., 1994). Keloids are further distinguished by their ability to breach the 
margin of the original lesion and aggressive growth often likened to (benign) tumours 
(Rudolph, 1987).  Keloids develop from small and large injuries and are particularly 
resistant to medical management, and are too aggressive for surgery owing to a high 
likelihood of recurrence (Rudolph, 1987). Hypertrophic scars may develop after deep 
and/or extensive cutaneous insults such as burns and surgical incisions and can be 
treated through grafting and surgical corrections.   
 
In normal cutaneous healing, the complete formation of granulation tissue marks the 
beginning of the remodelling phase achieved through rapid granulation tissue 
contraction, degradation of matrix and loss in cellularity through apoptosis (Gabbiani et 
al., 1971, Darby et al., 2002, Desmouliere et al., 1995). In contrast, fibroproliferative 
disorders show failure to resolve the connective tissue formation phase of normal 
healing. Fibroproliferative disorders are often multifactorial with a variety of underlying 
and secondary factors contributing to the wound healing defect. The underlying factors 
may include genetic predisposition and age, while secondary effects may include 
persistent auto-induction of growth factors, defective apoptotic pathways and increased 
tissue hypoxia (Schmid et al., 1998, Ladin et al., 1998, Kischer et al., 1982, Clark et al., 
2009).  
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The temporal expression of growth factors is important in orderly and organised 
regulation of event during wound healing and deregulated expression of growth factors 
can alter these orderly events resulting in abnormal wound healing. Biopsies of 
fibroproliferative lesions often show elevated levels of growth factors and their cognate 
receptors. (Schmid et al., 1998, Peltonen et al., 1991). For example, elevated levels of 
both TGFβ and its receptors (TGFβRI/TGFβRII) have been well defined and suggested to 
lead to increased auto-induction of TGFβ and excessive production of collagenous 
matrix (Peltonen et al., 1991, Schmid et al., 1998). Furthermore, increased auto-
induction of TGFβ in hypertrophic scars has been correlated to the persistence of the 
myofibroblast phenotype and the possible development of fibrotic contractures (Schmid 
et al., 1998). In addition to TGFβ, other elevated growth factors have been identified 
and include FGF2, VEGF, PDGF and CTGF, suggesting a possible synergetic effect of 
multiple growth factors in the development of excessive scarring disorders. (Jiang et al., 
2004, Haisa et al., 1994, Colwell et al., 2005). In cell culture, fibroblasts harvested from 
fibroproliferative lesions show increased sensitivity to growth factors and deposit 
increased amounts of collagen in comparison to normal dermal cells, which further 
supports an enhanced growth factor response paradigm in the development of these 
disorders (Haisa et al., 1994, Bettinger et al., 1996, Fujiwara et al., 2005, Colwell et al., 
2005).   
 
As mentioned above, in normal wound healing fibroblasts/myofibroblasts and 
endothelial cells undergo  massive apoptosis during the remodelling phases leading to a 
loss in cellularity (Desmouliere et al., 1995). However, in keloid scars and keloid 
fibroblasts in culture, focal dysregulation of p53 expression and up-regulation of Bcl-2 is 
proposed to produce a combination of increased cell proliferation and decreased cell 
death via apoptosis (Ladin et al., 1998).  
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Keloids appear to be prevalent amongst populations of darker skinned people. This is 
now supported by evidence demonstrating familial autosomal dominant inheritance 
amongst African populations (Clark et al., 2009). Links to vitamin D deficiency amongst 
coloured people have been postulated as possible reason for predisposition to keloids 
(Cooke et al., 2005). Vitamin D is a robust  endogenous anti-inflammatory agent, and 
due to high pigmentation, darker skinned individuals absorb less sunlight and 
metabolise less Vitamin D (Cooke et al., 2005). However, apart from evidence provided 
by one  in vitro study, demonstrating some beneficial effects of introducing Vitamin-D 
derivatives into keloid cells (Zhang et al., 2010a), there is little evidence to support 
causal effects of Vitamin-D in the pathogenesis of keloid scarring. 
 
Perivascular contraction by myofibroblasts and microvascular occlusion in hypertrophic 
scars and keloids lead to tissue hypoxia which has been suggested to be important in 
the pathogenesis of excessive scarring disorders (Kischer et al., 1982). Consistent 
elevation of HIF-1α protein levels are observed in keloid and scleroderma tissues 
compared with normal skin and has been linked with increases in fibrotic related factors 
such TGFβ1, thrombospondin-1, PAI-1 and VEGF (Zhang et al., 2003b, Distler et al., 
2007). It is also tempting to postulate that HIF-1α gene polymorphisms, which have 
been correlated to increased susceptibility in scleroderma (Wipff et al., 2009), may 
potentially be involved in increasing susceptibility to other fibroproliferative disorders 
such as keloid and hypertrophic scars.    
 
At present, fibroproliferative disorders have no cure and scarring is often permanent. 
Several treatments may be administered to manage and minimize the scarring outcome 
including anti-inflammatory drugs, glucocorticoid steroids, occlusive dressings 
containing silicone, calcium chelators and apoptosis inducers have been reviewed as the 
common non-invasive scar management approaches (Roseborough et al., 2004). 
However, their specificity to wound repair is lacking and systemic side effects may be a 
concern. Plastic surgery and skin grafts remains the most widely used approach in 
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management of large scars. But recurrence of lesions remains may be a concern with 
surgery. For example, keloid scars have a 70% recurrence rate within the first year of 
postoperative correction (van de Kar et al., 2007). Overall treatment of fibroproliferative 
scars via non-invasive methods remains unspecific and surgical approaches offer no 
guarantees. Targeting wound-specific factors would seem a better approach and may 
offer more targeted and specific treatment with minimal systemic adverse effects. 
 
Research into wound specific factors including growth factors and chemokines has been 
the focus of the last 2 to 3 decades. These factors can alter the behaviour of wound 
repair cells such as macrophages, endothelial cells and fibroblasts/myofibroblast. 
Therefore targeting growth factor offers a specific approach to managing wound healing 
disorders. TGFβ1 is the most important growth factor in the wound milieu, through its 
potent stimulation of inflammation, angiogenesis, collagen synthesis and myofibroblast 
differentiation (Desmouliere et al., 1993, Roberts et al., 1986). Minimising the effects of 
TGFβ1 is viewed to be an important approach in the regulation of scarring and fibrosis 
as is demonstrated through several studies (Roberts et al., 1986, Distler et al., 2007). 
Neutralization of TGFβ1 and 2 with antibodies has been effective in reducing scarring in 
rabbit hypertrophic ears models and mice incision wounds (Shah et al., 1995, Lu et al., 
2005). Furthermore, anti-sense TGFβ1 has been shown to reduce deranged TGFβ-Smad 
signal transductions, collagen synthesis, inhibit growth and reduce collagen receptors 
expression in keloid fibroblasts (Bran et al., 2010a, Bran et al., 2010b, Bran et al., 2010c). 
Delivery of anti-sense TGFβ1 oligonucleotides into third degree burns and postoperative 
wounds has been beneficial in reducing scar formation and hypertrophy (Luo et al., 
2002, Cordeiro et al., 2003). TGFβ3 is thought to antagonise the fibrotic effects of 
TGFβ1-2 and its application on rodent and human cutaneous wounds is demonstrated 
to improve scarring (Shah et al., 1995). Human synthetic TGFβ3 was in the final phase of 
clinical trials for use in regeneration of normal skin and scar reduction after injury of 
surgery (Occleston et al., 2009, Occleston et al., 2008). Disappointingly perhaps, TGFβ3 
has recently been reported to have failed phase III clinical trials (Press release, February, 
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2011) and will be unlikely to be pursued further as a therapy in the short term (Obstoj-
Cardwell, 2011).  Reduction of TGFβ ligand and receptor bidding though retroviral 
delivery of a dominant negative TGFRII has been shown to reduce hypertrophy in 
scarring rodent models and is a potential therapeutic approach of the future (Reid et al., 
2007). 
 
In addition to targeting TGFβ, inhibition of its down stream inducers may be effective in 
regulating scarring. For example, inhibition of CTGF mRNA with anti-sense sequences is 
effective in limiting hypertrophy, reduces scarring and decreases myofibroblast 
persistence in the late phase of rabbit hypertrophic wound models, without hampering 
or delaying wound healing  (Sisco et al., 2008).  
 
Fibrotic disorders are usually diagnosed once tissue scarring is already in progress, and it 
is plausible that treatment will require the targeting of specific fibroblastic cell 
populations. For example, targeting of myofibroblast contractile apparatus through 
inhibition of αSMA polymerisation. Failure to assemble αSMA into stress fibres leads to 
a reduction in contractile ability and reduced collagen synthesis (Hinz et al., 2002). This 
might be of significance to patients with hypertrophic scars that have a high density of 
myofibroblasts and are prone to painful contractures (Ehrlich et al., 1994, Schmid et al., 
1998). 
 
1.6.2.  Chronic ischaemic wounds 
The vast majority of cutaneous chronic wounds clinically present as venous, pressure 
and diabetic ulcers (Mustoe, 2004). Chronic wounds show persistent inflammation 
devoid of a proliferative phase, poor deposition of matrix components and failure to 
heal in a defined time line (Wilkinson et al., 1993, Palolahti et al., 1993, Moor et al., 
2009). The pathogenesis of chronic wounds is multifactorial and mostly associated to 
underlying conditions related to age and diabetes or both, for example, reduced gene 
transcription with increasing age causes reduced protein synthesis and non enzymatic 
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glycosylation of proteins plus microvascular dysfunction in diabetes can retard growth 
factor function and alter vascularization respectively (Wheaton et al., 1996, Algenstaedt 
et al., 2003, Sen, 2009). Fibrin cuffing of microvessels, oedema and increased venous 
pressure occurs in venous ulcers, pressure may be an issue in diabetic ulcers, and a 
common factor in most chronic wounds is varying degrees of local tissue ischaemia 
(Browse and Burnand, 1982, Mustoe, 2004, Mustoe et al., 2006).  
 
Chronic ischaemia has got several important consequences to wound healing cells 
including reduced cell responsiveness to growth factors (Kim et al., 2003, Sen, 2009). 
Ischaemia has been suggested to reduce peptide growth factor receptor binding 
(Falanga et al., 1994). Treatment with oxygen (hyperbaric or topical oxygen) would 
therefore seem relevant and is currently one of many approaches used to improve 
healing in chronic ischaemic wounds. However, oxygen treatment alone is not sufficient 
when treating ischaemic wounds which are often chronic due to multifactorial causes 
(Zhao et al., 1994). Combination therapy, for example with hyperbaric oxygen and 
growth factors (PDGF and TGFβ1) has synergistic effects and improves healing outcomes 
of ischaemic wounds (Zhao et al., 1994). In addition, actin remodelling proteins such as 
Flightless 1 have now emerged as important regulators of wound repair and their 
manipulation has been shown to modulate wound healing in transgenic mice wound 
repair models, where over-expression of Flightless 1 impaired wound healing and 
deficiency improved and accelerated wound healing (Cowin et al., 2007). Furthermore, 
topical application of a Flightless inhibiting antibody has been shown to improve wound 
repair and therefore may be of therapeutic importance to conditions where wound 
healing is impaired (Cowin et al., 2007).     
 
It is now well appreciated that underlying mechanisms such as age and diabetes have 
detrimental effects on HIF-1 expression or stabilisation therefore reducing the cellular 
responses during local tissue ischaemia (Liu et al., 2008, Catrina et al., 2004, Loh et al., 
2009).  Therapeutic approaches that stabilise HIF-1α would therefore be beneficial in 
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driving the expression of downstream HIF-1 target genes which enhance angiogenic 
responses and promote wound healing. Indeed, the use of drugs that inhibit HIF-1 
hydroxylation have been beneficial in stabilising HIF-1α and improving wound healing in 
diabetic mice (Botusan et al., 2008). Correction of HIF-1α deficiency with 
electroporation-facilitated gene therapy increases wound healing, angiogenesis, and 
circulating angiogenic cells in diabetic aged mice (Liu et al., 2008). 
 
Please refer to figure (See Figure 1-3) for schematic representation of therapeutic 
approach 
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Figure 1-3. Schematic of therapeutic approached to improve healing in ischaemic 
wounds and reduce hypoxia induced fibrosis.  Hypoxia, through HIF-1 stabilisation up-
regulated the expression of several factors (PAI-1, VEGF, TGFβ, CTGF) that promote 
wound healing. Over-expression of HIF-1 may lead to deranged expression of these 
factors and increase the risk of fibrosis. On the other hand, deficient HIF-1 stabilisation 
may impair adaptive ability in hypoxia and increase the risk of impaired healing. 
Targeting HIF-1 may have valuable therapeutic implications in both impaired and fibrotic 
wound healing. Adopted from (Botusan et al., 2008, Distler et al., 2007, Higgins et al., 
2004, Hong et al., 2006, Zhang et al., 2006, Zhang et al., 2003b)  
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1.7. TGFβ1-Smad signalling in wound healing  
TGFβ1 and its other mammalian isoforms TGFβ2 and 3,  belong to a superfamily of 
growth factors that include bone morphogenic protein (BMP), nodals , activins, the anti 
Mullerian hormone and several other related proteins found in different classes of 
eukaryotes (Roberts, 1998, Massague, 1998). TGFβ1 is a multifunctional cytokine with 
broad ranging activities that are both contextually inhibitory and stimulatory to cell 
proliferation, extracellular matrix synthesis or degradation and mesenchymal-epithelial 
interactions during development, wound repair and carcinogenesis (Roberts, 1998, 
Massague, 1998, Verrecchia and Mauviel, 2002).  
 
During wound healing TGFβ1 is released by a variety of cells including platelets, 
macrophages, keratinocytes and fibroblasts within and surrounding the wound bed. It is 
secreted in a latent form (L-TGFβ) that binds to extracellular matrix requiring proteolytic 
cleavage through various proteases including plasmin, thrombin and matrix 
metalloproteinase (Roberts, 1998). Mechanical activation of latent L-TGFβ can be 
achieved through integrin-dependant mechanisms during cell contraction (Wipff and 
Hinz, 2008, Wipff et al., 2007).  
 
Bioactive TGFβ1 exerts its effect by binding to a subunit of a heterodimeric serine 
threonine kinase receptor complex consisting of a Type I (TGFRI) and II (TGFRII) 
(Massague, 1998, Piek et al., 1999). TGFβ1 binds to TGFRII which activates kinase 
activity leading to the recruitment and activation of TGFRI and the subsequent 
phosphorylation of receptor activated Smad-2 and 3 proteins (Massague, 1998, Piek et 
al., 1999, Massague and Chen, 2000, Massague and Wotton, 2000). Phosphorylated 
Smads (P-Smad)-2/3 complex with Smad-4 (translocator) and consequently become 
translocated to the nucleus to function as transcription factors and enable the 
expression of TGFβ-regulated genes (Massague and Chen, 2000, Massague and Wotton, 
2000). Smad7 is a regulatory Smad and can inhibit Smad2/3 phosphorylation through 
Chapter 1 
a 
62 
competition for the TGFRI binding domain, being the predominant mechanism through 
which TGFβ signalling is switched off (Nakao et al., 1997). A schematic of TGFβ-Smad 
signalling is represented below (Figure 1-4). 
 
 
Figure 1-4. A schematic of TGFβ-Smad signalling pathway. Bioactive TGFβ binds to 
TGFRII receptor and activates kinase activity. Ligand bound TGFRII complexes with and 
phosphorylates TGFRI (transducer receptor). TGFRI kinases get activated which recruits 
and phosphorylates R-Smad (Smad-2/3). Phosphorylated R-smad complex with co-Smad 
(Smad-4) and translocates to the nucleus to function as a transcriptional regulator of 
TGFβ regulated genes. Smad-2/3 phosphorylation is negatively regulated by Smad-7 
(Adopted from (Verrecchia and Mauviel, 2002)) 
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The importance of TGFβ-Smads signal transduction, in physiological conditions such as 
development and wound repair, is demonstrated in various transgenic rodent models 
where proteins in the TGFβ-Smad signal chain have been deleted or mutated. For 
example, cutaneous models with deleted or abrogated TGFβ1, TGFβRII and Smad are all 
characterised by altered wound healing although some findings have been somewhat 
surprising. TGFβ null mice with suppressed auto-immune responses are characterised 
with defective wound healing (Crowe et al., 2000). Similar results are observed following 
specific over-expression of dominant negative TGFRII in dermal fibroblast populations in 
cutaneous mice models (Denton et al., 2009). Additionally, in such models Smad 
expression and phosphorylation is reduced or absent (Denton et al., 2009). However, 
wound healing studies from Smad null mice have been somewhat surprising and indeed 
contrary to TGFβ and TGFRII null mice studies.   
 
Smad-2 is critical in development and its absence as demonstrated in Smad-2 null mice 
causes failure to achieve development of mesodermal cells and consequently prenatal 
lethality (Waldrip et al., 1998) which supports the role of the TGFβs and Smad-2 in 
development. The role of Smad-2 has not been properly tested in vivo due to lethality of  
Smad-2 homozygous null mice and heterozygous Smad-2 null mice show no obvious 
phenotypes (Ashcroft et al., 1999). In contrast, Smad-3 homozygous null mice are 
embryonically sound and survive into adulthood without any obvious phenotype until 
challenged with injury (Ashcroft et al., 1999, Wang et al., 2007).  
 
Paradoxically, Smad-3 null mice show accelerated wound healing characterized by rapid 
re-epithelialisation, an impaired local inflammatory response, reduced granulation 
tissue formation and normal responses to exogenous TGFβ, implying that Smad-3 
negatively regulates wound healing (Ashcroft et al., 1999, Wang et al., 2007). 
Furthermore, fibroblasts from Smad-3 null mice produce normal amounts of collagen in 
response to TGFβ1, implying that Smad-3 is dispensable during granulation tissue 
formation during cutaneous healing (Ashcroft et al., 1999). Taken together, TGFβ-Smad-
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2 signal transduction may be important in promoting wound healing while TGFβ-Smad-3 
negatively regulates it. However, the significance of this is still not well understood.   
 
1.8. Co-operation between hypoxia and TGF-β pathways   
Local relative hypoxia occurs in all forms of wound healing.  Normal wounds are often 
transiently hypoxic post injury and hypoxia regresses once a sufficient level of 
vascularization is achieved in the granulation tissue (Lokmic et al., 2006). Hypoxia in 
normal healing wounds is detected between 3 to 10 days post injury and also correlates 
with the increase in HIF-1α during the some period (Lokmic et al., 2006, Haroon et al., 
2000, Elson et al., 2000).  Inflammation, re-epithelialisation, angiogenesis and 
fibrogenesis are wound healing events that progress during acute tissue hypoxia. TGFβ 
plays a central and critical role in all phases of wound healing and its expression is high 
during tissue hypoxia (Lokmic et al., 2006). Thus the question of co-operation or synergy 
between hypoxia and TGFβ becomes relevant in our understanding of early wound 
healing.  Please refer to schematic below (Figure 1-5). 
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Figure 1-5. Schematic overview of the overlapping wound healing phases, acute 
hypoxia and spatio-temporal expression of TGFβ1, HIF1α and Glut-1.  Disruption of 
vessels and influx of inflammatory cells results in tissue hypoxia (low PO2). HIF-1α and 
TGFβ levels are high during the early hypoxic phase of wound healing. Glut-1 is a 
downstream target of HIF-1 that increases cell metabolism and can be used as a marker 
of HIF-1 transcriptional activity. Co-expression of HIF-1 and TGFβ may be indicative of 
synergy between HIF-1 and TGFβ pathways during early wound healing. Adopted from 
(Elson et al., 2000, Haroon et al., 2000, Lokmic et al., 2006)         
 
Dermal fibroblasts treated with anti-sense HIF-1α or TGFβ1 oligonucleotides both show 
inhibition of TGFβ1 expression in hypoxia which is further enhanced using a 
combination of both antisense sequences, indicating that hypoxia can induce TGFβ1 
through both HIF-1-dependant and HIF-1-independent pathways (Distler et al., 2007). 
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However, it is not clear if TGFβ1 induction occurs directly through HIF mediated gene 
transcription and moreover, a HIF-1 promoter region (hypoxia response element) has 
yet to be defined on the TGFβ1 gene, as fur as we know. Interestingly, TGFβ2 contains a 
hypoxia response element with an active HIF-1 promoter region that can be induced to 
increase autocrine TGFβ2 in hypoxia independently of Smad activation, an important 
process in the stimulation of vascular endothelial cells and angiogenesis (Zhang et al., 
2003a). HIF-1 can also up-regulate the expression of thrombospondin-1, a TGFβ1 
activating protein, which is a plausible indirect mechanism of TGFβ up-regulation and 
may then increase expression of collagenous matrix in dermal fibroblasts during hypoxia 
(Distler et al., 2007, Murphy-Ullrich and Poczatek, 2000). Furthermore, TGFβ1 has also 
been described to stabilise HIF-1α proteins through inhibition of HIF-1- prolyl-4-
hyroxylases (PHDs) and consequently results in an increase in HIF-1 targets such as VEGF 
(McMahon et al., 2006). Such cross-talk between HIF and TGFβ pathways may provide a 
mechanism by which HIF-1 target genes may be expressed in the absence of oxidative 
stress (McMahon et al., 2006). Importantly, this also implies that HIF-1 may be 
important in some wound healing events, including tissue remodelling and wound 
contraction, which proceed in normoxic conditions where TGFβ1 expression is still 
relatively high. Furthermore, TGFβ expression in fibrotic disorders is often persistent 
(Distler et al., 2007, Schmid et al., 1998). Thus, increased HIF-1 expression through a 
TGFβ induced mechanism might be possible and is likely then to be a contributing factor 
in the pathogenesis of fibrotic disease.   
 
 
Accumulating research suggests the possibility of cross-talk between HIF-1 and TGFβ 
pathways through direct physical interaction of HIF-1 and Smad transcription factors. It 
is well established that enhanced VEGF expression by hypoxic endothelial cells, 
macrophages and fibroblasts occurs in response to increased levels of TGFβ (Sanchez-
Elsner et al., 2001, Jeon et al., 2007, Berse et al., 1999). Evidence suggests that this may 
partly involve a physical interaction between smad2/3-smad4 complex and HIF-1α at 
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the promoter region of genes containing both a hypoxia response element (HRE) and a 
Smad binding element (SBE), for example the VEGF gene (Sanchez-Elsner et al., 2001, 
Jeon et al., 2007). The physical interaction requires the recruitment of co-activator 
proteins such as 300 Kilo-Dalton co-activator protein (p300), which enables the 
formation of a HIF-1-Smad complex (Jeon et al., 2007) (Figure 1-6). It is plausible that 
similar synergistic mechanisms occur on other genes where the promoter regions 
contain both a HRE and a SBE. For example, HIF-1 up-regulates CTGF directly in hypoxia 
through a HRE on the promoter region of the CTGF gene (Higgins et al., 2004), a gene 
which also contains an active SBE that can be switched on in the presence of TGFβ1 
(Higgins et al., 2004). Consequently, a synergy between Smad and HIF-1 during hypoxia 
would seem likely and may have important pathogenic implications in fibrotic diseases 
in general as well as tumourigenesis, where increased HIF-1 and CTGF expression is 
common (Higgins et al., 2004, Hong et al., 2006). A similar model of HIF-Smad 
interaction is suggested in the synergystic expression of erythropoietin-1 and TGFβ co-
receptor, endoglin both important factors during angiogenesis (Sanchez-Elsner et al., 
2004, Sanchez-Elsner et al., 2002)    
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Figure 1-6. Synergy of TGFβ and hypoxia involves a physical interaction between HIF-1 
and Smad complex at the promoter region of HIF and TGFβ inducible genes. 
Complexing of HIF and Smad through a co-activator protein, p300, leads to synergistic 
expression of genes in hypoxia including VEGF and possibly other genes which contain 
both a SBE and a HRE sequence on the promoter region. Adopted from (Jeon et al., 
2007, Verrecchia and Mauviel, 2002) 
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Interaction of TGFβ1 and HIF-1 pathways might also occur indirectly through activation 
of mitogen activated protein kinases (MAPK). For example, activation of HIF-1α requires 
phosphorylation through p42/p42 and p38 MAPK which can both be induced 
mechanically during oxidative stress and chemically through TGFβ1-induced pathways 
(Hur et al., 2001, Richard et al., 1999, Sato et al., 2002) (Figure 1-7). Consequently, 
reduced TGFβ1 induced p42/p42 MAPK phosphorylation is suggested to reduce HIF-1α 
stabilisation and TGFβ induced responses (migration) of aged cells exposed to hypoxia 
(Mogford et al., 2002). Inhibition of p38 MAPK has also been shown to reduce TGFβ1 
induced CTGF expression in hypoxia, a process that partly requires induction through 
HIF-1 (Rong et al., 2005, Lee et al., 2009, Higgins et al., 2004). Activation of HIF-1α 
through MAPK has been demonstrated in fibroproliferative disorders. For example, 
activation of HIF-1 by several MAPK including p42/p42, PI3-K and AKT, has been shown 
to induce expression of PAI-1 in keloid fibroblasts (Zhang et al., 2004). Induction of PAI-1 
inhibits matrix metalloproteinase activity and is an important marker of fibrotic disease. 
Activation of HIF-1 through MAPK in conditions where TGFβ and hypoxia are common 
may thus have important pathogenic implications. 
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Figure 1-7. A schematic of HIF-1α and TGFβ1 cross-talk through mitogen activated 
protein kinase (MAPK). TGFβ1 can induce responses through activation of MAPK and 
Smad dependent pathways. Response to hypoxia requires activation of HIF-1α through 
oxidative stress mediated activation of MAPK. TGFβ may also enhance HIF-1α activity 
through activation of MAPK.  HIF-1α and smad complexes can also physical interact at 
the promoter region of some genes (e.g. VEGF and CTGF) to synergistically enhance 
their expression during hypoxia. Adopted from (Jeon et al., 2007, Verrecchia and 
Mauviel, 2002, Hur et al., 2001, Richard et al., 1999, Sato et al., 2002)  
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1.9. Regulation of hypoxia by HIF-1 
Metazoan organisms ubiquitously express HIF-1, a helix loop-helix Per-Arnt-Sim family 
transcription factor. It is composed of a dimer of an alpha (HIF-1α) and a beta (ARNT or 
HIF-1β) subunit which bind together to acquire transcriptional properties predominantly 
under hypoxic conditions (Wang et al., 1995). To date, HIF-1 is still thought to be the 
master regulator of oxygen homeostasis and is described to regulates the transcriptional 
activity of hundreds of genes that promote angiogenesis, cell proliferation, increase 
metabolism and survival in hypoxic conditions (Semenza, 1998, Semenza, 1999). Of 
interest to the wound repair process are pro-inflammatory, angiogenic and pro-fibrotic 
genes that are up-regulated or enhanced by HIF-1 transcription factor activity including 
PAI-1 VEGF, GLUT1, erythropoietin, CTGF, TGFβ2 and PDGF, just to mention a few 
(Zhang et al., 2003a, Semenza, 1999, Higgins et al., 2004, Zhang et al., 2003b). 
Furthermore, TGFβ1 is increased during hypoxia through both a HIF-1 dependent and 
independent manner, however it is not clear if HIF-1 can regulate TGFβ1 transcription 
directly (Distler et al., 2007).  
 
The HIF-1α and β subunits are continuously expressed in cells at all times highlighting 
the importance of HIF-1 as an evolutionary adaptation. Its regulation is almost solely 
based on the rapid degradation or stabilisation of the HIF-1α subunit post translation 
(Kamura et al., 2000). In normal tissue oxygen conditions, HIF-1α is rapidly and 
continuously degraded post translation (Kamura et al., 2000). This is mainly due to the 
O2-dependent hydroxylation of HIF-1α amino acid (aa) proline residues, Pro 
402 and Pro 
564, in a reaction catalysed by HIF-Prolyl 4- hydroxylases (PHD) 1, 2 and 3 in presence of 
cofactors, O2 and 2-Oxoglutarate (Bruick and McKnight, 2001). Hydroxylation of the 
amino acid residues results in conformational changes that allow HIF-1α to become a 
target of the Von Hippel-Lindau Tumor Suppressor Protein (pVHL), an important E3 
ubiquitin ligase that binds to HIF-1α and complexes with elongin B, C and cullin 2 
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resulting in HIF-1α ubiquitination and subsequent proteosomal degradation (Kamura et 
al., 2000).(Figure 1-8)  
In addition to hydroxylation through PHDs, HIF-1α is also regulated through an 
asparaginyl-hydroxylase, FIH (factor inhibiting HIF-1) in an O2 dependant manner. HIF-1α 
has two trans-activation domains, TAD-N (residues 531-575) and TAD-C (residues 786-
826), which bind to co-activators including CREP binding protein (CBP) and p300 (Mahon 
et al., 2001). In the presence of O2, FIH hydroxylates asparagine residue (ASN
803) within 
the TAD-C, preventing the interaction of HIF-1α with the transcriptional co-activators, 
p300 and CBP, thereby decreasing the transcriptional ability of HIF-1 (Mahon et al., 
2001). This is suggested to be a secondary oxygen regulatory mechanism for HIF-1α 
proteins that have evaded the PHD-mediated regulation.  
 
In hypoxia HIF-1α is stabilised and its ubiquitination is limited through reduced oxygen 
cofactor and depletion of both PHDs and FIH through degradation by proteosomes 
(Nakayama et al., 2004, Fukuba et al., 2007). Seven in absentia homologues (Siah) 1 and 
2, have E3 ubiquitin ligase activity and tag target proteins for degradation by 
proteosomes (Fukuba et al., 2007, Nakayama et al., 2004). In hypoxia, Siah activity is 
increased and correlates with the increased abundance and maintenance of HIF-1α and 
reduced stability of FIH and PHDs (Nakayama et al., 2004)(Fukuba et al., 2007). The 
relevance of Siah in the regulation of HIF-1 activity is demonstrated in Siah2 null cells 
which show marked reduction in HIF-1α stabilisation in hypoxia and reduced 
downstream transcription of hypoxia inducible genes (VEGF and GLUT-1)(Nakayama et 
al., 2004)  
 
Following stabilisation, HIF-1 is activated by phosphorylation. Activation of HIF-1α in 
hypoxia occurs through stress activated MAPK such as p42/p42 and P38 MAPK (Hur et 
al., 2001, Richard et al., 1999) (Figure 1-8). These MAPKs can also be activated following 
cytokine-receptor binding (Sato et al., 2002). Thus it is plausible that MAPKs provide a 
potential avenue for the regulation of HIF-1 and its regulated genes by cytokines. 
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Following phosphorylation, HIF-1α dimerises with HIF-1β and is translocated into the 
nucleus where it binds to the hypoxia regulatory element (HRE) sequence on the 
promoter region of HIF inducible genes. Transcriptional co-activators p300 and CBP are 
also required to bind to trans-activation domains on the HIF-1α protein, enabling HIF-1 
to be transcriptionally active (Figure 1-8). Under extreme (anoxia) or prolonged forms of 
hypoxia, p300 and HIF-1α interaction may be inhibited leading to HIF-1 transcription 
repression (Schmid et al., 2004). This occurs through induction of tumour repressor 
protein p53 which competes with HIF-1α for p300 co-activator (Schmid et al., 2004)   
 
HIF1 is an important regulator of hypoxia induced events in several physiological and 
pathological conditions including normal and pathological wound healing. In normal 
cutaneous wounds HIF1 is important for good angiogenic responses, mobilisation of 
circulating angiogenic cells and wound contraction and consequently partial reduction 
of HIF1α is sufficient to impair wound healing (Zhang et al., 2010b). In fibrotic disease, 
over-expression of HIF-1 correlates to an increase in expression of pro-fibrotic factors 
associated with excessive production of collagenous matrix, while HIF-1 deficiency in 
aged and diabetic related ischaemic wounds correlates to reduced adaptive hypoxia 
responses and impaired healing (Kimura et al., 2008, Distler et al., 2007, Zhang et al., 
2006, Zhang et al., 2003b, Zhang et al., 2004, Botusan et al., 2008, Liu et al., 2008). 
Consequently, positive (Siah proteins) and negative regulators (PHDs, pVHL and FIH) of 
HIF provide important therapeutic targets for drugs that could potentially be used to 
manipulate HIF-1 abundance in pathological conditions where over-expression or 
deficiency in HIF-1 correlates to pathogenesis. For example, PHD inhibitors can stabilise 
HIF-1α and subsequently drive expression of downstream HIF-1 target genes (Botusan 
et al., 2008). PHD inhibitors have been useful in improving healing of diabetic ischaemic 
wounds in mice and are now currently undergoing clinical trials for treatment of several 
human ischaemia based conditions including ischaemic wounds, anemia, ischaemic 
heart disease and pulmonary hypertension (Botusan et al., 2008, Smith and Talbot, 
2010, Katschinski, 2009).    
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Figure 1-8. Schematic on HIF-1α degradation, stabilisation and activation. Normal 
physiological oxygen levels favour catalytic activity of FIH-1 and PHDs resulting in 
hydroxylation of HIF-1α and subsequent ligation with pVHL, which tags HIF-1α-OH for 
degradation by proteosomes. Low oxygen levels limit the catalytic activity of HIF-
hydroxylase (PHDs & FIH) due to reduced substrate oxygen and an increase in the 
inhibitory effects of Siah proteins. Consequently hypoxia favours HIF-1α stabilisation, 
activation through MAPK, dimerisation of HIF-1α and HIF-1β and transcription of HIF-1 
inducible genes. Adopted from (Kamura et al., 2000, Bruick and McKnight, 2001, Mahon 
et al., 2001, Nakayama et al., 2004, Fukuba et al., 2007, Hur et al., 2001, Richard et al., 
1999).  
Chapter 1 
a 
75 
 
1.10. Seven in absentia homologue 
1.10.1.  Introduction 
The Siah proteins were first isolated and characterised from drosophila in the early 
1990s and found to exist as three highly conserved genes in mice, Siah 1a 1b and 2 
(Della et al., 1993). The genes were initially shown to be widely expressed during 
development and also in adult tissue suggesting general functions, but shown to be 
elevated in olfactory epithelium, retina, forebrain, gonad and areas of proliferating 
cartilage during late development suggesting a critical role in the development of these 
specific areas (Della et al., 1993). The Siah family of proteins possess a RING finger 
structure with potent E3 ubiquitin ligase activity that controls the proteosomal 
degradation of a wide range of proteins including TNF-receptor associated factor 2 
(TRAF2), synphilin-1, N-cor, m-cyb and β-catenin amongst others (Liu et al., 2001, 
Matsuzawa and Reed, 2001, Hu et al., 1997, Hu and Fearon, 1999, Li et al., 2002) .  
1.10.2. Generation of Siah transgenic mice and role of Siah in HIF-1α availability 
Determination of the role of Siah family proteins in cell physiology has been possible 
through generation of Siah 1a and 2 knockout transgenic mice (Dickins et al., 2002, Frew 
et al., 2003). Siah1a homozygous (Siah1-/-) mutation leads to severe growth retardation, 
frequent lethality and impaired spermatogenesis (Dickins et al., 2002). In contrast, Siah2 
homozygous (Siah2-/-) mutant mice are mostly phenotypically normal and grow to 
adulthood without any obvious complications (Frew et al., 2003). Heterozygous double 
mutants (Siah1+/- Siah2+/-) have also been generated and are mostly phenotypically 
normal, suggesting redundancy between the two genes (Frew et al., 2003). Siah 1 and 2 
homozygous double knock down mutation causes neonatal lethality which is indicative 
of the overlapping roles of Siah1 and 2 in growth and development (Frew et al., 2003). 
Additionally, the loss of Siah2 alone does not significantly impair described Siah2 
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associated activity such as degradation of TRAF2 and further supports the existence of 
functional redundancies amongst the Siah family of proteins (Frew et al., 2003).   
 
Siah1/2 null cells also show relatively normal behaviour in culture in terms of cell cycle, 
proliferation and survival (Frew et al., 2002). However, when challenged with hypoxic 
conditions, Siah1 and 2 null cells showed reduced availability of HIF-1α and reduced 
expression of HIF-1 target genes (Nakayama et al., 2004, Fukuba et al., 2007). Complete 
failure to stabilise HIF-1 is observed in the double Siah1 and 2 knockout cells, suggesting 
that Siah is critical for HIF-1α availability in hypoxia (Nakayama et al., 2004). This 
phenomenon is explained by increased half-life of HIF-1 hydroxylases (PHDs and FIH) in 
the absence of Siah (Nakayama et al., 2004). Siah has a high binding affinity for HIF-
hydroxylases (PHDs and FIH) and is critical for their ubiquitination–dependent 
degradation the consequence of which is the stabilisation of HIF-1α during hypoxia 
(Nakayama et al., 2004). More recent studies also point to the role of p38 MAPK in the 
activation and subcellular localisation of Siah under hypoxic conditions (Khurana et al., 
2006). Phosphorylation of Siah2 by p38 MAPK, for example, significantly enhances its 
ability to degrade PHD3 in hypoxia (Khurana et al., 2006) 
 
The relevance of Siah in HIF-1 stabilisation has been further tested using Siah specific 
inhibitors including the drosophila protein Phyllopod and vitamin K3 (menadione), both 
of which cause a marked reduction in HIF-1α abundance and the expression of HIF1 
target genes (VEGF and GLUT1) (Moller et al., 2008, Shah et al., 2009).  
 
1.10.3. The potential role of Siah proteins in wound healing  
Local acute hypoxia and increased stabilisation of HIF-1 is important for good angiogenic 
responses and acceleration or maintenance of normal wound healing (Zhang et al., 
2010b). Hypoxia through HIF-1 controls  the expression of several important genes in 
multiple wound repair cells including macrophages, endothelial, keratinocytes and 
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fibroblasts. These genes may encode soluble factors (PAI-1, CTGF, VEGF, TGFβ), 
receptors (VEFGR) and metabolic proteins (Glut-1) that stimulate cell migration, 
differentiation, survival, matrix production and release of more soluble factors to 
collectively promote the healing process. Moreover, several examples of cross-talk 
between HIF-1 and TGFβ1 pathways have been reported and are likely to be important 
in wound healing. Consequently, altered HIF-1 expression may contribute to abnormal 
wound healing. Over-expression of HIF-1 and persistent hypoxia may contribute to 
pathogenesis of fibrotic disorders (keloids and scleroderma), while deficiency in HIF-1 
may cause failure to respond to hypoxia and impair wound healing (aged and diabetic 
ischaemic wounds). Given that Siah is an upstream positive regulator of HIF-1 through 
its ability to degrade HIF-hydroxylases in hypoxia, it is plausible that Siah plays an 
important role in the regulation of early tissue repair events that proceed when the 
wound is markedly hypoxic. Furthermore, use of HIF specific PHD inhibitors in the 
treatment of impaired ischaemic wounds, implies that constitutive expression of Siah 
may also be beneficial in treatment of disorders where HIF-1 is deficient. Defective Siah 
expression may also represent a potential mechanism in the impairment of wound 
healing. 
 
In addition to HIF-1 regulation, Siah is also an important positive regulator of RAS 
signalling. Inhibition of Siah has been shown to reduce Ras-mediated transformation 
and tumorigenesis in lung and pancreatic cancers models (Ahmed et al., 2008, Schmidt 
et al., 2007). This may be important during wound healing, given that Ras signalling is 
shown to be a downstream enhancer of TGFβ-Smad responses in normal cells, cancer 
cells and fibrotic disease (Yue and Mulder, 2000, Mulder, 2000, Leask and Abraham, 
2004). Thus taken together Siah may regulate wound healing responses through both 
HIF-1 dependent and Ras mediated pathways. For this reason, the availability of Siah 
transgenic knockout mice offers a rare opportunity to test the role of Siah in wound 
healing. Thus, this thesis aims to address the role of Siah2 in dermal wound healing in 
vivo by examining the effect of Siah2 deficiency using Siah2 knockout (transgenic) mice 
Chapter 1 
a 
78 
and in vitro through the study of cultured dermal fibroblasts (murine Siah2-deficient 
fibroblasts and human fibroblasts).       
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2. Chapter 2 
 
 
 
 
 
 
 
General Methods and Materials  
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2.1. Materials 
 All reagents and chemicals for cell culture were obtained from Gibco Invitrogen (Aus), 
gas mixtures were from BOC (Aus), and all other chemicals were obtained from Merck 
and Sigma Chemical company (Aus), except those listed below : 
 
Table 2-1. Materials and Source 
Materials Source 
Biopsy punches (5mm) Steifel, UK 
Coomassie brilliant blue gel stain Invitrogen, Aus 
DAKO EnVision™ System, Peroxidase Kit Dako, Aus 
Fetal Bovine Serum Bovogen, Aus 
Human Dermal Fibroblasts (HDFs), harvested 
from adult skin biopsy 
Invitrogen, Aus 
Human VEGF Enzyme Linked Immuno Sorbent 
Assay (ELISA) 
PeproTech, USA 
Mayer’s Haematoxylin  Dako, Aus 
Nair Hair removal cream Church & Dwight, Aus 
Nitrocellulose membrane  BioRad Laboratories, Aus 
Opsite™ occlusive dressing 3M, Aus 
pcDNA phyllopod expressing and control vectors  Kind gift from Dr Andreas Möller of 
Peter MaCallum Cancer Centre, East 
Melbourne 
Polyvinylidenefluoride (PVDF) membrane BioRad Laboratories, Aus 
Prestained kaleidoscope molecular weight marker 
(broad range) 
BioRad Laboratories, Aus 
REAL® Antibody diluent Dako, Aus 
Recombinant human Transforming growth factor 
beta 1 (TGFβ1) (mammalian derived) 
PeproTech, USA and Invitrogen, Aus 
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Super Frost Plus + slides Menzel, Germany 
Terminal deoxynucleotidyl transferase dUTP nick 
end labeling (DeadEnd TUNEL) Kit 
Promega Corporation, USA  
Vectastain ABC Elite Kit Vector Laboratories, USA 
 
Table 2-2. Antibodies and Sources 
 Key:  f= flowcytometry, i= immunohistochemistry, w= western blotting,  
 
 
Table 2-3. Instruments and sources  
Instruments Source 
BD FAC Calibur flow cytometer BD Bioscience, USA 
Beckman Centrifuge Beckman Coulter, USA 
Cabinet Laminar Flow Horizontal HSW180 Crown Scientific, Aus 
Antibody Dilution Source 
Mouse monoclonal anti-β-actin 1:1000(w) Sigma, Aus 
Mouse monoclonal anti-HIF1α 1:100(f),1:500(w) Abcam Inc, USA 
Mouse monoclonal anti-SMAD2 1:100 (f), 1:1000(w) Cell Signalling, USA 
Mouse monoclonal anti-αSMA 1:250 (f), 1:200(i) Dako, Aus 
Mouse monoclonal anti-PCNA 1:200 (f &i) Dako, Aus 
Polyclonal rabbit anti-
phosphorylated SMAD2 
1:100(f), 1:1000(w) Cell Signalling, USA 
Rabbit polyclonal anti- CD31  1:50(i) Abcam Inc, USA 
Rabbit polyclonal anti- TGFβ type 
II receptor  
1:100(f) Abcam Inc, USA 
Rabbit polyclonal anti-COL1A1 1:100(f), 1:500(w),  Abcam, USA. 
Rabbit polyclonal anti-Glucose 
transporter 1 (Glut1) 
1:400(i) Abcam Inc, USA  
Rabbit polyclonal anti-HA  1:300 (i) Abcam Inc, USA 
Rat monoclonal anti-F4/ 80 1:50(i) Abcam Inc, USA 
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Humidified chamber (5% CO2, 95% air) Crown Scientific, Aus 
Hypoxia chamber RMIT, Aus 
Leica (DMD108) micro-imager Leica Microsystems, Germany 
Leica Tissue processor Leica Microsystems, Germany 
Microtome (RM2125) Leica Microsystems, Germany 
Mini-PROTEAN CELL 3 Biorad Laboratories, USA 
Molecular Imager ChemiDoc XRS System Biorad Laboratories, USA 
Olympus microscope BX50 Olympus, USA 
Olympus polarizer Olympus, USA 
Semi-Dry Trans-Blot Electrophoretic Transfer Cell  Biorad laboratories, USA 
 
2.2. Dermal wound healing model  
2.2.1. Animal procurement and care 
Male C57BL/6 background mice of either Siah2 homozygous knock out (-/-) or wild type 
(+/+) genotype and were a kind gift from Dr Andreas MÖller of the Peter MacCallum 
Cancer Centre (East Melbourne, Victoria). The animals were bred and reared at the Peter 
MacCallum animal housing facility and transported to the RMIT Animal Facility prior to 
surgery. The mice were kept at standard and constant room temperature and constant 
day-night light cycle. Standard mice diet feed and water were available ad libitum. All 
transported animals were allowed to acclimatise for at least 48 hours before 
experimental procedures. All experiment procedures were in line with the required 
institutional animal experimentation ethics committee guidelines and the project 
approved (AEC# 0828).  
2.2.2. Animal preparation and surgical procedure: 
All mice were checked before the start of any procedures and utilized if they were alert, 
active, responsive and able to be handled. The mice were anesthetised with a Ketamine 
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(80mg/Kg) and Xylazine (5mg/Kg) cocktail formulated on the basis of an average mouse 
weight of 20g.  The mice were shaved on the dorsum and then depilatory cream was 
applied to produce smooth hairless skin for wounding and to assist subsequent dressing 
adhesion.  Depilatory cream (Nair) was used as described in the manufacturer’s 
instructions. The skin area was then disinfected with povidine-iodine solution and 
swabbed with alcohol (70% ethanol) before wounding with a full-thickness wound by 
punch biopsy (5mm radius) (Figure 2-1).  Wounds were rinsed with sterile saline for 
irrigation, local anaesthetic (bupivicaine 0.25%) applied into the wound space and then 
the wound was dressed with surgical occlusive dressing (Opsite™, 3M).  All mice were 
allowed to recover under a heating lamp. 24 hours post-wounding, all dressings were 
removed to limit variation caused by dressing detaching at different times.  Wounds 
were then allowed to heal by secondary intention. 
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Figure 2-1. Schematic summary of sequence of events during dermal wound infliction 
from both an aerial and cross sectional perspective. 5mm radius (r) biopsy punches 
were used to create full thickness wounds on dorsum as illustrated in the cross section. 
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Figure 2-2. Illustration showing sequence and technique of wound extraction and 
trimming post healing. Cross section of wounds illustrates the desired orientation of the 
granulation tissue after trimming.  
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2.2.3. Animal sacrifice and sample extraction 
After wounding, animals were killed at different time points (6, 9 or 12 days post 
wounding) by CO2 inhalation and then cervical dislocation. Wounds were dissected and 
trimmed to include the granulation tissue of the wound and a 1-2mm margin of normal 
skin (Figure 2-2).  Wounds were predominately harvested at day 6 in order to target 
described events related to hypoxia in early wound healing (Elson et al., 2000, Lokmic et 
al., 2006). Wounds were fixed in buffered formalin (10% v/v in PBS) for 24 hours prior to 
paraffin embedding.  Mouse tails were disinfected with ethanol (70%v/v in dH2O) and 
collected for cell extraction (see description below). 
2.3. Histology 
2.3.1. Sample preparation and paraffin embedding 
Tissue was transferred to sucrose-PBS solution (7% v/v) for 24 hours to remove fixative 
then transferred to 70% alcohol. The fixed tissue was then dehydrated by immersion in a 
series of ascending grades of alcohol (70%-100% ethanol, followed by 100% Xylene) using 
an automated tissue processor (Leica, Germany) and then embedded into paraffin blocks. 
 
2.3.2.  Histological sectioning  
All wound sections were cut at a thickness of 4μm using a rotary microtome (Leica, 
Germany) and transferred onto Superfrost plus glass slides (Menzel, Germany). Slides 
were baked at 50° C overnight and used for general histological staining, 
immunohistochemistry and TUNEL (sections 2.4 to 2.6). 
2.4. Histological staining 
2.4.1. De-waxing of histological sections 
All paraffin sections were de-waxed by immersion in two changes of xylene for 5 minutes 
and then hydrated by successive immersion in descending concentrations of alcohol 
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(100%, 90% 70%) and then transferred to water or phosphate buffered saline (0.01M, pH 
7.4). 
2.4.2.  Haematoxylin and eosin staining   
Haematoxylin and eosin (H&E) staining was performed to visualise general histological 
structures of wound sections as previously described with minor modifications (Kiernan, 
2001). Briefly paraffin embedded sections were de-waxed and rehydrated by successive 
immersion in alcohol (section 2.4.1). Sections were immersed in Harris‘ haematoxylin for 
2 minutes to stain the nuclei blue following by a 5 minute wash in running tap water. 
Sections were immersed in Scott’s tap water for 1 minute to ‘blue’ nuclear staining 
followed by immersion in running water for 2 minutes. Excessive staining was removed 
by short immersion in acid alcohol (1% HCL, 70% ethanol).  
 
For better contrast, cytoplasm and matrix tissue were stained by immersion in 1% 
aqueous Eosin (w/v) for 1 minute followed by a 2 minute wash in running water. The 
sections were dehydrated by successive immersion in ascending grades of alcohol 70%, 
90%, 100% followed by two successive immersions in xylene for 2 minutes each. Sections 
were mounted using xylene based mountant (DePeX, Merck). 
 
H&E stained sections were used to measure the area of granulation tissue and calculate 
% re-epithelialisation using micro-imager (Leica, Germany). H&E stained sections were 
also used to count the number of vessel profiles within the granulation tissues.   
   
2.4.3. Picrosirius red staining   
Picrosirius red staining was performed to visualize collagen fibres using previously 
described methods (Constantine and Mowry, 1968). Briefly, sections were de-waxed and 
hydrated (see section 2.4.1) by immersion in xylene and descending grades of alcohol. 
After washing in water, sections were immersed in picrosirius red (0.1% w/v Sirius red 
stain dissolved in saturated picric acid) for 1 hour. This was followed by two quick washes 
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in acidified water (5% acetic acid v/v) to remove excessive staining and better 
differentiate the stain. Sections were quickly dehydrated by successive immersion in 
ascending grades of alcohol followed by immersion in xylene. Slides were mounted with 
Depex and visualised under polarised light using Olympus BX50 microscope.  
 
To assess the level of collagen deposition, quantitation of polarized picrosirius stained 
areas of the wounds was performed. Staining intensity varies in polarised light depending 
on the thickness and maturity of the collagen fibres (Constantine and Mowry, 1968). 
Green to yellow birefringence was consistent with newly formed granulation tissue with 
fine collagen fibres, and intense yellow to red birefringence was characteristic of mature 
granulation tissue with thicker collagen fibres. Images of stained sections were taken and 
analysed using image analysis software (ImagePro Plus®). Collagen deposition was 
expressed as a percentage of staining within the margins of the wounded area. 
 
2.5. Immunohistochemistry  
In order to visualize different antigens expressed in the wound sections 
immunohistochemistry was utilized. Primary antibodies raised against αSMA, PCNA, 
CD31, F4/80 and Glut1 were used to visualize the myofibroblast phenotypic 
transformation, proliferating cells, neovascularisation, macrophage infiltration and 
glucose transmembrane transporter protein respectively. Similar staining protocols have 
been described previously in other wound healing studies (Darby et al., 1990, Vollmar et 
al., 2002, Elson et al., 2000, Hewitson and Darby, 2009).     
 
2.5.1. Antigen retrieval of paraffin embedded sections  
Briefly, paraffin embedded section were de-waxed and hydrated (see section 2.4.1) by 
immersion in xylene and descending grades of alcohol. Sections were immersed in PBS 
for 2 minutes and then into antigen retrieval solution (citrate buffer, 0.1M pH 6.0). The 
Chapter 2 
a 
89 
solution was heated to 90°C for 10mins and allowed to cool to room temp. Sections were 
washed twice in wash buffer (0.01M PBS).  
 
2.5.2. Blocking endogenous peroxidase activity  
To prevent any non-specific reactions between endogenous peroxidase and 3, 3’-
diaminobenzidine (DAB), endogenous peroxidase activity in tissue was quenched by a 10 
minute incubation in hydrogen peroxide buffer (3% H2O2 : 0.01M PBS), followed by a 
thorough wash with wash buffer.   
 
2.5.3. Blocking non-specific antigen binding  
To prevent non-specific binding to proteins in sections a blocking step using bovine 
serum albumin (1% BSA in PBS) or normal goat serum (2% NGS in PBS) was applied. 
Blocking solution was applied for 30 to 60 minutes at room temperature and later tipped 
off the sections.     
 
2.5.4.  Primary antibody application  
Antibodies were diluted in REAL® antibody diluent (Dako, Aus) based on optimised 
antibody concentrations that were determined using sections of mouse wound. Briefly, 
final antibody concentrations used were determined after trialling each primary antibody 
at various dilutions and incubation times. Optimal concentration was determined by the 
best contrast between positive specific staining versus non-specific background staining. 
Please refer to experimental chapters (see Chapter 3) for incubation conditions of 
individual antibodies. After the prescribed incubation times sections were washed 
thoroughly for a total of 10 minutes in three changes of wash buffer. 
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2.5.5. Secondary antibody application  
Horse radish peroxidase (HRP) conjugated secondary antibodies against immunoglobulin 
G (IgG) of primary antibody hosts were used to probe for the applied primary antibodies. 
In all immunohistochemistry experiments unless other wise stated, a prediluted dual link 
anti- mouse/anti-rabbit polymer conjugated to HRP was used as secondary antibody 
(DAKO EnVision™ System, Peroxidase Kit, Dako, Aus). This was applied to sections for 30 
minutes at room temperature and thoroughly washed off at the end of incubation. The 
specificity of primary antibody and the level of background staining generated by the 
secondary antibody was tested on samples by omission of the primary antibody.  
 
For antibodies raised in species other than rabbit or mouse, for example rat monoclonal 
anti-F4/80, sections were incubated after the primary antibody with a biotinylated 
secondary antibody.  Vectastain ABC Elite Kit (Vector Laboratories, USA) was then used 
for the detection steps. Briefly, the primary antibody was detected using a biotinylated 
anti-rat secondary antibody for 30 minutes followed by a thorough wash. ABC Elite 
avidin-biotin-HRP was then applied for 30 minutes at room temperature and thoroughly 
washed off. 
  
2.5.6. Horseradish Peroxidase (HRP) and 3, 3’-diaminobenzidine (DAB) colorimetric 
reaction.       
The chromagen 3, 3’-diaminobenzidine (DAB) was used to visualise the localisation of 
probed antigens through HRP catalysed reaction. The colorimetric reaction turned DAB 
from clear to dark brown colour that could be visualised under a microscope.  Sections 
were washed thoroughly in water and later counterstained with haematoxylin, then  
dehydrated in ascending grades of alcohol and mounted (See section 2.4.2). Images of 
stains were taken using DMD108 micro-imager (Leica microsystems, Germany) and 
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analysed using image analysis software (ImagePro Plus®). Stains were expressed as a 
percentage of staining within the margins of the wounded areas.  
 
2.6.  Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) 
Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) was used to  
visualise apoptotic cells at different stages of wound repair using previously described 
methods (Desmouliere et al., 1995) with minor alterations. Briefly, paraffin embedded 
sections were de-waxed and hydrated in alcohol (see section 2.4.1). Sections were 
permealized for 15 minutes in proteinase K solution (20μg/ml proteinase K in PBS) and 
washed thoroughly in wash buffer (0.01M PBS). Apoptotic nuclei were probed using the 
reaction of terminal deoxynucleotidyl transferase and biotinylated dUTP (Promega, USA) 
at 37°C for 60 minutes. The TUNEL reaction was stopped and sections thoroughly 
washed. Nuclei with incorporated biotin-dUTP were detected by incubation with HRP-
conjugated streptavadin (1:500, dilution) for 30 minutes and then DAB colorimetric 
reaction to visualise staining (see 2.5.6). Sections were counterstained, dehydrated 
through alcohol and mounted. Apoptotic nuclei were visualised at higher magnification 
(x20) and images taken using the micro-imager.          
2.7. Dermal fibroblasts and wound healing in vitro models 
Dermal fibroblasts are critical for collagen deposition and wound remodelling. In vitro 
they have previously been used to provide valuable insights into the mechanisms that 
affect wound repair in a controlled and more easily defined setting (Falanga and Kirsner, 
1993, Falanga et al., 2002, Steinbrech et al., 1999). In the thesis both primary mouse 
dermal fibroblasts (MDFs) and primary human dermal fibroblasts (HDFs) were used to 
investigate the involvement of Siah2 regulated pathways in established hypoxia and 
cytokine induced processes such as cell proliferation, migration, matrix synthesis, 
contraction and cytokine release.  
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2.7.1. Sample collection and preparation 
For preparation of primary fibroblasts from Siah2 knockout and wild-type mice, tails were 
collected from sacrificed animals (see section 2.2.3), disinfected in alcohol (70% ethanol) 
and immersed in ice-cold sterile PBS containing antibiotics (5% penicillin: 5% 
streptomycin) for about 60 minutes. Tails were then washed thoroughly (4-5 washes) in 
ice cold buffer. The joined epidermis and dermis of the tail were removed by dissection 
under sterile conditions, washed and maintained in ice cold sterile PBS. In contrast, HDFs 
(Invitrogen Aus) were established cell lines acquired frozen in freeze mix media (10% 
DMSO, 20% Fetal bovine serum (FBS), specialised media)(Invitrogen, Aus) and transferred 
to standard culture media when required (see section 2.7.3). 
 
2.7.2. Separation of dermis from epidermis and fibroblast isolation  
Fibroblasts were isolated by enzymatic separation of dermis and epidermis followed by 
digestion of collagen matrix to isolate single cells following previously described methods 
with minor modifications (Wu et al., 2005).  Briefly, the dermis and epidermis were 
separated by overnight digestion in dispase solution (10mg/ml dispase: 0.01M PBS) at 
4°C.  The dermis was then immersed in dispase- collagenase solution (4mg/ml dispase 
and 3mg/ml collagenase) for 45-60 minutes. Collagenase activity was quenched by 
dilution (1:15) in buffered fetal bovine serum (2% FBS, 0.01M EDTA. 0.1M PBS). The 
digested cells and buffer were then filtered and centrifuged to isolate the cell pellet. 
Supernatant was replaced with cell culture medium (DMEM, 5% FBS, 1% 
penicillin/streptomycin) (Figure 2-3). 
 
2.7.3. Growth and maintenance of fibroblast cultures 
MDFs/HDFs were grown in a standard cell culture humidified incubator (37°C, 5% CO2, 
21% O2, humidified) and medium (DMEM, 5% FBS, 1% penicillin/streptomycin) changed 
every second day in line with standard cell culture protocols (Freshney, 2005).  
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MDFs/HDFs were grown until 70 - 80 % confluence and passaged based on experimental 
needs. Cells used between passages P1 to P4 for MDF and P1 to P5 for HDFs 
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Figure 2-3. Methodological over view of fibroblast extraction by enzymatic digestion. 
The process involves dissociation of tail dermal layer from cartilage and skeletal muscle, 
digestion of dermis to epidermis links (basement membrane) and further digestion of 
dermis in collagenase to release cells from the matrix. Detached cells can be filtered, 
washed and transferred to cell culture conditions.       
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2.7.4. Counting and seeding cells 
As is standard for in vitro based assays using cells, cell counts are imperative in the 
generation of reliable data. Briefly, cultured cells were detached using trypsin (0.05% 
trypsin, 0.01M EDTA) and resuspended in equal volumes of trypan blue. Cell counts were 
performed on 1/400 mm haemocytometer and viability assessed by trypan blue 
exclusion. Average viable cell number (clear) in 4 large squares (1mm2) was used to 
estimate cell number within a given suspension based on the following formulae: 
 
Cell no. = x / Sq × 104 × D × V 
Where: 
x = number of cells  
Sq = number of large squares counted  
D = dilution factor 
V = Volume (ml) 
 
 
To achieve equal cell density when comparing two groups of cells (i.e. knockout vs wild 
type) a dilution of the higher cell density group was performed.  The dilution volume 
calculated using the following equations 
              
             V2 = C1× V1                         Vd = V1-V2                     
                         C2 
Where: 
C1= lower cell no. 
V1= Volume with lower cell no 
C2 = higher cell no   
V2 =Volume of suspension that contains equal cell number as C1  
Vd =Volume of medium required for dilution  
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2.7.5. Pre-treatment of cells before experiments    
To reduce differences due to variation in cell proliferation and cell cycle, cells were serum 
starved before any experimental process following previously described methods (Suri et 
al., 1998, Sumiyoshi et al., 2003, Oberringer et al., 2008). Briefly, cells were washed once 
with sterile PBS and incubated with low serum medium (DMEM 1-2% FCS) for 4 to 6 
hours then washed and treated according to the experimental condition to be tested (e.g 
hypoxia and TGFβ incubations). Please refer to method sections in experimental chapters 
(4 and 5) for specific conditions used.  
 
2.8. MDF/HDF scratch-wound assays  
MDF or HDF monolayer migration assays were performed by scratching plated cells to 
mimic cell migration during wound repair. In vitro scratch assay has been widely used and 
were prepared as previously described with minor changes (Oberringer et al., 2008). 
Briefly, this involved counting and then evenly seeding cells at equal density (see section 
2.7.4) and allowing them to grow until close to full confluence (about 80-90%). Cells were 
then serum starved (see section 2.7.5), exposed to the desired culture conditions, the 
scratch wound made with a 1ml pipette tip and then allowed to migrate over time. 
Scratched areas were measured over time and migration expressed as change in area of 
the scratch.  
 
2.9.  Fibroblast-populated collagen lattice contraction assays  
Fibroblast can differentiate to express contractile actin isoform (αSMA) which then 
generates the force required for contraction during wound closure (Darby et al., 1990, 
Gabbiani et al., 1971).  Several growth factors can influence fibroblast differentiation but 
the main regulator of myofibroblast phenotype is TGFβ1 (Desmouliere et al., 1993). In 
order to investigate changes in function of this contractile phenotype, fibroblasts were 
seeded into 3 dimensional collagen lattices as previously described with minor changes 
(Sumiyoshi et al., 2003, Masterson et al., 2004, Montesano and Orci, 1988).  Briefly, cells 
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were detached with trypsin, counted and diluted in collagen (2.1mg/ml) to approximately 
1 x 105cell/ml. Lattices were prepared on ice using the following volumetric equations 
provided in manufacturer’s instructions with minor changes (Gibco-Invitrogen,  Aus).  
 
V1 = (Final conc. of collagen) x (Total Volume (V)) 
             Initial conc. of collagen  
  
V2 = Total volume (V) 
        10 
 
V3 = V1 x 0.025 
 
V4 = (V) - (V1 + V2+ V3) 
 
Where:  
  
V = Total required volume of collagen lattice 
V1 = Volume of collagen required 
V2 = Volume of 10X DMEM required 
V3 = Volume of 1M NaOH required 
V4 = Volume of cell suspension required to give desired cell density 
 
Reagents were mixed under sterile conditions. 1 ml aliquots per lattice were added to 12 
well plates. Lattices were then allowed to polymerize in standard cell culture conditions 
(37°C, 5% CO2, 21% O2, humidified) for 30 minute after which growth medium was added 
to wells. Cells were allowed to recover and grown in lattices for 1 day during which time 
some tension develops in the lattice. Lattices were then subjected to desired 
experimental conditions, released from the edge and bottom of the well using a needle. 
Lattices were returned to experimental conditions and allowed to contract for 24 hours 
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after which they were fixed in formalin (10% buffered formalin). Plates were scanned and 
area of lattices calculated to scale.  Contraction was defined the change in area (pixels2) 
before (0 hour) and after lattice release (48 hours). 
 
Chapter 2 
a 
99 
 
 
 
Figure 2-4. Schematic of collagen contraction lattice protocol. Cells seeded at equal 
density into lattices which are then allowed to polymerize and gain tension, after which 
they are incubated in experimental conditions for varying times and then detached 
(released) from well walls and allowed to contract.   
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2.10. Protein extraction, SDS gel electrophoresis and Western blotting 
To investigate changes in protein expression between groups, protein from cells was 
extracted by detergent (Triton-x100) cell lysis, separated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS PAGE) and transferred onto polyvinylidene 
fluoride (PVDF) or nitrocellulose membranes and then probed for specific proteins using 
primary antibody as per standard SDS-page protocol and manufacturer’s 
recommendations.  
 
2.10.1. Cell lysis and protein content determination 
Briefly, after experimental treatments, cells were washed in Tris-buffer (TBS) (150mM 
NaCl, 10mM Tris-HCL) and lysed using ice cold lysis buffer solution (1% Trition-x100 and 
proteinase inhibitor diluted in TBS). Lysates were centrifuged at 12000x g for 10 minutes 
at 4°C. Supernatants were collected into separate tubes and the protein content (mg/ml) 
measured using a bicinchoninic acid assay (BCA assay) kit (Bio-Rad, Aus). Absorbance 
values of the colorimetric reactions were determined using a micro plate reader. 
Unknown protein values were extrapolated from the equation of a bovine serum albumin 
standard curve (standard concentrations were 2, 1, 0.5, 0.25 and 0.125 μg/μl).   
  
Equation: 
Y = MX + C 
Where: 
Y = absorbance value of protein 
X = protein value in μg/μl or mg/ml 
M = gradient or slope 
C = Y intercept  
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2.10.2. Protein sample preparation  
Unless otherwise stated, proteins were loaded at a normalised mass of 10µg per well. 
The final protein samples comprised of 3 parts; cell lysate (10µg), 1 part loading buffer 
(4x Invitrogen, Aus) and reducing agent (0.1mM dithiothreitol). The final volume of the 
protein sample loaded (VL) was determined by following formula: 
 
VL = VS + SB + R 
Where:  
VL= final loading sample preparation volume per well  
VS = volume protein sample containing desired protein mass (10µg) 
SB = volume 4X sample buffer required (1/4 of protein volume) 
R = volume of reducing agent (1M DTT) required to give final concentration of 0.1mM 
DTT       
 
Protein samples were denatured at 90°C for 10 minutes and cooled on ice before loading.  
2.10.3. SDS PAGE and PVDF/ nitrocellulose membrane transfer 
Denatured protein samples were loaded on SDS PAGE gels (10% acrylamide) and 
separated at 160 to 200 Volts direct current for 45 to 50 minutes in ice-cold running 
buffer (0.025M Tris glycine and 0.1% SDS). Proteins were transferred on to either PVDF 
(Bio-Rad, Aus) or nitrocellulose (Bio-Rad, Aus) membranes that were electrolyte soaked 
(0.025M Tris & glycine and 20% methanol) using a semi-dry transfer cell (Bio-Rad 
laboratories, USA) at 19 volts direct current for 75 minutes. Protein transfer was 
confirmed by aqueous protein staining solution (0.05 % Ponceau red S). 
      
2.10.4.  Immunoblotting and protein detection  
Non-specific protein binding sites on membranes were blocked (60 minutes in 5% non fat 
powdered milk diluted in 0.01M Tris Base Saline buffer, 0.05% (v/v) Tween 20, pH 7.6 
(TBST)). Primary antibodies (diluted in TBST) (see Table 2-2 and Chapter 4) were added 
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onto the membrane and incubated overnight (about 16 hours) at 4°C. Membranes were 
washed in TBST for 30 minutes. HRP-conjugated secondary antibodies (diluted 1: 1000 in 
TBST) were added to membranes for 60 minutes at room temperature and washed off 
thoroughly in TBST. Protein bands on membranes were visualised via peroxidase -
catalysed chemiluminescence reaction detected using a Chem-Doc ® unit (Bio-Rad, Aus). 
Protein band density was analysed using Quantity One ® densitometry analysis software.    
 
To control for errors in loading, β-actin was used as a housekeeping protein, detected 
using anti-β-actin antibody (Sigma, Aus). All protein expression values were collected as a 
ratio of the housekeeper optical density, except for phosphor-Smad2 which was 
expressed as the ratio of total Smad2 (see Chapter 4).    
2.11. Flow Cytometry  
Flow cytometry analysis (FAC) technique was used to distinguish multiple parameters of 
individual cells or cell populations in samples based on the scatter of light passed through 
individual cells, as previously descrided with minor changes(Wang et al., 2008b). Briefly, 
the forward scatter was used to generate data about the size of the cells while the side 
scatter was used to generate information about the internal components of the cells, for 
example granularity. In combination with appropriate excitation and emission filters, FAC 
was used to detect fluorescence intensity in a specific population of cells using side and 
forward scatter analysis. Thus in this thesis the technique was adopted for immuno-
phenotyping, the use of fluorescently- labelled antibodies to determine differences in 
expression of specific proteins within cell samples. The difference in the expression of 
Smad2, phosphor- Smad2, PCNA, αSMA, COL1, Siah2, TGFRI and HIF-1α in dermal 
fibroblasts after specific treatments was analysed by this technique (see Chapters 3 and 
4).  
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2.11.1.  Sample preparation  
 Briefly, cells were counted, starved and incubated in the desired experimental conditions 
(see section 2.7.4 to 2.7.5). After which cells for FAC were enzymatically detached using 
trypsin (0.05% trypsin, 2% BSA in PBS), washed and centrifuged (300x g for 5 minutes).  
Cells were fixed with formalin (2% formalin, 2% BSA in PBS) for 20 mins and 
permeabilized by 20 mins incubation in saponin (0.05% saponin, 2% BSA in PBS).  Cells 
were pelleted by centrifugation at 300x g for 5 minutes and the supernatant discarded. 
2.11.2. Immuno-labelling for FAC 
Cells were resuspended in the primary antibody (diluted in 2% BSA in PBS) of interest and 
incubated at room temperature for 30 minutes.  Primary antibodies were washed off 
with PBS. Cells were centrifuged at 300x g, PBS was then discarded and cells were 
resuspended in the appropriate secondary antibody (diluted in 2% BSA in PBS) and 
incubated for 30 minutes at room temperature. Cells were washed in PBS and 
centrifuged at 300x g (washing steps repeated twice). Cells were then resuspended in 
PBS containing 2% BSA. Negative controls (incubation in secondary antibody only) and 
unstained cells were prepared for each experimental condition.  
2.11.3. FAC of samples and data collection 
Cells were collected at a high flow rate (up to 70 cells per second). Forward and side 
scatter characteristics (i.e size and granularity) of cells were used for their preliminary 
identification and appropriate gates were further used to localise cells and exclude 
cellular aggregates and debris. Fluoresence intensity of negative controls and stained 
samples were analysed for at least 2,000-10,000 gated events per sample. Mean 
fluorescence intensity of samples was analysed using Weasel ™ FAC software (Walter and 
Eliza Hall Institute, Aus). Mean fluorescence intensity of negative controls (secondary 
antibody labelled only) was used to subtract background fluorescence of test samples.   
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2.12. Human dermal fibroblast - Siah protein inhibition model 
Briefly, transient transfection of HDFs with a Phyllopod expressing vector was used to 
investigate the effect of inhibiting Siah proteins in an in vitro human fibroblast model. 
Phyllopod (PHYL) is a drosophila melanogaster protein which has inhibitory effects on 
both Siah 1 and 2 activity (Moller et al., 2008). PHYL expressing vectors have been 
successfully transfected in mammalian cells and demonstrated inhibition of Siah 
expression and of proteins downstream of the Siah (and HIF1) pathway (Moller et al., 
2008).  PHYL expression vectors were introduced into cells to compare and validate the 
effects of Siah2 gene deletion on mouse primary fibroblast cultures (see Chapter 3), with 
the major difference that PHYL inhibits both Siah1 and Siah2. The PHYL expression vector 
was constructed and kindly donated by Andreas MÖller (Moller et al., 2008), a 
collaborator at Peter MacCallum Cancer Centre. Transient transfection of HDF cells with 
PHYL was performed using previously described protocols and following the 
manufacturer’s transfection guidelines with minor modifications (Tandara et al., 2006) 
(Invitrogen, USA). 
 
2.12.1. Generation of competent E.coli 
E.coli colonies were grown in fast shaking Luria broth (LB) cultured overnight at 37°C.  
Colonies were used to inoculate 100-fold dilution of LB containing MgSO4 (20mM) and 
grown at 37°C for 5 to 6 hours. Cells were immediately chilled and centrifuged. The pellet 
was resuspended in ice cold calcium chloride (CaCl2) (0.1M) and swirled on ice (30mins). 
Cells were centrifuged and resuspended in CaCl2/ Glycerol (0.1M /15%v/v). 
 
2.12.2. Transformation of competent E.coli 
Plasmid complementary dinucleotide acids (pcDNA) (10ng) was added to competent cells 
and mixed gently before heat shocking at (42°C) for 40 to 60 seconds. Cells were 
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returned to ice for 2 mins before addition of 3ml of LB medium without antibiotic and 
then incubated at 37°C for 45 minutes.  
 
2.12.3. Selection and growth of Transformed E.coli 
To select for transformed cells, aliquots of cells were streaked onto antibiotic (100ug/ml 
Ampicillin) containing LB plates and incubated overnight at 37°C. Ampicillin resistant 
E.coli colonies were selected by wire loop and then grown in liquid cultures of LB 
containing selection antibiotic overnight at 37°C with agitation.  
 
2.12.4. Purification of cDNA Plasmid 
Plasmids were purified using Midi and Maxi Pure Link ™ prep kits (Invitrogen, Aus) as per 
manufacturer’s guidelines. Briefly, cells were lysed and supernatants washed and filtered 
through a series of column filters. Plasmid quality and quantity was determined using a 
UV spectrophotometer in line with manufactures guidelines (Invitrogen, Aus). Quality of 
pcDNA was determined by comparing absorbance of plasmid preps at 260 and 280 nm. 
High quality preps had an absorbance ratio (260/280nm) between 2.0 to 1.8. 
Concentration of pcDNA was determined using the following equation: 
 
X = A260 x 50μl/ml 
 
Where:  
X = pcDNA concentration  
A260 = Absorbance of pcDNA at 260nm 
50μl/ml = Concentration of double stranded DNA when A260 equals 1.0 
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2.12.5. Lipofectamine 2000™ Transfection  
Transient transfection of HDF cells was performed using Lipofectamine 2000™ with 
reference to the previously described methods (Tandara et al., 2006) and manufacturer’s 
instructions albeit with slight modifications. HDFs were grown to about 70 to 80% 
confluence.  Cells were incubated for 5 to 6 hours in transfection solution containing 
Lipofectamine 2000™ (1.0µl/cm2) and plasmid (0.35μg/cm2) diluted in low serum 
medium.  Following transfection, cells were washed with PBS and allowed to recover 
under normal cell culture conditions for 24 hours. The cells were the passaged (1 in 4 to 
5) and allowed to grow under normal cell culture conditions until about 70% confluent 
(about 3 days post-transfection). Please refer to Chapter 5 for specific experimental 
procedures performed post-transfection.  
 
2.12.6.  Transfection efficiency   
Positive transfection was determined by analysis of HA- expression using a rabbit 
polyclonal Anti-HA antibody (Abcam, USA) as previously described (Moller et al., 2008).  
Briefly, Phyllopod expression vectors contained a HA incorporating sequence that 
allowed Phyllopod proteins to be tagged when expressed in transfected cells (Moller et 
al., 2008). After the described transfection time cells were fixed and permeabilized by 
addition of 100% methanol for 10 minutes and then hydrated. Primary anti-HA antibody 
(1:200) was added and incubated for 30 minutes in line with manufacturer’s guidelines 
(Abcam, USA). Secondary antibody, Anti-rabbit IgG Alexa-Fluora ®488 (1:300, Molecular 
Probes, Invitrogen) was used to probe primary IgG. Images of protein expression were 
taken using an Olympus BX-50 fluorescent microscope and compared to that of empty or 
scrambled vector-transfected cells. 
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2.13.  Vascular endothelial growth factor (VEGF) ELISA 
Dermal fibroblasts increase expression of VEGF in hypoxia conditions (Steinbrech et al., 
1999). VEGF is a well described down stream target of hypoxia through HIF1 inducible 
pathways (Semenza, 1999, Forsythe et al., 1996) and therefore is also a downstream 
target of Siah activity (Moller et al., 2008, Nakayama et al., 2004, Shah et al., 2009). To 
investigate the impact of Siah inhibition on fibroblast release of VEGF, a VEGF ELISA was 
used to measure HDF VEGF secretion.  VEGF ELISA was performed according to 
manufacturer’s instructions (PeproTech, USA). Briefly, anti-VEGF capture antibody 
(0.2µg/ml anti-VEGF in PBS with 2% BSA in) was coated onto a high-binding 96-well plate 
for 24 hours and washed off thoroughly. Non-specific binding was blocked with bovine 
serum albumin (2% BSA in PBS). Samples were bound to capture VEGF for 2 hours then 
washed off thoroughly. Bound samples were then probed with biotinylated anti-VEGF 
(0.2µg/ml) for 2 hrs and again washed thoroughly. Avidin conjugated with HRP (1: 2000 
dulation in PBS with 2% BSA)) was added to detect the secondary antibody and the 
excess washed off. Absorbance readings of colorimetric reactions of TMB (3, 3’, 5, 5’-
tetramethyl-benzidine) catalysed by HRP (Clear to Blue) were used to measure VEGF 
concentration using a plate reader.  The amount of VEGF captured from samples was 
calculated using a VEGF standard curve with concentrations from 0.06 to 2ng/ml. 
2.14. Statistical analysis 
Statistical analysis was performed using two way analysis of variance (ANOVA) and 
Bonferroni’s correction for multiple comparisons. In addition, Mann- Whitney’s 
nonparametric test (U-test) was performed for planned comparisons. Results were 
expressed as the mean ± standard error of the mean (S.E.M) for atleast 3-10 separate 
observations. A P value of less than 0.05 was considered statistically significant (*). 
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3. Chapter 3 
 
 
 
 
 
 
 
 
 
       Deficiency of Siah2 and its effect on murine 
cutaneous wound healing 
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3.1. Introduction  
Wound healing in the skin is a complex and well orchestrated process involving the 
interaction of numerous cell types as healing progresses through phases involving 
inflammation, proliferation and remodelling (Clark, 1996). Infiltration by inflammatory 
cells debrides the wound of damaged tissue, minimises microorganism accumulation 
and initiates the beginning of the proliferative phase through the release of soluble 
factors that are chemotactic for mesenchymal cells, in particular keratinocytes, 
endothelial cells and fibroblasts (Leibovich and Ross, 1975, Mirza et al., 2009). The 
proliferative phase seals the wound site through rapid re-epithelialisation by 
keratinocytes from the wound edge and restores tissue architecture through the 
deposition of extracellular matrix by fibroblasts, while simultaneously restoring 
vasculature through endothelial cell proliferation and differentiation (Singer and Clark, 
1999). In adult skin, the generation of granulation tissue and its eventual remodelling as 
wound maturation occurs, results in a scar with reduced functionality compared to the 
original tissue. Impairment of any of these processes results in delayed or aberrant 
healing. Abnormal wounds clinically present mostly as fibroproliferative lesions and 
chronic ischaemic wounds and are a significant burden to patients and healthcare 
systems (Sen et al., 2009). Due to loss of function associated with scarred tissue and the 
difficulty in healing chronic wounds, there is considerable interest in the factors involved 
in the regulation of normal healing.  
 
 Following injury, vascular damage often occurs resulting in hypoxia which may 
be further sustained by the rapid influx of inflammatory and mesenchymal cells with 
high metabolic demands for oxygen (Remensnyder and Majno, 1968). Detection of 
hypoxia during wound healing has been demonstrated convincingly both 
immunochemically and by direct measurement of oxygen pressure (Lokmic et al., 2006, 
Haroon et al., 2000, Knighton et al., 1983).  Acute hypoxic tissue gradients are important 
for stimulating adequate wound healing angiogenesis as well as enhanced matrix 
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deposition and re-epithelialisation (Knighton et al., 1981, O'Toole et al., 1997, Ridgway 
et al., 2005, Siddiqui et al., 1996). Slight changes in systemic and cellular oxygen 
concentrations induce tightly regulated response pathways that modulate cell function 
in hypoxic conditions. Most of these responses occur through the induction of the HIF-1 
transcription factor which is increased during wound healing and regulates many 
processes needed to carry out tissue repair processes during wound ischaemia. HIF-1 
transcriptionally up-regulates expression of metabolic proteins (Glut-1), adhesion 
proteins (integrins), soluble factors (PAI-1, thrombospondin-1, CTGF, TGFβ, and VEGF) 
and matrix components (collagens and fibronectin) which enhances the healing process 
(Elson et al., 2000, Zhang et al., 2003b, Distler et al., 2007, Higgins et al., 2004). For 
these reasons, HIF-1 is viewed as a positive regulator of wound healing and when over-
expressed, it has been hypothesised to be an important factor in tissue fibrosis. The 
relevance of HIF-1 is effectively demonstrated in numerous in vitro systems and in HIF-1 
deficient animal models which are shown to have impaired wound healing (Distler et al., 
2007, Tang et al., 2004, Zhang et al., 2010b). Furthermore, HIF-1 deficiency has been 
linked to defective hypoxic responses in diabetic- and age- related chronic wounds 
where healing is impaired (Botusan et al., 2008, Distler et al., 2007, Liu et al., 2008, Loh 
et al., 2009, Thangarajah et al., 2009).  
 
 HIF-1 is negatively- and positively-regulated by several proteins. Briefly, HIF-1 is a 
heterodimer of alpha and beta subunits (Wang et al., 1995). Both subunits are 
constitutively expressed, however tight regulation of HIF-1 activity occurs primarily 
through post-translational modification of HIF-1α subunit (Wang et al., 1995). Under 
normal physiological oxygen HIF-1α is tagged for proteosomal degradation by pVHL, a 
process that requires HIF-1α hydroxylation by HIF-hydroxylases (PHDs and FIH) and 
oxygen co-activator (Kamura et al., 2000, Bruick and McKnight, 2001, Mahon et al., 
2001). In hypoxia conditions HIF-hydroxylases are reduced which allows HIF-1α to 
escape ubiquitination machinery thus increasing its abundance (Bruick and McKnight, 
2001, Mahon et al., 2001).  
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 Siah proteins are a family of E3 ubiquitin ligases that tag HIF-hydroxylases for 
degradation during hypoxia and increase HIF-1α abundance (Nakayama et al., 2004, 
Fukuba et al., 2007). In this context, Siah knockout mice have delayed and abrogated 
responses to hypoxic conditions (Nakayama et al., 2004). The importance of Siah 
induced degradation of PHD in the regulation of HIF-1, has been well defined in hypoxia 
driven pathological conditions such as tumourgenesis and metastasis (Shah et al., 2009, 
Qi et al., 2008, Moller et al., 2008). However, the role of Siah in wound healing has not 
been previously studied. We hypothesise that Siah, through its regulatory effects on 
PHD activity and thus downstream HIF-1α avalability, will have an effect on early wound 
healing, where hypoxia is prevalent requiring adaptive response through HIF-1 for 
cellular responses to hypoxia. The aims of this chapter are to cutaneously wound Siah2 
homozygous knockout mice (Siah2-/-) mice and to compare their early wound healing 
events to that of matched Siah2 wildtype mice (Wt). 
 
3.2. Results 
3.2.1. Macroscopic and histological wound size and re-epithelialisation  
To evaluate the physiological role of endogenous Siah2 in wound healing, Siah2-/- and 
Wt mice were subjected to full thickness excisional wounds on shaved dorsal skin using 
a 5mm punch biopsy. The wounds were allowed to heal by secondary intention then 
collected for histological and immunochemical analysis with particular focus on days 6 
and 9, where hypoxic wound conditions have previously been described (Lokmic et al., 
2006, Haroon et al., 2000). Figure 3-1 shows a series of typical macroscopic and 
histological images from excisional wounds of Wt versus Siah2-/- mice. Macroscopic 
wound closure of Siah2-/- mice is delayed and wounds appeared to be gaping and raw at 
day 4 and 6 compared to Wt wounds. This macroscopic difference was indistinguishable 
from the Wt mice at day 9 (Figure 3-1a). The macroscopic observations were also 
supported with histological analysis of granulation tissue area (mm2) (Figure 3-1b and 
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Figure 3-1c). Wound areas is Siah2-/- mice were significantly larger at days 6 (5.30 ± 
0.83mm2, P<0.001, n=10) and 9 (2.97 ± 0.28mm2, P<0.01, n=8) in comparison to Wt 
mice at days 6 (2.17 ± 0.23mm2,,n=10) and 9  (0.76 ± 0.13mm2,n=8) (Figure 3-1c). 
Although wounds in Siah2-/- were still larger at day 12, they had substantially contracted 
and were not significantly different (1.87 ± 0.17 mm2, P = 0.70, n=3) to Wt mice (1.07 ± 
0.33 mm2, n=3).  
 
 The percentage of re-epithelialisation (% re-epithelialisation) was also analysed 
histologically by measuring the distance covered by re-epithelising sheet compared to 
diameter of wound (Figure 3-1d). At day 6, % re-epithelialisation in Siah2-/- wounds was 
significantly delayed (66.33 ± 9.28%, P<0.001, n=10) compared to Wt mice (99.18 ± 
0.82%, n=10). % re-epithelialisation at day 9 was mostly complete and undistinguishable 
between Siah2-/- (85.6 ± 5.92%, P = 0.506, n=8) and Wt wounds (91.03 ± 6.06%, n=8). 
Siah2-/- wounds at day 6 also appeared to have more residual provisional matrix (fibrin 
clot) compared to Wt mice in the central regions of the wounds indicative of delayed 
debridement or invasion and replacement with granulation matrix (Figure 3.1b). By day 
9 normal granulation features appeared to be formed in Siah2-/- but not Wt wounds. No 
overt signs of infection or chronic inflammation were observed in any of the analysed 
wounds. These results suggest that Siah2 plays an important role in promoting wound 
closure and re-epithelialisation. 
 
Chapter 3 
a 
113
 
Chapter 3 
a 
114
Figure 3-1. Macroscopic and histological analysis of wound closure in Siah2
-/-
 and Wt 
mice. (a) Qualitative macroscopic  comparison of Siah2-/- and Wt wounds at day 0, 4, 6 
and 9 post injury (b) H&E sections of Wt and Siah2-/- wounds at 6, 9 and 12 days (c) 
histological analysis of average wound area (mm2) and (d) percentage (%) re-
epithelialisation calculated using these H&E sections. Key: F=Fibrin clot, E=epithelial 
layer, D=unwounded dermis, G=newly formed granulation tissue. Each data point 
represents a mean ± SEM (day 6 n=10, day 9 n=8 and day 12; n=3). Mann-Whitney‘s U-
test analysis was used to determine statistical significance. *** P<0.001, ** P<0.01. 
(Macroscopic of images, (a) 1 small bar =1 mm) (Magnification, (b) = х4) 
  
3.2.2. Delayed collagen deposition in Siah2
-/- 
wounds  
Replacement of provisional matrix (fibronectin rich fibrin) with collagenous matrix is 
critical to the establishment of granulation tissue and restoration of tissue integrity 
during wound healing. To investigate the impact of Siah2 deficiency on collagen 
deposition, sections were stained with picrosirius red and analysed under polarized light 
(Figure 3-2) which shows mature and immature collagen fibres. As shown in Figure 3-
2a,c newly synthesised granulation collagen fibres appeared fine and demonstrated a 
weak green-yellow birefringence, while increasingly mature granulation tissue collagen 
fibres were thicker and demonstrated a bright orange-yellowish birefringence 
(Constantine and Mowry, 1968). Areas lacking in collagen deposition appeared dark-
grey (without birefringence). At day 6, Siah2-/- granulation tissue contained deposits of 
fine collagen fibres (green-yellow) in peripheral regions of the granulation tissue and 
reduced collagen deposition (dark-grey) in central regions of the granulation tissue 
while Wt wounds demonstrated homogenous deposition of fine collagen fibres (green-
yellow birefringence) throughout the granulation tissue (Figure 3-2 a, c). By day 9, Siah2-
/- wounds appeared to have matured collagen fibres (yellow birefringence) in the 
peripheral regions of the granulation tissue and some areas of fine collagen fibres in the 
central areas, while Wt wounds appeared to have a homogenous distribution of mature 
collagen fibres (yellow birefringence) throughout the granulation tissue (Figure 3-2 b). 
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The percentage of picrosirius red birefringence was analysed (Figure 3.2d). At day 6 
Siah2-/- wounds had significantly less collagen in the granulation tissue (30.73 ± 4.46%, 
p<0.01, n=10) compared to Wt wounds (54.75 ± 5.83%, n=10). At day 9, the percentage 
collagen deposited in Siah2-/- granulation tissue was still less (68.5 ± 5.39%, p = 0.165, 
n=8) but not significantly different to Wt wounds (80.2 ± 4.16%, n=8). These results 
suggest that the downstream effects of Siah2 are important in enhancing deposition of 
collagenous matrix during normal wound healing. 
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Figure 3-2 Picrosirius red staining and analysis of collagen deposition in Siah2
-/-
 and Wt 
wounds. (a)(c) Birefringence of picrosirius red in Wt and Siah2-/- sections at day 6 and (b) 
day 9 under polarised light (areas of low birefringence are indicated by white arrows).  
Analysis of % picrosirius red stain in Siah2-/- sections at day 6 and 9 compared to Wt (d). 
Each data point represents a mean ± SEM (day 6, n=10; day 9, n=8). Mann-Whitney‘s U-
test analysis was used to determine statistical significance. ** P<0.01. Magnification, (a), 
(b) = х4 and (c) = х20) 
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3.2.3. Proliferation of cells in granulation tissue of Siah2
-/-
 wounds  
Increased proliferation and rapid migration of mesenchymal cells, from unwounded skin 
to replace damaged tissue, is a hallmark of wound repair and regeneration.  To examine 
the impact of Siah2 on cell proliferation, sections were immunostained with an antibody 
directed against PCNA. Figure 3-3a shows typical PCNA stained sections of 6, 9 and 12 
day wounds from Wt and Siah2-/- mice.  During the earlier phases of wound healing (day 
6) PCNA stained cells in Siah2-/- and Wt wounds were localised on re-epithelialising basal 
keratinocytes and the peripheral regions of the wounds (wound margins). Mesenchymal 
cells also appeared to be proliferating and migrating from the unwounded dermis. By 
day 9 and 12 the proliferating cells were detectable almost homogeneously throughout 
the granulation tissue of both Siah2-/- and Wt wounds. Analysis of the percentage area 
of PCNA staining (Figure 3-3b) showed that Siah2-/- (3.25 ± 0.24%, n=10) and Wt (3.56 ± 
0.35%, n=10) wounds had similar levels of proliferation during the early phases of 
healing at day 6. Surprisingly, at day 9 the percentage of PCNA positive cells was 
significantly higher in Siah2-/- wounds (5.37 ± 0.33%, P<0.05, n=8) in comparison to the 
Wt wounds (4.02 ± 0.36%, n=8) indicating a slight increase in the rate of proliferation. At 
day 12 Siah2-/- wounds (2.89 ± 0.437 %, n=3) had similar levels of PCNA positive cells in 
comparison to the Wt wounds (3.05 ± 0.82%, n=3). The results indicate that Siah2 does 
not appear to impact overall cell proliferation during the early phase of wound healing 
but might instead modulate cell migration. Surprisingly, the absence of Siah2 causes a 
transient increase in the rate of proliferation, seen at day 9 post-injury, which may be 
suggestive of a compensatory mechanism by which impairment of cell migration is 
overcome.  
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Figure 3-3.  Cell proliferation activity in wounds of Siah2
-/-
 and Wt wounds assessed by 
immunohistochemistry using PCNA. (a) PCNA immunostained wound sections at day 6, 
9 and 12 and (b) analysis of percentage (%) PCNA staining in wounds sections of Siah2-/- 
compared to Wt mice. Each data point represents a mean ± SEM (day 6, n=10; day 9, 
n=8 and day 12, n=3). Mann-Whitney‘s U-test analysis was used to determine statistical 
significance. * P<0.05. Magnification, (a) = х10. Scale, 1 bar =100 µm. Annotation: black 
arrows inidicate wound edge, E= epithelial layer, G= granulation tissue, L= leading 
epithelial edge and P= provisional matrix. 
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3.2.4. Reduced macrophage infiltration into Siah2
-/- 
wounds  
In the inflammatory phase of wound healing, macrophages play a vital role in infection 
control, tissue debridement and initiation of the proliferative phase through the release 
of paracrine factors (Mirza et al., 2009). Hypoxia induces macrophage invasion, 
activation and the release of cytokine release (Hempel et al., 1996, Scannell, 1996, 
Albina et al., 1995). HIF-1 stabilisation is critical for myeloid cell mediated inflammation 
and function during tissue hypoxia (Cramer et al., 2003).  To determine the role of Siah2 
on macrophage invasion, sections were immunostained with anti-F4/80 antibody. Figure 
3-4a shows typical sections of F4/80 immunostained Wt and Siah2-/- wounds at day 6 
and 9 post-injury. In the earlier phases of healing at day 6, F4/80 positive cells in Siah2-/- 
wounds were mostly present in the peripheral regions of the granulation tissue. In 
contrast, F4/80 positive cells in Wt wounds appeared to be homogeneously distributed 
throughout the granulation tissue. At day 9, F4/80 positive cells in Siah2-/- wounds were 
increasingly detectable in central and peripheral areas of the granulation tissue but 
appeared to be sparse in the central regions compared to Wt. Analysis of percentage 
F4/80 staining in the granulation tissue was performed using). At day 6, Siah2-/- wounds 
had a significantly lower percentage of F4/80 staining (1.98 ± 0.35%, P<0.01, n=10) than 
the Wt wounds (4.51 ± 0.82%, n=10) (Figure 3-4b). At day 9, Siah2-/- wounds continued 
to have a significantly lower percentage of F4/80 positive cells (2.15 ± 0.18%, P<0.01, 
n=8) than the Wt wounds (3.09 ± 0.18%, n=8). The results demonstrate the importance 
of Siah2 and HIF-1 in regulating wound inflammatory phase. Regulation of macrophage 
infiltration may have important implications on granulation tissue levels of macrophage 
derived soluble factors (cytokines and growth factors) that impact on proliferative 
processes such as re-epithelialisation, matrix synthesis and angiogenesis. 
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Figure 3-4 Macrophage infiltration of Siah2
-/-
 and Wt wounds. (a) F4/80 
immunostained sections of wounds at day 6 and 9 and (b) analysis of percentage F4/80 
staining in the granulation tissue of Siah2-/- compared to Wt wounds. Mann-Whitney‘s 
U-test analysis was used to determine statistical significance. ** P<0.01. Magnification, 
(a) = х10 
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3.2.5. Myofibroblast profile and wound contraction in Siah2
-/-
 wounds  
Transient expression of αSMA in the granulation tissue during fibroblast-myofibroblast 
transition is a hallmark of normal wound healing and is synonymous with wound 
contraction (Darby et al., 1990). The presence of myofibroblasts is also associated with 
increased production of collagen (Schmid et al., 1998). To investigate the effect of Siah2 
on fibroblast to myofibroblast transition wound sections were immunostained with anti-
αSMA for immunohistochemistry. Figure 3-5 shows typical images of αSMA 
immunostained Wt and Siah2-/- wounds at day 6 and 9 post-injury. At day 6, Siah2-/- 
wounds had a smaller peripheral area of αSMA positive cells and fewer αSMA positive 
cells leading into the central regions of the granulation tissue compared to Wt. At day 9, 
αSMA stained cells in granulation tissue of Siah2-/- were less pronounced in the central 
area and mostly concentrated in peripheral areas compared to Wt wounds. Analysis of 
the percentage area of αSMA in granulation tissue was performed using image analysis 
software. At day 6, Siah2-/- wounds had significantly less αSMA positive cells (14.8 ± 
2.87%, P<0.001, n=10) in comparison to Wt wounds (36.5 ± 2.61%, n=10) (Figure 3.5e). 
αSMA levels in Siah2-/- wounds remained significantly lower up to day 9 albeit only 
marginally (34.4 ± 5.27%, P<0.05, n=8) when compared to Wt wounds (52.9 ± 4.54%, 
n=8). The results suggest that the downstream effects of Siah2 activity are important for 
normal functionality of fibroblast during wound healing including matrix synthesis, 
differentiation and contraction.  
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Figure 3-5  Presence of myofibroblasts in Siah2
-/-
 and Wt wounds. (a-d) αSMA stained 
and scanned sections of wounds at day 6 and 9 and (e) analysis of  percentage α-SMA in 
the granulation tissue of Siah2-/- wounds compared to Wt wounds.  Each data point 
represents a mean ± SEM (day 6 n=10, day 9 n=8). Mann-Whitney’s U-test analysis was 
used to determine statistical significance. *** P<0.001, * P<0.05        
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3.2.6. Vessel distribution in Siah2
-/-
 wounds  
Angiogenesis in a critical physiological process in wound healing that involves growth of 
new vessels from damaged pre-existing vessels and possibly from circulating precursor 
cells. Blood vessels function as conduits for the delivery of oxygen and nutrients to the 
repairing tissue.  To investigate the impact of Siah2 deficiency on angiogenesis, vessels 
were counted and vascularity (vessels counts/area) analysed in Siah2-/- and Wt wounds. 
CD31 immunostaining was used to localise vessels in wound sections and gain a 
qualitative view of vessel distribution. However, due to difficulties associated with non-
specific staining on paraffin embedded sections, CD31 immunostaining was only used to 
generate representative images of wound angiogenesis. H&E stained sections were 
instead used to count vessels and analyse vascularity.  Additionally, CD31 staining and in 
fact other vessel markers tested, tended to have heterogeneous staining patterns with 
some micro-vessels detected and some not and for this reason, vessel profiles were 
counted. Overall granulation tissue vascularity (vessels counts/area) was analysed using 
H&E stained sections (Figure 3-6e). At both day 6 (0.29 ± 0.03 counts/μm2, P<0.05, 
n=10) and 9 (0.23 ± 0.03 counts/μm2, P<0.05, n=8) post-injury Siah2-/- wounds had 
significantly less vascularity in the granulation tissue in comparison to Wt wounds (0.37 
± 0.02 counts/μm2, n=10 and 0.31 ± 0.03 counts/μm2, n=8, respectively).  
 
 Further analysis of central granulation tissue vascularity was performed (Figure 
3-6d). At 6 days post-injury Siah2-/- wounds (0.18 ± 0.04 counts/μm2, P<0.01, n=10) had 
significantly less vascular density in central regions of granulation tissue in comparison 
to the Wt wounds (0.39 ± 0.05 counts/μm2, n=10). At 9 days post-injury, Siah2-/- wounds 
(0.12 ± 0.04 counts/μm2, P= 0.08, n=8) had less vascularity in the central granulation, 
albeit not significantly when compared to Wt wounds (0.26 ± 0.06 counts/μm2, n=8). 
The results demonstrate the importance of Siah2 activity in wound healing 
angiogenesis. These results also support other studies that show a role for Siah2 in 
regulation of pathological angiogenesis, mostly in cancers (Nakayama et al., 2004, 
Moller et al., 2008, Qi et al., 2008).   
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Figure 3-6. Vessel distribution in Siah2
-/-
 and Wt wounds. (a-d) CD31 immunostained 
and scanned sections of Wt and Siah2-/- wounds at day 6 and 9 are shown (leading edge 
of newly formed vessels indicated by black arrows and yellow dashed lines). (e) Analysis 
of vessel counts per area (µm) in whole wounds and (f) wound centres using H&E 
sections at high magnification (х 20).  Each data point represents a mean ± SEM (day 6 
n=10, day 9 n=8). Mann-Whitney’s U-test analysis was used to determine statistical 
significance. ** P<0.01, * P<0.05        
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3.2.7. Glut-1 expression and HIF-1 transcriptional activity in Siah2
-/-
 wounds 
Glucose transporter-1 has been used as a surrogate marker of hypoxia by virtue of its 
regulation by HIF-1. As cells become hypoxic and switch to anaerobic respiration for 
energy, they up-regulate Glut-1(Young and Moller, 2010). Spatio-temporal expression of 
HIF-1 and its downstream targets (Glut-1 and PGK-1) have been well described during 
wound healing (Elson et al., 2000). To confirm the role of Siah2 on HIF-1 transcriptional 
activity, Glut-1 immunostaining was performed on wound sections, with particular 
emphasis of day 6 and 9 sections where hypoxia is reported to be prevalent (Lokmic et 
al., 2006) (Figure 3-7). At day 6 post-injury, Siah2-/- wounds showed positive but faint 
Glut-1 staining along the cell membranes of re-epithelialising basal keratinocytes 
compared to strong staining in Wt keratinocytes (Figure 3-7a). By day 9 post-injury, both 
Siah2-/- and Wt wounds had relatively low Glut-1 staining around the membranes of 
scattered basal keratinocytes (Figure 3-7b) suggesting that hypoxia had reduced by this 
time. Glut-1 expression is a marker for hypoxia and increased HIF-1-regulated 
transcriptional activity. Therefore, the results indicate that HIF-1 activity and normal 
responses to wound hypoxia may be highly dependant on Siah2 activity.  
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Figure 3-7 Activation of hypoxia induced signalling in Siah2
-/-
 and Wt wounds using 
Glucose transporter 1 (Glut-1) as a marker. (a) Qualitative Glut-1 immunostained 
wound sections at day 6 and (b) day 9 post-injury. Magnification, (a) = х20 and (b) = х40. 
Scale in (a), 1 bar =100µm. 
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3.2.8. Apoptosis in Siah2
-/-
 wounds  
As the wound closes, myofibroblastic and vascular cells undergo programmed cell death 
which eventually causes a loss in cellularity and scar maturation (Darby et al., 1990, 
Desmouliere et al., 1995). To test if Siah2 had any effect on the onset or level of 
apoptosis, TUNEL staining was performed. Figure 3-8 (a-c) shows typical sections of 
Siah2-/- and Wt wounds at day 6, 9 and 12 post-injury. In the earlier phases of healing 
(day 6) TUNEL staining was barely detected in both Siah2-/- and Wt wounds. Apoptotic 
nuclei were more pronounced in both Siah2-/- and Wt wounds at days 9 and 12 post-
injury. The results suggest no obvious effect of Siah2 on the rate apoptosis.   
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Figure 3-8. Visualisation of apoptotic nuclei in the granulation tissue. (a-c) TUNEL 
stained Siah2-/- and Wt wounds at days 6, 9 and 12. Black arrows show TUNEL stained 
apoptotic nuclei in the granulation tissue. Magnification of (a), (b) and (c) = х20. 
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3.3. Discussion  
3.3.1. Hypoxia through HIF-1 regulates wound healing  
Wound healing consists of three overlapping phases: inflammation, proliferation, and 
maturation and remodelling (Clark, 1996). These phases are regulated by complex 
signalling pathways that may be activated or deactivated by an array of soluble factors 
secreted by inflammatory and mesenchymal cells. These highly orchestrated events may 
be subject to several abnormalities. These abnormalities can occur at different phases of 
wound repair and lead to different types of abnormal wound healing with significant 
burden to the patient and health care system (Darby and Hewitson, 2007, Sen et al., 
2009).  
 
Acute tissue hypoxia is a characteristic microenvironment of injured tissues owing to 
vessel disruption and the high metabolic demands of wound repair cells (Remensnyder 
and Majno, 1968, Haroon et al., 2000, Lokmic et al., 2006). Low oxygen tension provides 
a strong biological stimulus for chemotaxis of tissue repair cells particularly 
inflammatory and mesenchymal cells. In normal healing acute hypoxic gradients are 
important stimuli for inflammation, re-epithelialisation, matrix synthesis and 
angiogenesis (Knighton et al., 1981, Knighton et al., 1983, O'Toole et al., 1997, Ridgway 
et al., 2005, Falanga et al., 2002, Steinbrech et al., 1999). Therefore, abnormal responses 
to hypoxia present an important mechanism by which wound healing may be impaired 
or overstimulated.   
 
Cellular adaptive responses to hypoxic conditions are mostly regulated by HIF-1, a 
master regulator of oxygen homeostasis (Semenza, 1998). HIF-1 directly and indirectly 
controls the transcription and activation of hundreds of genes that can enhance cell 
function during low oxygen tension. The relevance of HIF-1 in the wound healing milieu 
has been demonstrated in several transgenic and pathologically HIF-1-deficient 
cutaneous wound studies, most of which are characterised by delayed wound healing 
(Loh et al., 2009, Botusan et al., 2008, Tang et al., 2004, Zhang et al., 2010b). 
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Additionally, abnormal accumulation of HIF-1 is associated with the pathogenesis of, 
and predisposition to fibroproliferative disorders (Distler et al., 2007, Zhang et al., 
2003b, Wipff et al., 2009). Therefore, targeting HIF-1 and its regulatory factors may have 
important clinical implications in the treatment and management of abnormal wounds. 
 
HIF-1 transcriptional activity is tightly regulated through several proteins which control 
post-translational availability of the HIF-1α subunit. Siah proteins are a family of E3 
ubiquitin ligases that tag HIF-prolyl hydroxylases for degradation during hypoxia and 
thus positively regulate HIF-1α availability and the expression of hypoxia inducible genes 
(Nakayama et al., 2004, Fukuba et al., 2007). The relevance of Siah-HIF-1 axis in hypoxia 
driven pathophysiology has been demonstrated in several mice cancer models using 
xenografts including prostate, breast and lung (Ahmed et al., 2008, Moller et al., 2008, 
Qi et al., 2008). Here, the role of Siah2 in normal healing of an excisional skin wound is 
described for the first time.  
 
3.3.2. Delayed wound healing in Siah2
-/-
 mice  
Inflammation acts as a protective attempt to remove microbes and injurious debris 
during wound healing. In addition, inflammatory cells in particular macrophages are 
widely appreciated as important regulators of cytokines and growth factors during 
wound healing (Leibovich and Ross, 1975). These released factors are critical for normal 
wound healing, so much so, that selective and specific ablation of skin macrophages 
results in severe impairment to multiple phases of adult cutaneous wound healing 
including re-epithelialisation, angiogenesis, formation of granulation tissue and wound 
contraction (Mirza et al., 2009). In contrast, an alternative study has reported normal 
wound healing kinetics using young PU-null mice, which are genetically incapable of 
raising an immune response due to a lack of macrophage progenitor lineages and 
functioning neutrophils, and that healing in these mice results in embryonic-like scarless 
wound repair (Martin et al., 2003). A similar study has yet to be conducted in adult 
animals where a reliance on immune responses would be more likely.    
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Macrophages typically accumulate in hypoxic areas, characteristic of most injured tissue 
and pathological lesions (Lewis et al., 1999, Bosco et al., 2008). Hypoxia is a feature of 
inflammation and has a profound effect on a several myeloid cells properties including 
cytokine expression, phagocytosis, cell surface maker expression, migration and cell 
survival (Lewis et al., 1999).  It is now well appreciated that HIF-1 directly regulates 
genes associated with survival and myeloid cell function in the inflamed 
microenvironment (Cramer et al., 2003). Importantly, HIF-1 regulates myeloid cell 
aggregation, metabolism, motility, invasiveness, cytokine release and phagocytic 
potential during inflammation (Cramer et al., 2003). In cutaneous wound healing, the 
relevance of HIF-1 in inflammation is demonstrated by considerable delays in myeloid 
cell infiltration and cytokine release in HIF-1α deficient mouse models (Botusan et al., 
2008, Zhang et al., 2010b).  
 
This study provides evidence of a role of the Siah2-HIF-1 axis in macrophage invasion 
during wound healing. Herein, Siah2-/- mice show reduced wound macrophage numbers 
particularly at six days post injury when compared to Wt mice, as determined by F4/80 
immunostaining (Figure 3-4). The finding is indicative of attenuated macrophage 
invasion in the absence of Siah2 and correlates to a delayed or abrogated inflammatory 
response during wound hypoxia. This finding is consistent with the role of HIF-1 in 
myeloid cell function during tissue inflammation and the positive regulation of HIF-1 
availability by Siah2 (Cramer et al., 2003, Zhang et al., 2010b, Nakayama et al., 2004). 
Macrophages are critical to the debridement of apoptotic cells and damaged tissue, 
which are important stimuli for the secretion of several important cytokines (TGFβ1 and 
VEGF) (Peters et al., 2005, Mirza et al., 2009). Therefore secondary to reduced HIF-1 
availability, Siah2-/- wounds with reduced macrophages are likely to be deficient in 
macrophage-derived cytokines.   
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Following inflammation, rapid restoration of the epithelial barrier helps to seal the 
wounded area from the external environment and prevents further infiltration by micro-
organisms (Clark et al., 1982a). Furthermore, keratinocytes are an important source of 
paracrine factors that regulate the spatio-temporal function of other mesenchymal cells 
including fibroblasts and endothelial cells (Werner et al., 2007). Successful re-
epithelialisation relies on rapid proliferation, differentiation and migration of 
keratinocytes from the edges of the wound to cover a mostly fibronectin-rich 
provisional matrix (Clark et al., 1982a).  
 
Re-epithelialisation of the wound requires adaptive responses to acute hypoxia, as 
migration of keratinocytes proceeds over an avascular provisional matrix. During wound 
re-epithelialisation HIF-1α and the expression of its downstream targets (Glut-1, 
phosphoglycerate kinase (PGK)-1, and VEGF are transiently increased correlating to the 
presence of tissue hypoxia and an adaptive response to the hypoxic stimulus (Elson et 
al., 2000, Haroon et al., 2000, Lokmic et al., 2006). Increased expression of Glut-1 and 
PGK-1 would be necessary for the provision of metabolic energy required for increased 
cell migration and proliferation which may suggest that rapid re-epithelialisation is 
partly hypoxia-driven. In vitro, hypoxia enhances keratinocyte migration on connective 
tissue (fibronectin and collagen), a process associated with increased integrin and MMP 
expression (O'Toole et al., 1997, Ridgway et al., 2005). Additionally, given that HIF-1α 
inhibition or deficiency dramatically delays keratinocyte migration (Fitsialos et al., 2008, 
Xia et al., 2001), it is likely that HIF-1 plays a central role in directly or indirectly 
regulating integrins and MMPs. Furthermore, HIF-1 suppresses expression of the cell to 
cell adhesion protein, E-cadherin, thus allowing keratinocytes to switch to a migratory 
phenotype (Grzesiak and Pierschbacher, 1995, Esteban et al., 2006).  
 
The Siah2-HIF-1 axis appears to be relevant in the regulation wound re-epithelialisation. 
Herein, Siah2-/- mice show delayed wound re-epithelialisation (Figure 3-1) and reduced 
Glut-1 expression in the basal keratinocytes of the re-epithelialising sheet (Figure 3-7) at 
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days six post-injury in comparison to Wt mice. Rapid re-epithelialisation is a high energy 
demanding event requiring up-regulation of metabolic proteins. Reduced Glut-1 
expression would therefore partly explain the delay in epithelial regeneration in Siah2-/- 
wounds. Furthermore, because Glut-1 is a well defined downstream marker of HIF-1 
transcriptional activity, it is conceivable that other HIF-1 regulated processes are 
reduced in the Siah2-/- wound milieu that may have contributing effects to the delay in 
closing the epithelial defect. For, example reduction in macrophage invasion in the 
absence Siah2 would correlate to a reduction in macrophage-derived cytokines. 
Macrophage derived cytokines including FGF2, KGF, TGFβ1 and TGFα and these are 
viewed as important in stimulating re-epithelialisation (Gailit et al., 1994, Li et al., 2004, 
Li et al., 2006). Additionally, HIF-1 deficiency in the absence of Siah2, may have a 
negative bearing on modulation of migratory proteins, such as regulation of cell to cell 
adhesion proteins (e-cadherin), cell matrix receptor (integrins) and MMPs, which are 
normally modulated by hypoxic stimuli to enhance migration (O'Toole et al., 1997, 
Ridgway et al., 2005, Esteban et al., 2006). 
 
In addition to epithelial regeneration, the restoration of tissue integrity and vasculature 
are fundamental functions of the granulation tissue during wound healing. Following 
tissue insult, fibroblasts infiltrate the provisional matrix from local mesenchymal 
connective tissue and bone marrow-derived circulating progenitor lineages in response 
to released inflammatory factors (Leibovich and Ross, 1975, Leibovich and Ross, 1976, 
Abe et al., 2001). As fibroblasts migrate into the wound they replace provisional matrix 
with granulation tissue matrix (mostly type I and III collagen) whilst simultaneously 
releasing proteolytic factors and their inhibitors ensuring organised formation of 
granulation tissue through remodelling (Salo et al., 1994, Darby et al., 2002). 
Furthermore, autocrine and paracrine factors released by activated fibroblasts take over 
from overlapping inflammatory cell-derived factors becoming the central regulators of 
subsequent cell proliferation and tissue remodelling events including angiogenesis, 
matrix synthesis/remodelling and wound contraction (Denton et al., 2009). With 
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increasing tension generated by matrix remodelling, mechano-perception via cell-matrix 
junctions (fibronexi and focal adhesions) become activated causing fibroblasts to further 
differentiate into myofibroblasts characterized by expression of α-SMA (Tomasek et al., 
2002, Hinz et al., 2003, Hinz and Gabbiani, 2003a, Hinz and Gabbiani, 2003b).  In 
addition to tension, TGFβ and the fibronectin splice variant ED-A fibronectin are also 
required for this phenotypic change (Desmouliere et al., 1993, Serini et al., 1998). The 
expression of αSMA in the granulation tissue is transient and correlates to a contracting 
phase of healing (Gabbiani et al., 1971, Darby et al., 1990). Furthermore, the presence 
of myofibroblasts is synonymous with increased production of collagenous matrix 
(Schmid et al., 1998).  
 
Over the years the role of HIF-1 and hypoxia on fibroblast function has been well 
defined. In culture acute hypoxia (0 to 72 hours) there is enhancement of several 
fibroblast functions including migration, proliferation and production of collagenous 
matrix through up-regulation of TGFβ1 (Falanga and Kirsner, 1993, Falanga et al., 1991, 
Falanga et al., 2002, Steinbrech et al., 1999).  Accumulating evidence, points to a strong 
correlation between HIF-1 activity and enhanced TGFβ signalling by dermal fibroblasts. 
Increased HIF-1 signalling enhances fibroblast expression of matrix proteins (collagens 
and fibronectin), growth factors (TGFβ, CTGF, and VEGF) and TGFβ1 activating factors 
(thrombospondin-1) (Distler et al., 2007, Higgins et al., 2004). The relevance of HIF-1 in 
the regulation of these factors during hypoxia has been convincingly tested using HIF-1 
depleted or inhibited fibroblasts (Distler et al., 2007, Higgins et al., 2004). The evidence 
suggests that HIF-1 is important in the regulation of dermal fibroblast function during 
angiogenesis and granulation tissue formation, events that occur in relatively hypoxic 
conditions (Lokmic et al., 2006). Indeed recent cutaneous burn wound healing in HIF-1α 
heterozygous null mice showed a significant reduction in wound vascularization, 
perfusion and granulation tissue contraction (Zhang et al., 2010b).  
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Consistent with other HIF-1 depletion studies (Distler et al., 2007), the findings of the 
current study demonstrate the importance of hypoxia signalling in fibroblast function in 
vivo.  In our study, Siah2-/- mice show delays in collagen deposition six days post injury in 
comparison to Wt mice, as determined by picrosirius red staining (Figure 3-2). Acute 
hypoxia increases collagen production by dermal fibroblast in a manner that is most 
likely TGFβ-dependant (Falanga et al., 2002, Siddiqui et al., 1996). The type I collagen 
gene has not been shown to contain a HRE and therefore HIF-1 does not directly 
regulate its transcription (Falanga et al., 2002). Instead, HIF-1 regulates the expression 
and activation of factors which can directly augment collagen production by dermal 
fibroblast in hypoxia including procollagen hydroxylase, TGFβ, CTGF and the TGFβ 
activating protein thrombospondin-1 (Hofbauer et al., 2003, Distler et al., 2007).  
Therefore by virtue of HIF-1 deficiency it is conceivable that matrix deposition 
enhancing events during hypoxia are defective in Siah2-/- wounds. Furthermore reduced 
macrophage invasion in Siah2-/- may also restrict the levels of paracrine cytokine 
expression and secretion required for normal fibroblast function and matrix synthesis. 
Collectively, this would explain the simultaneous delay in αSMA expression seen in the 
granulation tissue of Siah2-/- mice (versus Wt)(Figure 3-5), a process that is matrix and 
cytokine dependent. Consequently, the delay in αSMA expression and collagen 
deposition suggests impairment in wound contraction (Figure 3-1). 
 
Blood vessels function as conduits for the delivery of oxygen and nutrients in all 
physiological and pathological states (Clark, 1996). Following full-thickness cutaneous 
injury, vessels are generally disrupted and neovascularization of the newly formed 
granulation tissue is essential for successful wound healing (Remensnyder and Majno, 
1968). Hypoxic gradients are mandatory stimuli for achieving good angiogenesis during 
wound healing (Knighton et al., 1981). Hypoxia is well known to induce the up-
regulation of major angiogenic factors, the recruitment of inflammatory and progenitor 
endothelial cells as well as the migration of fibroblasts and keratinocytes which 
coordinate the angiogenic effort (Steinbrech et al., 1999, Cramer et al., 2003, Berse et 
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al., 1999, Weir et al., 2011, Albina et al., 1995, Jeon et al., 2007, Harmey et al., 1998, 
Kuwabara et al., 1995, Zhang et al., 2010b).  
 
Expression of virtually all critical angiogenic growth factors required for local activation 
of vascular cells during angiogenesis is induced by HIF-1, including FGF-2, VEGF, stromal 
derived factor 1 (SDF-1), Ang 2, PDGF and TGFβ (Forsythe et al., 1996, Loh et al., 2009, 
Distler et al., 2007, Semenza, 2010). The released factors also serve as homing signals 
for mobilization and recruitment of circulating angiogenic cells (CACs) (progenitor 
endothelial cells and bone marrow derived myeloid cells) from distant sites such as bone 
marrow and vessels from other tissue (Botusan et al., 2008, Loh et al., 2009, Zhang et 
al., 2010b).  
 
Impairment of HIF-1-dependent responses to hypoxia is a major factor contributing to 
the impaired vascular responses to wound ischaemia. For example, defective HIF-1 
signalling has been identified in ageing- and diabetes-related impaired angiogenesis 
during wound healing in animal models, and correction by constitutive expression or 
stabilization of HIF-1 significantly improves the angiogenic defect and accelerates 
wound healing (Botusan et al., 2008, Liu et al., 2008). Conversely, prolonged hypoxia 
and over stimulation of HIF-1 associated responses are viewed as an important 
mechanism involved in elaborate angiogenesis that could drive pathological conditions. 
High levels of HIF-1 and its downstream targets (such as VEGF) are reported in a variety 
of pathological wound healing or fibroproliferative disorders including keloid lesions, 
arthritis,  pulmonary fibrosis and liver cirrhosis (Distler, 2003, Zhang et al., 2006, 
Tzouvelekis et al., 2007, Bozova and Elpek, 2007). Consequently, targeting HIF-1 
signalling is viewed as an important candidate therapeutic target for the treatment of 
fibrotic diseases (Distler et al., 2007, Moon et al., 2009) Furthermore, impaired 
angiogenesis and reduced mobilisation of endothelial progenitor cells and has been 
demonstrated in wound healing models of HIF-1 heterozygous null and conditional HIF-1 
deficient (endothelial) mice (Tang et al., 2004, Zhang et al., 2010b). These studies 
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confirm that acute hypoxia responses mediated through HIF-1 are required for good 
angiogenic responses during wound healing.   
 
The findings of this present study demonstrate the relevance of Siah2 in the regulation 
of angiogenesis during wound healing. Herein, Siah2-/- mice showed a delay and overall 
reduction in vascularity (Counts/area) at day six and nine post injury (Figure 3-6(e)). 
Furthermore, analysis of central regions of the granulation tissue revealed the greatest 
difference in vascularity between Siah2-/- and Wt mice, indicating that angiogenic 
responses in Siah2-/- wounds were especially impaired towards the central likely most 
hypoxic regions of the granulation tissue, since these are most distant from blood 
supply (Figure 3-6(f)). The findings of delayed angiogenesis are consistent with results in 
other HIF-1 deficient wound healing models where reduced angiogenic factors such as 
VEGF and SDF-1 are a major contributing factor (Tang et al., 2004, Zhang et al., 2010b). 
VEGF is arguably the most potent and important angiogenic growth factor and is an 
important downstream target of HIF-1. In this context Siah2-/- mice have previously been 
shown to have reduced VEGF expression in hypoxia (Nakayama et al., 2004). This would 
partly explain the delay in angiogenesis seen in the present study. Furthermore, 
paracrine sources of VEGF such as macrophages, fibroblasts and keratinocytes are fewer 
or delayed in invasion of Siah2-/- wounds. Additionally, rapid and organised capillary 
formation by endothelial cells is highly dependent on the presence of collagen 
(Montesano et al., 1983). Therefore reduced collagen deposition by 
fibroblasts/myofibroblast may also contribute to rate limiting of the angiogenic process 
in Siah2-/- mice. Additionally, it is likely that lack of macropahges seen in the Siah2-/- 
wounds could also inpart be due to the reduced number blood vessels which may have 
potentially prevented a steady influx of these cells into the site of injury. 
 
Siah2 has also been described to regulate pathophysiological events such as 
angiogenesis through HIF-1-independent mechanisms (Qi et al., 2008). Mammalian 
Sprouty (Spry) gene expression is rapidly induced upon activation of the FGF receptor 
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signalling pathway in multiple cell types, including cells of mesenchymal and epithelial 
origin, where it functions as a negative regulator of FGF mediated signaling (Nadeau et 
al., 2007). Siah2 negatively regulates Spry 1 and 2 (tumour repressor protein) by tagging 
it for proteosomal degradation (Nadeau et al., 2007). Endogenous Spry2 has recently 
been shown to function as a negative regulator of angiogenesis in the late phase of 
wound healing (Wietecha et al., 2011) suggesting that its activity is tightly regulated 
during the early phases of healing. Additionally, wounds treated with the dominant-
negative Spry2 exhibit a moderate increase in vascularity (Wietecha et al., 2011). It is 
therefore conceivable that Siah2 regulates endogenous Spry activity in the early phases 
of wound healing when rapid and organized angiogenesis is critical.  
 
Interestingly, despite the delay in major wound healing parameters observed in Siah2-/- 
wounds, proliferation as determined by PCNA staining did not reveal any significant 
difference at day six (versus Wt) (Figure 4-3). And even more surprising, was the 
significant increase in proliferation observed in the Siah2-/- nine day wounds (Figure 4-
3). The reasons for this observation are not clear, but raise the possibility of 
compensatory mechanism(s) in the wound leading to the recovery of Siah2-/- mice. Siah 
E3 ubiquitin ligases tag a range of proteins for proteosomal degradation including TNF-
receptor associated factor 2 (TRAF2), synphilin-1, N-cor, m-cyb, Sprouty and β-catenin  
(Liu et al., 2001, Matsuzawa and Reed, 2001, Hu et al., 1997, Hu and Fearon, 1999, Li et 
al., 2002, Nadeau et al., 2007). Reduced regulation of one or more of these proteins in 
Siah2-/- wounds may be a possible explanation for the increase in proliferation. 
Deregulated β-catenin expression for example, has previously been described to 
promote cell hyperproliferation during wound healing (Cheon et al., 2006). Furthermore 
m-cyb functions as a promoter of hematopoietic progenitor cells proliferation during 
normal murine fetal hepatic hematopoiesis and mesenchymal cell proliferation during 
skin wound healing (Mucenski et al., 1991, Kopecki et al., 2007). Additionally, functional 
redundancies between Siah1 and Siah2 isoforms have previously been described (Frew 
et al., 2003) and cannot be ruled out as a possible factor for the increase in proliferation 
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seen in Siah2-/- mice. Unfortunately, lethality in Siah1/2 double knockout transgenic 
mice has restricted investigations in absolute Siah deficient models (Frew et al., 2003).  
 
Remodelling is characterised by contraction of the granulation tissue, degradation of 
collagen and a significant loss in cellularity in the wound bed, the net result of which is a 
markedly less cellular and less vascular scar (Darby et al., 2002, Gabbiani et al., 1971, 
Desmouliere et al., 1995) Myofibroblasts expressing contractile actin (αSMA) align 
parallel to the direction of mechanical tension by adhering to collagen through focal 
adhesion proteins and integrins (Darby et al., 1990, Tomasek et al., 2002, Tomasek et 
al., 1992, Hinz et al., 2003). Myofibroblasts also make fibronexus connections to each 
other (Singer et al., 1985). TGFβ1 in combination with the splice variant fibronectin (ED-
A FN) and mechanical stress stimulate contraction of αSMA bundles which significantly 
reduces the granulation tissue area (Desmouliere et al., 1993, Serini et al., 1998). 
Following contraction αSMA positive myofibroblasts and vascular numbers in the 
granulation tissue are reduced by the induction of apoptosis late in wound healing when 
re-epithelialisation has occurred (Desmouliere et al., 1995).  
 
In this study the role of Siah2 in tissue contraction and remodelling was considered 
through analysis of αSMA expression (Figure 3-5) and localisation of apoptotic nuclei 
(Figure 3-8). Siah2-/- wounds show reduced αSMA expression in granulation tissue 
correlating with the delay in wound contraction (Figure 3-1), suggesting a possible delay 
in granulation tissue remodelling. Paradoxically, no overt differences in apoptosis were 
visible following localization of apoptotic nuclei using TUNEL immunostaining. The 
phenotypic difference in rate of healing as analysed by granulation tissue size (Figure 3-
1) would demand a difference in the rate of cellular loss as the wounds contract at 
different rates. The inability of TUNEL staining to differentiate between necrotic and 
apoptotic nuclei may be a factor in the lack of difference between Siah2-/- and Wt 
wounds or the possibility that small differences observed at any one timepoint may 
have significant effects on the rate of cell loss and these were not picked up using the 
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TUNEL technique. Therefore other apoptotic makers such as activated caspase-3 
staining may be required to draw a conclusion on the effect of Siah2 in wound 
remodelling.  
 
3.3.3. Clinical implications 
The results of this study may have several important clinical implications. Firstly, genetic 
or pharmacological strategies to increase Siah levels may be beneficial in increasing HIF-
1α levels in tissue. Increased HIF-1α has been shown to promote vascularisation and 
improve healing in ischaemic, excisional and burn wounds (Botusan et al., 2008, Liu et 
al., 2008). This is especially important for specific groups such as the aged and diabetic 
subjects who may be prone to HIF-1 deficiency in hypoxia (Catrina et al., 2004, Botusan 
et al., 2008, Liu et al., 2008, Loh et al., 2009) The use of HIF-hydroxylase (PHD) inhibitors 
to improve wound healing has also been demonstrated in cutaneous wound healing 
models in animals (Botusan et al., 2008). PHD inhibitors are now in clinical trials for the 
treatment of several ischaemia-related pathologies such as chronic wounds, anaemia, 
ischaemic heart disease, stroke, cancer, and pulmonary hypertension (Smith and Talbot, 
2010). This strongly supports the use of Siah or a pharmacological mimetic in the 
treatment of ischaemic wounds. Accelerated healing by Siah over-expression may also 
be beneficial in preventing scar formation, as slower healing wounds tend to scar 
excessively (Cubison et al., 2006). Furthermore, Siah may be relevant in enhancing skin 
graft “take rates”, granulation tissue formation and epithelialisation, which have 
recently been demonstrated to be dependent on myeloid cell HIF-1 activity (Vural et al., 
2010).  
 
Conversely, inhibition of Siah using specific pharmacological inhibitors may prove 
beneficial in the treatment of fibroproliferative disorders, where HIF-1α is over-
expressed or expressed chronically and thought to promote fibrosis (Distler et al., 2007, 
Zhang et al., 2006). This may be especially important for patients with increased 
susceptibility to fibrotic disorders owing to HIF-1A gene polymorphisms (Wipff et al., 
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2009).  At present, menadione (a Vitamin K derivative) is the only pharmacological 
inhibitor of Siah2 (Shah et al., 2009). Menadione topical creams are currently in trials for 
treatment or prevention of EGFR inhibitor-induced skin rashes (Li and Perez-Soler, 
2009). Based on the results of the current study, experiments to test effect of 
menadione in a wound healing scenario would seem desirable.   
 
3.4. Conclusion 
In summary, hypoxia is an important part of the microenvironment in early wound 
healing. Adaptive responses to hypoxia are controlled by HIF-1, which is positively 
regulated by Siah2. This study demonstrates for the first time a role for Siah2 in wound 
healing. Cutaneous wound healing of Siah2-deficient mice results in delayed 
recruitments of macrophages, delayed migration of vessel cells, delayed fibroblast – 
myofibroblast transformation and reduced extracellular matrix deposition during the 
early phase of wound healing. Modulation of Siah may therefore have important clinical 
implications in the treatment of abnormal wounds. 
 
3.5. Specific experimental methods: 
Mentioned here are summarised methods including only relevant details pertaining to 
this chapter. For specific details of individual methods please refer to the general 
methods and materials chapter (Chapter 2).  
 
3.5.1. Wound preparation, extraction and embedding 
42 mice of C57 strain (genotype; 21 Siah2-/- and 21 Siah2+/+ (Wt)) were kindly provided 
by our collaborator Dr A MÖller of Peter MacCallum Institute. Animals were age (10 ± 2 
weeks) and sex matched (male only) anaesthetised, shaved, the skin disinfected and 
wounded (5mm radius full-thickness using a sterile punch biopsy) on the upper dorsum. 
Wounds were dressed and allowed to heal by secondary intention. Hypoxia in wound 
Chapter 3 
a 
147
healing is evident between days 3-10 post injury (Lokmic et al., 2006) and therefore 
animals were sacrificed and wounds were extracted mostly after 6 days (n=10) and 9 
days (n=8) and to a lesser extent  at 12 days (n=3). Wounds were then trimmed, fixed 
(4% paraformaldehyde) and embedded in paraffin. Histological analysis was performed 
on serial sections from the central portion of the wound.  
  
3.5.2. Histological staining 
Sections were stained with haematoxylin and eosin (H&E) and picrosirius red (F3B4). 
H&E section were used to measure wound size (Cross section area (mm2)), % re-
epithelialisation and to estimate vascular density (vessel counts /μm2). Polarised light 
viewing of picrosirius red staining was used to determine percentage area of deposited 
collagen within the granulation tissue.   
 
3.5.3. Immunohistochemistry and TUNEL staining 
Immunohistostaining was performed by overnight incubation with primary mouse 
monoclonal anti- α SMA (1: 200 ) (Dako), rabbit polyclonal anti- CD31 (1: 100) (Abcam), 
mouse monoclonal anti - PCNA (1: 250), rabbit polyclonal anti-Glut-1(1: 400) or rat 
monoclonal anti – F4/80 (1: 50) (Abcam). Dual linked anti Mouse/ Rabbit IgG – Horse 
radish peroxidase (HRP) conjugated secondary antibody and a DAB kit (Dako) were used 
to visualise probed antigens. A biotinylated anti rat IgG secondary (Vector) and Vector 
ABC DAB kit (Vector) were used to visualise rat anti F4/80 staining.  
 
Terminal deoxynucleotidyl transferase mediated X-dUTP nick end labelling (TUNEL) 
staining kit (Promega, DeadEnd colorimetric kit) was used to detect DNA fragmentation 
(apoptotic nuclei). Immunohistochemistry and TUNEL sections were lightly 
counterstained with haematoxylin.  
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3.5.4. Statistical analysis  
Results are expressed as the mean ± standard error of mean (S.E.M) for 3 to 10 separate 
observations. Statistical analysis was determined by Mann-Whitney’s U-test analysis. P 
values between compared groups (Siah2-/- vs. Wt) less than or equal to 0.05 were 
considered to be statistically significant. 
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4. Chapter 4 
Deficiency of Siah2 and its effect on mouse 
dermal fibroblast function   
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4.1. Introduction 
The ability of dermal fibroblasts to migrate, proliferate, differentiate, contract and 
deposit collagenous matrix during wound healing is critical to events that lead to the 
formation/remodelling of granulation tissue, angiogenesis and the eventual restoration 
tissue integrity to damaged tissue (Ross and Benditt, 1962, Gabbiani et al., 1971, Darby 
et al., 1990, Denton et al., 2009). Acute tissue hypoxia is suggested to play an important 
role in modulating several fibroblast functions that promote wound healing (Siddiqui et 
al., 1996, Steinbrech et al., 1999, Falanga et al., 2002). Cell function in hypoxia is thought 
to be highly reliant on adaptive responses mediated through HIF-1 pathways (Semenza, 
1998), and may therefore be subject to regulation by Siah which positively regulates 
HIF-1α abundance during hypoxia (Nakayama et al., 2004). In the previous chapter 
(Chapter 3), the relevance of Siah2 was defined in early wound healing and delayed 
healing was observed in Siah2-/- mice. In the current chapter further characterisation of 
the effect of Siah2-deficiency on fibroblast function was studied in vitro using primary 
adult dermal fibroblasts derived from Siah2-/- mice as the primary cell model. We 
hypothesized that Siah would have a regulatory role during dermal fibroblast function in 
hypoxia. Additionally, the effect of Siah on dermal fibroblast response to growth factors 
such as TGFβ1 has not yet been tested in normoxia or hypoxia. Thus, the aim was to test 
the role of Siah2 in cell migration, proliferation, matrix synthesis, myofibroblast 
transition and cell contraction in three basic culture conditions that may be of relevance 
to wound healing; culture conditions supplemented with a growth factor (TGFβ1), 
hypoxic culture conditions alone and hypoxic conditions supplemented with TGFβ1. 
Furthermore, the impact of Siah2 on TGFβ1 signalling transduction in the three culture 
conditions was also tested. 
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4.2. Results  
4.2.1. Reduced HIF-1α levels in hypoxic Siah2
-/- 
dermal fibroblasts  
Siah2-/- embryonic fibroblasts show relatively normal behaviour in culture in terms of 
cell cycle, proliferation and survival (Frew et al., 2002). However, when challenged with 
hypoxic conditions, Siah2-/- show reduced availability of HIF-1α and expression of HIF-1 
target genes (Nakayama et al., 2004, Fukuba et al., 2007). To confirm that Siah2-/- mouse 
dermal fibroblasts (MDFs) derived from adult skin were impaired in their ability to 
stabilise HIF-1α during hypoxia, western blot analysis of HIF-1α protein levels was 
determined in Wt and Siah2-/- MDF cells incubated in hypoxia (1% O2) over time (0 to 48 
hours) under normal serum conditions (5%FBS)(Figure 4-1). Qualitatively, Wt MDFs 
increased HIF-1α abundance over time in hypoxia, with a peak in HIF-1α stabilization 
observed after 8 hours in hypoxia, after which HIF-1α protein levels gradually reduced 
but remained relatively stable for up to 48 hours, which was in keeping with other 
studies that show parabolic increases in HIF-1α expression in different tissue and a 
return to baseline levels over time in hypoxia (Stroka et al., 2001). In contrast HIF-1α 
was dramatically reduced and mostly undetectable in Siah2-/- MDFs using western blot 
analysis. These findings are in line with previous studies that have demonstrated the 
regulatory effects of Siah on HIF-1-prolyl hydroxylases (PHDs) and the role of Siah2 as a 
positive regulator of HIF-1α abundance in hypoxia (Nakayama et al., 2004)     
 
4.2.2. Reduced collagen expression in Siah2
-/-
 dermal fibroblasts  
Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the 
actions of TGFβ1 (Falanga et al., 2002) and a HIF-1α dependent mechanism (Distler et 
al., 2007). To investigate if the Siah-HIF1 axis had any regulatory effects on collagen 
synthesis, western blot analysis of COL1A1 protein levels was determined in Wt and 
Siah2-/- MDF cells incubated in hypoxia (1% O2) over time (0 to 48 hours) in normal 
serum conditions (5% FBS) (Figure 4-1). Protein levels (COL1A1) were analysed as 
arbitrary units derived from the ratio of COL1A1 and house keeper (β-actin) optical 
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density readings. β-actin readings appeared to be relatively strong and manifested with 
some non-specific binding around 30 to 50 Kilo Daltons, possibly due to high proteins 
loads (20ug), but appear to be consistent across all bands and of relativelyof similar 
intensity. Densitomery readings at 42 kilo Daltons only were used as house keepers. Wt 
showed an upward trend in COL1A1 expression with increasing time in hypoxia between 
0 (0.39 ± 0.23), 8 (0.48 ± 0.21), 24 (0.66 ± 0.06) and 48 hours in hypoxia (0.88 ± 0.08). In 
contrast, collagen protein levels in Siah2-/- MDFs appeared to decrease with increasing 
duration of hypoxia (0.53± 0.11, 0.44 ± 0.18 and 0.145 ± 0.04 at 0, 8 and 24 hours of 
hypoxia respectively) with the reduction becoming significant after 48 hours in hypoxia 
(0.09 ± 0.02, P<0.01) when compared to the Wt cells (0.66 ± 0.06).  These findings were 
suggestive of the regulatory effects of hypoxia on collagen expression (Distler et al., 
2007) and show that Siah2, presumably through HIF-1-regulated genes, may be involved 
in the regulation of collagen synthesis during hypoxia.  
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Figure 4-1. HIF-1α and COL1A1 protein levels in Wt and Siah2
-/-
 MDFs over time in 
hypoxia (0-48 hours). Western blot analysis of (a) HIF-1α and (b) COL1A1 protein levels 
in normalized protein amounts (20µg and 10µg respectively) of Wt and Siah2-/- MDF 
lysates after 0 to 48 hours in hypoxia (1%O2). β-actin loading control blots are also 
shown.(c) Analysis of COL1A1 protein levels in Wt (black bars) and Siah2-/- (grey bars), 
where arbitrary units represent the ratio of optical densities of COL1A1 to that of β-actin 
loading control. Each point represents the mean ± SEM of at least three independent 
experiments. Bonferroni’s two-way ANOVA was performed to determine significance.  
**P<0.01 (Molecular weight (Mw), HIF-1α, COL1A1 and β-actin ≈ 120, 90-140, and 42 
kilo-Daltons (kD) respectively) 
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4.2.3. Reduced TGFβ1 mediated COL1A1 expression in Siah2
-/-
 dermal fibroblast 
Exogenous TGFβ1 causes marked and rapid increase of collagen synthesis by dermal 
fibroblasts in vitro and inflammatory cell and mesenchymal cell release of TGFβ1 is 
important in regulating the formation of granulation tissue during wound healing and 
pathological fibrosis in vivo (Roberts et al., 1986). To examine whether Siah2 had any 
role in the regulation of collagen synthesis in response to exogenous TGFβ, Wt and 
Siah2-/- MDFs were serum starved then treated with TGFβ1 (5ng/ml), hypoxia or a 
combination of the two for 48 hours under low serum conditions (2% FBS). Western blot 
analysis was used to determine COL1A1 protein levels. Protein expression is 
represented as arbitrary units derived from the ratio of optical densities of COL1A1 to 
that of β-actin. In normoxic untreated culture conditions COL1A1 levels were similar 
between Siah2-/- and Wt MDFs (1.42 ± 0.13 and 1.43 ± 0.05, respectively). Conversely, 
Siah2-/- MDFs (1.32 ± 0.16, P<0.001) showed a failure to increase COL1A1 in normoxic 
conditions when supplemented with TGFβ1 compared to Wt MDFs (2.23 ± 0.21) 
suggesting a reduced responsiveness to the growth factor. Interestingly no significant 
differences were observed between Siah2-/- and Wt MDFs in hypoxia (1.61 ± 0.16 and 
1.30 ± 0.04 respectively) or hypoxic conditions supplemented with TGFβ1 (1.01 ± 0.01 
and 1.30 ± 0.04 respectively). This was somewhat contradictory to preliminary 
observations made above (Figure 4-1) where differences in COL1A1 protein levels 
between Wt and Siah2-/- MDFs were observed with increasing time in hypoxia. The 
reasons for this difference are not clear but may be reflective of different effects of the 
different serum levels (2% and 5% FBS) and varying ability of MDFs cells to adapt in 
response to hypoxic conditions in reduced versus normal serum conditions. The inability 
of Siah2-/- MDFs to increase collagen in normoxic conditions may still be relevant to 
Siah2 having a role in fibrogenesis and is suggestive of a role of Siah2 to regulation 
collagen beyond the hypoxic milieu.      
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Figure 4-2. Effect of Siah2 deficiency on TGFβ1-induced COL1A1 expression in 
normoxia and hypoxia. Western blot analysis of COL1A1 and β-actin using normalized 
protein mass (10µg) from Siah2-/- and Wt MDFs after 48 hours in TGFβ1 (5ng/ml) (N+), 
hypoxia (1%O2) (H) or both (hypoxia and TGFβ1) (H+). Control untreated Wt and Siah2-/- 
MDFs (N) are also shown. Collagen (COL1A1) protein levels in Siah2-/- (grey bars) and Wt 
(black bars) are analysed as arbitrary units (ratio of COL1A1 and β-actin optical density). 
Each point represents the mean ± SEM of at least three independent experiments. 
Bonferroni’s two-way Anova was performed to determine significance.  *** P<0.001   
(Molecular weight (Mw), COL1A1 and β-actin ≈ 90-140 and 42 kilo-Daltons (kD) 
respectively) 
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4.2.4. Normal proliferation in Siah2
-/-
 dermal fibroblasts 
Hypoxia has previously been demonstrated to be a modulator of proliferation and 
expansion of adult and neonatal human dermal fibroblasts seeded as single cells 
(Falanga and Kirsner, 1993, Oberringer et al., 2008). To investigate the effect of acute 
hypoxia and Siah-HIF-1 axis on cell proliferation, Siah2-/- MDF cells were exposed to 
TGFβ1 (5ng/ml), hypoxia (1%O2) or combined TGFβ1 and hypoxia for 48 hours and 
proliferation determined by an anti-PCNA antibody and flow cytometry analysis (Figure 
4-3). Forward and side scatter characteristics of MDFs were used for their preliminary 
identification and appropriate gates were further used to localise MDF cells and exclude 
cellular aggregates and debris. Proliferative activity was evaluated by a stimulation 
index, which was the ratio of mean fluorescence intensity of PCNA in treated MDFs to 
that of untreated MDFs . PCNA stimulation index in Wt MDFs increased by 30% (1.30 ± 
0.10) in TGFβ1, decreased by 7% (0.93 ± 0.07) in hypoxia and decreased 8% (0.92 ± 0.16) 
in hypoxic conditions supplemented with TGFβ1. In Siah2-/- MDFs, PCNA stlimulation 
index was unchanged in  TGFβ1 (0.98 ± 0.10), decreased by 15% (0.85 ± 0.08) in hypoxia, 
and decreased by 33% (0.67 ± 0.10) in hypoxic conditions supplemented with TGFβ1. 
PCNA stimulation index in Siah2-/- MDFs appeared to be unchanged in response to 
TGFβ1 in normoxia and decreased in hypoxia conditions when compared to Wts, 
however, the difference was not statistically significant. The results also fail to support 
the findings of other studies which have reported that hypoxia increases human dermal 
fibroblast proliferation (Falanga and Kirsner, 1993), but support the findings of other 
studies that report no significant change in proliferative activity of dermal fibroblast in 
hypoxia(Boraldi et al., 2007). It may be that proliferation in hypoxia as reported  by 
Falanga and others requires high amounts serums (20% FBS) (Falanga and Kirsner, 
1993), instead of low serum conditions (2% FBS) as used in our study or that longer 
periods of hypoxia are required to cause a difference. Overall, proliferation of MDFs 
appeared to be relatively unaffected by hypoxia and may be indicative of their ability to 
proliferate in hypoxia without the need for adaptive machinery regulated through Siah2-
HIF-1 axis, within the conditions applied and time point used in this study.  
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Figure 4-3. Characterization of the role of Siah2 in MDF proliferative activity. (a) Flow 
cytometry histograms of typical PCNA expression in Wt and Siah2-/- MDFs. Overlays; 
black (secondary antibody only), grey shaded (untreated group), red (5ng/ml TGFβ1), 
blue (hypoxia (1%O2)) and yellow (combined TGFβ and hypoxia)). (b) Dot plot of FSC 
versus SSC of MDFs and the cells gated for analysis are shown. (c) Proliferative activity in 
Wt (dot filled bars) and Siah2-/-(unfilled bars) was analysed as a stimulation index of 
PCNA, where the stimulation index was the ratio of mean fluorescence intensity of 
PCNA in treated (TGFβ1 (N+), hypoxia (H) and combination of both (H+) after 48 hours) 
to that of untreated MDF cells (N). Each point represents mean ± standard error of the 
mean of three separate experiments. Bonferroni’s two way ANOVA analysis was 
performed to determine significance. 
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4.2.5. Reduced αSMA expression in Siah2
-/-
 dermal fibroblasts   
Transient expression of αSMA in the granulation tissue during fibroblast-myofibroblast 
transition is a hallmark of normal wound healing and is synonymous with wound 
contraction (Darby et al., 1990). TGFβ1 induces αSMA expression and myofibroblast 
transition in quiescent and growing cultured fibroblasts (Desmouliere et al., 1993). To 
investigate the impact of Siah on fibroblast-myofibroblast transition in hypoxia, an anti- 
αSMA antibody and flow cytometry analysis was used following treatment of Siah2-/- 
and Wt MDF cells with TGFβ1 (5ng/ml), hypoxia (1%O2) or the combination of both 
(hypoxia and TGFβ1) for 48 hours. Forward and side scatter characteristics of MDFs 
were used for their preliminary identification and appropriate gates were further used 
to localise MDF cells and exclude cellular aggregates and debris. αSMA induction in 
response to treatment was evaluated by a stimulation index, which was the ratio of 
mean fluorescence intensity of αSMA in treated to that of  untreated control cells 
(Figure 4-4). In normoxic conditions, TGFβ1 equally increased the stimulation index of 
αSMA in both Siah2-/- (1.59 ± 0.06) and Wt MDFs (1.69 ± 0.07).  However, under hypoxic 
conditions the stimulation index of αSMA was significantly reduced in Siah2-/- MDFs 
(0.65 ± 0.04 , P<0.001) when compared to Wt MDFs (1.10 ± 0.04) where αSMA induction 
was moderately increased. Addition of TGFβ1 to hypoxic conditions failed to increase 
αSMA stimulation index in Siah2-/- MDF (1.15 ± 0.05, P<0.01), remaining significantly 
lower when compared to the Wt MDFs (1.51 ± 0.07) where αSMA stimulation index was 
markedly increased. The results indicate that Siah-HIF-1 axis may have a role in 
regulating maintenance of αSMA in hypoxia and the enhancement of TGFβ-stimulated 
αSMA induction in hypoxia. This implies that Siah2 via HIF-1 may have regulatory effects 
on fibroblast to myofibroblast differentiation in mouse skin fibroblasts.    
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Figure 4-4. Effect of Siah2 deficiency on αSMA induction in mouse dermal fibroblast. 
(a.) Flow cytometry histograms of αSMA expression in Wt and Siah2-/- MDFs. Overlays; 
black (secondary antibody only), grey shaded (untreated group), red (5ng/ml TGFβ1), 
blue (hypoxia (1%O2)) and yellow (TGFβ1 and hypoxia combined)). (b) Dot plot of FSC 
versus SSC of MDFs and the cells gated for analysis are shown. (c.) αSMA induction of 
Wt (dot filled bars) and Siah2-/- (unfilled bars) in response to treatment (TGFβ1 (N+), 
hypoxia (H) or both (hypoxia and TGFβ1)(H+) for 48 hours) was evaluated by a 
stimulation index, which was the ratio of mean fluorescence intensity of αSMA in 
treated to that of untreated controls cells (N-). Each point represents the mean ± SEM of 
at least three independent experiments. Bonferroni’s two-way ANOVA was performed 
(** P<0.01, *** P<0.001)      
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4.2.6. Effect of Siah2 on TGFβ1 mediated MDF collagen lattice contraction    
Wound contraction is generally associated with the presence of modified fibroblasts in 
granulation tissue and the transient expression of αSMA by these cells (Gabbiani et al., 
1971, Darby et al., 1990) although some contraction may be αSMA-independent and 
due to tractional forces generated by cell attachment and movement. TGFβ, 
extracellular matrix content and mechanical tension are also central to this contractile 
process (Montesano and Orci, 1988, Arora et al., 1999, Desmouliere et al., 1993). In 
monolayer cultures, αSMA stimulation index in Siah2-/- MDFs was found to be reduced 
in hypoxia (Figure 4-4). To investigate whether this had any impact on the ability of cells 
to contract, Siah2-/- and Wt MDFs were seeded into noncompliant collagen lattices (i.e. 
under tension) treated with TGFβ1, hypoxia or the combination of the two for 24 hours 
after which lattices were released, returned to their respective experimental conditions 
and allowed to contract for a further 24 hours. Contraction was calculated as the change 
in area (mm2) at time 0 and 48 hours after release. Siah2-/- MDFs showed reduced 
contraction in response to TGFβ1 (60.4 ± 2.31 mm2), hypoxia (21.8 ± 8.62 mm2) and 
hypoxia plus TGFβ1 (65.2 ± 3.00 mm2 ) when compared to the Wt MDFs (69.3 ± 7.20 
mm2, 31.2 ± 3.00 mm2, 80.7 ± 6.86 mm2 respectively), however, the results were not 
significantly different. The results are not conclusive but might be reflective of moderate 
impairment in Siah2-/- MDFs to respond effectively to stimuli from hypoxia and TGFβ1. 
Additionally, the results somewhat correlated to the finding of reduced αSMA 
expression in Siah2-/- MDF cells observed in monolayer cultures (Figure 4-5). Siah2 -HIF-1 
axis may have a role in regulating αSMA expression in hypoxia and to a lesser extent 
fibroblast contraction, which may be more dependent on additional factors such as 
mechanical tension, extracellular matrix content and stimuli from growth factors such as 
TGFβ1. 
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Figure 4-5. Effect of Siah2 deficiency on TGFβ1- and hypoxia-mediated MDF collagen 
lattice contraction.(a) Images of contracted collagen lattices (outline indicated by 
yellow dashed line) seeded with Wt and Siah2-/- MDFs following 48 hours of normoxic 
culture conditions (N) or treatment with either TGFβ1 (5ng/ml) (N+), hypoxia (1%O2) (H) 
or combined hypoxia and TGFβ1 (H+). (b) Analysis of contraction in Wt (black bars) and 
Siah2-/-(grey bars), where contraction was defined as the change in area (∆mm2) 
between time 0 and 48 hours after release. Each data point represents the mean ± 
standard error of the mean of three separate experiments (b). Bonferroni’s two way 
ANOVA analysis was performed to determine significance. 
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4.2.7. Effect of Siah2 on dermal fibroblast cell migration  
Hypoxia is a strong biological stimulus to dermal fibroblasts inducing migration during 
wound healing and has profound additive effects to migratory stimuli from cytokines 
and growth factors such as TGFβ (Mogford et al., 2002). However, hypoxia has also been 
shown to reduce dermal fibroblast migration with and without TGFβ1 in other studies 
(Oberringer et al., 2008). Migration of dermal fibroblasts in hypoxia is thought to be 
regulated mostly through HIF-1-dependent mechanisms (Li et al., 2007). To investigate 
the effect of Siah2 on dermal fibroblast migration, Siah2-/- and Wt MDFs were grown to 
full confluence and wounded by a scratch then incubated in TGFβ1 (1ng/ml), hypoxia 
(1%O2) or hypoxic conditions supplemented with TGFβ1. Migration was analyzed as the 
change in area (Pixels2X10000) of the wound at  0 time versus time posted treatment 
(16 hours). Siah2-/- MDF cells displayed a reduced (26.7 ± 4.47 Pixels2, P<0.01) migratory 
response to TGFβ1 in normoxic conditions compared to Wt MDFs (47.7 ± 3.07 Pixels2). 
Here, hypoxia appeared to be mostly inhibitory to migration in both Siah2-/- (29.9 ± 4.50 
Pixels2) and Wt MDFs (34.4 ± 4.37 Pixels2). And TGFβ1 was unable to attenuate the 
decrease in migration of hypoxic Siah2-/- (32.2 ± 3.05 Pixels2) and Wt MDFs (35.1± 6.04 
Pixels2). In hypoxia Siah2-/- MDFs appeared to migrate slower when compared to Wt 
MDFs, however, the difference was not significant. The findings demonstrate that Siah2 
may be important for the regulation migration in response to TGFβ in normoxic 
conditions. Additionally, Siah2 appeared to be dispensable in the regulation of migration 
in hypoxia where impairment to MDF migration may have occurred irrespective of 
adaptive responses regulated through Siah and presumably HIF-1.  
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Figure 4-6: Effect of Siah2 on TGFβ and hypoxia induced mouse dermal fibroblast 
migration. (a) Images of MDF monolayer scratch migration assay used to determine 
migration capabilities of Siah2-/- and Wt MDFs in TGFβ (1ng/ml) (N+) and hypoxia (1% O-
2) (H) or both (hypoxia and TGFβ1) (H+). Scratches of untreated MDF controls (N) are 
also shown. (b) Analysis of cell migration by Wt and Siah2-/- MDF, where migration 
represents the change in area (Pixels2) of the original scratch (T0) and wound area post 
treatment (TGFβ1, hypoxia or both (hypoxia +TGFβ1)) or control untreated conditions 
for 16 hours. Each point represents mean ± standard error of the mean of three 
separate experiments. Bonferroni’s two way ANOVA statistical analysis was performed 
to determine significance. **P<0.01 
4.2.8. Effect of Siah2-deficiency on TGFβ1 mediated Smad phosphorylation  
Cellular responsiveness to TGFβ1 is reliant on the growth factor binding to TGFβ 
receptors leading to phosphorylation of receptor activated Smad proteins and 
subsequent induction of TGFβ-regulated genes (Massague, 1998, Piek et al., 1999, 
Massague and Chen, 2000, Massague and Wotton, 2000). Siah2-/- MDFs showed 
reduced responsiveness to TGFβ in cell migration (Figure 4-6), collagen matrix synthesis 
(Figure 4-2) and αSMA expression (Figure 4-4). To investigate if Siah2 had an effect on 
TGFβ1 signal transduction western blot analysis of phosphorylated (p-Smad2) and total 
(t-Smad2) Smad2 was performed on MDFs cells treated with TGFβ1 (5ng/ml), hypoxia 
(1%O2) or hypoxic conditions supplemented with TGFβ1, while untreated MDFs served 
as controls (Figure 4-7). Smad2 phosphorylation was analysed as the ratio of phosphor-
Smad2 (p-Smad) and total Smad2 (Smad2) optical densities. P-Smad was undetectable in 
untreated MDF using western blot analysis. In normoxic conditions TGFβ1 induced 
equally strong levels of p-Smad2 in Siah2-/- and Wt MDFs (ratio of 0.24 ± 0.04 and 0.25 ± 
0.03 respectively). Hypoxia induced relatively low but similar levels of p-Smad in both 
Siah2-/- and Wt MDFs (0.07 ± 0.05 and 0.05 ± 0.05 respectively). Hypoxic conditions 
supplemented with TGFβ1 induced relatively robust but lower levels of p-Smad in Siah2-
/- MDFs compared to Wt cells (ratio of 0.18 ± 0.02 and 0.24 ± 0.02 respectively), however 
the observed differences were not significant.  The results indicate that Siah2 deficiency  
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had no significant effect on TGFβ or hypoxia induced Smad2 phosphorylation in MDF 
cells imply that its effects occurred either through non-Smad-dependent mechanism or 
downstream of Smad phosphorylation.   
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Figure 4-7. Impact of Siah2 deficiency on TGFβ1 and hypoxia induced Smad2 
phosphorylation. (a) Western blot of p-Smad2, Smad2 and β-actin protein levels in  
normalised proteins mass (10µg) of Siah2-/- and Wt MDF cell lysates collected from 
control untreated cells (N) or after 48 hours in TGFβ1 (5ng/ml) (N+), hypoxia (1%O2) (H) 
or both (H+). (b) Analysis of Smad2 phosphorylation in Wt (black bars) and Siah2-/- (grey 
bars), where arbitrary units represent the ratio of optical densities of p-Smad2 to that of 
Smad2. (c) Analysis of Smad protien levels in Wt (black bars) and Siah2-/- (grey bars), 
where arbitrary units represent the ratio of optical density of Smad2 to that of β-actin 
loading control. Each data point represents the mean ± SEM of four independent 
experiments. Bonferroni’s Two Way Anova was used to analyse significance. (Molecular 
weight (Mw) of p-Smad2, Smad2 and β-actin ≈ 55, 55 and 42 kilo-Dalton (kD) 
respectively)  
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4.3. Discussion  
4.3.1. Hypoxia through HIF-1 regulates skin fibroblast 
Fibroblasts are important stromal cells that synthesize the structural components of the 
extra-cellular matrix. During wound healing dermal fibroblasts are central in the 
regulation of granulation tissue development and its eventual remodelling and also 
modulate the angiogenic process through the release of extracellular matrix proteins 
and paracrine factors that are essential for both endothelial adhesion and chemoxatis 
during wound healing. In addition to soluble factors and matrix proteins released during 
inflammation, hypoxia has emerged as an important regulator of dermal fibroblast 
chemotaxis, production of autocrine and paracrine factors as well as extracellular matrix 
which ultimately accelerate wound healing through the promotion of granulation tissue 
formation and angiogenesis. HIF-1-regulated pathways are important adaptive 
responses to hypoxia and have important regulatory effects on fibroblast functionality in 
skin. For example, HIF-1 up-regulates Hsp90 transcription and release which in turn 
modulates cell migration (Li et al., 2007); increases a number of growth factors, 
metalloproteinase expression and collagen hydroxylases to enhance extra-cellular 
matrix synthesis and remodeling (Falanga et al., 1991, Hong et al., 2006, Zhang et al., 
2003b, Hofbauer et al., 2003).  Additionally HIF-1 regulates expression and release of 
angiogenic factors to promote neovascularisation (Thangarajah et al., 2009). 
 
 HIF-1 transcription activity is controlled by several proteins that regulate 
posttranslational availability of the HIF-1α subunit. Siah is an important upstream 
regulator of HIF-1 abundance and is required for adaptive cellular responses during 
tissue hypoxia by virtue of its inhibitory effects on HIF specific prolyl-hydroxylases 
(Nakayama et al., 2004). Here the role of Siah2 in murine dermal fibroblast function in 
response to TGFβ and hypoxia was tested using Siah2-/- dermal fibroblasts which have 
been shown to be HIF-1 deficient in hypoxia (Figure 4-1). 
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4.3.2. Impaired dermal fibroblast function in Siah2
-/-
 mouse dermal fibroblasts 
The ability of dermal fibroblasts to migrate and proliferate into the provisional matrix 
from local mesenchymal connective tissue and bone marrow-derived circulating 
progenitor lineages is dependent on their ability to respond to growth factors (Roberts 
et al., 1986, Denton et al., 2009) and their interactions with a variety of released matrix 
proteins (Postlethwaite et al., 1978, Kleinman et al., 1982). Additionally, adaptive 
responses to hypoxia through HIF-1 may be required as migration proceeds through an 
avascular and inflamed hypoxic tissue where the demands of metabolically active by 
inflammatory cells are a further draw on available oxygen, particularly during early 
wound healing.  Here the role of Siah2 deficiency in MDF cell migration (Figure 4-6) and 
(Figure 4-3) fibroblast proliferation in response to TGFβ and hypoxia were tested. The 
results of the current study do not reflect any significant effect of Siah2 deficiency in 
murine dermal fibroblast migration and proliferation in hypoxia. Furthermore, hypoxia 
in general appeared to impair migration in response to exogenous TGFβ, which was in 
contrast to other studies that report enhanced dermal fibroblast migration in hypoxia 
and additive effects of the growth factor during hypoxia, albeit that this effect was 
observed in human dermal fibroblasts (Mogford et al., 2002). The reasons for this 
difference are not very clear and may suggest an inability of the primary adult MDF cells 
to migrate under oxidative stress in monolayer cultures and that some differences in the 
migratory response to hypoxia may exist between MDF and human dermal fibroblasts.  
Interestingly, the results revealed that Siah2 may be important for TGFβ-induced 
migration in normoxic culture conditions, as demonstrated by reduced migration of 
Siah2-/- MDF in response to TGFβ (compared to Wt cells). This may be of relevance to 
wound healing where TGFβ induces rapid invasion of dermal fibroblasts (Roberts et al., 
1986, Denton et al., 2009). The findings may in part explain why fibrogenesis, which 
mostly relies of TGFβ induced chemotaxis and matrix synthesis, appeared delayed in 
Siah2-/- mice wounds. However, a conclusive outcome on the impact Siah in dermal 
fibroblast migration in hypoxia would require further investigation in human dermal 
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cells where an adaptive response to hypoxia has been previously reported. This is 
investigated further in the following chapter (see Chapter 5)   
 
As fibroblasts migrate into the wound, they replace the fibrin clot with type I collagen 
which is critical for providing tensile strength and to the restoration of tissue integrity 
(Darby and Hewitson, 2007). In human dermal fibroblasts cultured in hypoxia enhanced 
type I collagen synthesis through mechanisms dependent on HIF-1 and the up-
regulation of growth factors such as TGFβ and CTGF has been reported (Falanga et al., 
2002, Hong et al., 2006). Here a role for Siah2 in MDF collagen expression was tested 
over time in hypoxia (Figure 4-1) and in response to exogenous TGFβ (Figure 4-2). 
Herein, Siah2-/- MDFs cells showed reduced type I collagen expression over time in 
hypoxic conditions with the difference reaching significance with increasing time in 
hypoxia (compared to Wt MDFs) and this appeared to correlate with a reduction in HIF-
1α expression or stabilization in the absence of Siah2. Surprisingly, hypoxia appeared to 
have a negative effect on TGFβ induced collagen expression in the primary MDFs in 
general under low serum conditions, which is in contrast to other studies that suggest 
the involvement of the growth factor in human dermal fibroblast matrix synthesis 
during low oxygen tension and the involvement of HIF-1 in the regulation of this process 
(Siddiqui et al., 1996, Falanga et al., 2002, Distler et al., 2007). The reasons for this 
difference are not very clear and may once again be reflective of an inability of the 
primary adult MDF cells to adapt well to oxidative stress in culture in comparison to 
human dermal fibroblasts. However, Siah2-/- MDFs showed failure to up-regulate of 
COL1A1 in response to TGFβ in normoxic cultures conditions suggesting the possibility 
that Siah2 may also play a role in the regulation of collagen expression possibly through 
hypoxia independent mechanisms. The involvement of Siah in matrix synthesis, 
particularly in hypoxia would require further clarification owing to inconsistencies of the 
observations made here. Inconsistency in the reported data on fibroblasts is not entirely 
surprising as many studies vary in the passage and thus degree of myofibroblast 
differentiation of the cultures, the exact source of the fibroblasts used and the culture 
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conditions (serum vs serum-free or low serum) that are employed.  This is highlighted by 
a recent paper by Modaressi et al. who showed varying responses to hypoxia of 
fibroblasts taken from different levels of the dermis and different tissue (Modarressi et 
al., 2010). The role of Siah deficiency in matrix synthesis is further examined in the next 
chapter using primary human dermal fibroblasts.  
 
After collagen matrix is deposited to form the granulation tissue, the appearance of 
myofibroblasts with contractile actin fibres (αSMA) is a hallmark of the contraction 
phase of wound healing (Darby et al., 1990). Fibroblast to myofibroblast differentiation 
and activation of contractile apparatus is dependant on several factors including growth 
factors (TGFβ or CTGF)(Desmouliere et al., 1993, Garrett et al., 2004), mechanical 
tension (Tomasek et al., 1992) and matrix composition (Serini et al., 1998). Recently 
published research shows that hypoxia impairs human skin fibroblast to myofibroblast 
differentiation and contraction depending on the duration of hypoxia and the source of 
fibroblasts (Modarressi et al., 2010). The effects of acute hypoxia and Siah on αSMA 
expression (Figure 4-4) and cell contraction (Figure 4-5) in mouse dermal fibroblast were 
tested here. Firstly, acute hypoxia alone did not appear to have an effect on αSMA 
induction or cell contraction and addition of TGFβ to hypoxic cultures up-regulated 
αSMA induction and stimulated contraction of MDF cells. Additionally, Siah2-/- MDFs 
showed reduced αSMA induction in hypoxic culture conditions compared to Wt MDFs 
implying that Siah may have a role in maintaining αSMA expression in hypoxia. 
Furthermore, Siah2-/- MDFs showed reduced αSMA induction under hypoxic conditions 
supplemented with TGFβ suggesting that Siah2 was at least required for TGFβ to have 
additive effects on the induction of αSMA in MDFs cells in hypoxic conditions.  The 
effects of Siah2 deficiency on αSMA induction appeared to correlate with the contractile 
ability of MDFs, although differences in matrix contraction between Siah2-/- and Wt did 
not reach significance. The evidence provided here in part supports a role of Siah2 in 
regulation of myofibroblast differentiation in mouse skin and during wound healing 
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where αSMA expression and wound contraction appeared delayed in the absence of 
Siah2 (Chapter 3). 
 
 
Cellular responsiveness to TGFβ1 is dependent on the growth factor binding to TGFβ 
receptors leading to activation of Smad proteins and cytosolic mitogen activated protein 
kinases (MAPKs) which affect transcription of TGFβ-regulated genes (Souchelnytskyi et 
al., 1996, Massague, 1998, Piek et al., 1999, Massague and Chen, 2000, Massague and 
Wotton, 2000). Hypoxia has been reported to up-regulate TGFβ1 in human dermal 
fibroblast cells (Falanga et al., 1991) which then activates downstream signalling 
cascades including p42/p44 MAPKs (Mogford et al., 2002) and Smads (Falanga et al., 
1991) to induce cell migration and extracellular matrix synthesis. Here, the effect of 
Siah2 deficiency on Smad phosphorylation was investigated in response to TGFβ and 
hypoxic stimuli (Figure 4-7). Firstly, exogenous TGFβ and hypoxia were able to induce 
Smad phosphorylation which supports the hypothesis that some responses in hypoxia 
may in part be TGFβ-Smad driven (Falanga and Kirsner, 1993). However, the results 
showed no significant differences in the level of Smad phosphorylation between Siah2-/- 
and Wt MDFs cells in response to TGFβ, hypoxia or the combination of the two stimuli. 
 
Given that TGFβ induced migratory and matrix synthesis responses are reduced in Siah2-
/- MDFs cells in normoxic conditions, it may be conceivable that Siah has regulatory 
effects on TGFβ responses downstream of Smad or via non-Smad dependant pathways 
in a fashion independent of the hypoxia signalling machinery (HIF-1). The requirement 
of Ras signalling in the enhancement of TGFβ-Smad dependent responses may be a 
potential explanation for this result. Siah1 and Siah2 are highly conserved downstream 
components of the RAS pathway that are required for mammalian RAS signal 
transduction (Holloway et al., 1997). Depletion or inactivation of Siah inhibits Ras 
activated pathways that drive transformation and tumourgenesis leading to the 
reduction of these events (Schmidt et al., 2007, Ahmed et al., 2008). In fibroblasts, 
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activation with exogenous TGFβ leads to transient activation of RAS cascades and 
subsequent enhancement of TGFβ-Smad responses (Leask and Abraham, 2004). 
Activation of Ras signalling by TGFβ induces expression of genes including CTGF, a 
protein associated with cell migration, proliferation, angiogenesis and matrix synthesis 
(Phanish et al., 2005, Secker et al., 2008). It is therefore conceivable that TGFβ-Smad 
activated responses are reduced in Siah deficient cells due to impairment in Ras 
signalling. 
 
Furthermore, given that αSMA and COL1A1 induction in Siah2-/- MDF were reduced in 
hypoxia without any significant change to Smad phosphorylation, it may be conceivable 
that cross-talk between TGFβ and hypoxia signalling pathways downstream of Smad 
phosphorylation are affected in the absence of Siah, and presumably HIF-1α. This cross-
talk may involve a physical interaction between HIF-1α, Smad and a co-activator protein 
(p300) at the promoter region of genes containing hypoxia response element (HRE) and 
Smad response element (SRE) sequences (Sanchez-Elsner et al., 2001). Thus fur, Smad-
HIF-1α complexes are demonstrated in the activation of several angiogenic genes 
including VEGF, erythropoietin-1 and TGFβ co-receptor, endoglin (Sanchez-Elsner et al., 
2001, Sanchez-Elsner et al., 2004, Sanchez-Elsner et al., 2002).  However, a variety of 
genes which contain SRE and HRE sequences may potentially be regulated through 
TGFβ-hypoxia cross-talk, a good example being the CTGF which can be up-regulated 
through synergetic effects of hypoxia and TGFβ1 regulated pathways. (Hong et al., 2006, 
Higgins et al., 2004). CTGF is an important regulator of αSMA expression, cell 
contraction and matrix synthesis by dermal fibroblasts (Frazier et al., 1996, Garrett et 
al., 2004).  
 
Finally, although the results of this study show some differences between Siah2-/- and 
Wt MDFs and point to a potential role of Siah in the regulation of dermal fibroblast cell 
functionality, some of the results are not consistent with established roles of HIF-1 and 
hypoxia in the regulation of dermal fibroblasts functions, particularly in human skin. The 
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reasons for these differences are not very clear and may be indicative an inability of 
primary cells to adapt well to oxidative stress in culture conditions. Furthermore, adult 
primary MDFs, particularly from Siah2-/- mice, proved difficult to establish in culture, 
often displaying premature senescence and early differentiation at low passage number. 
Therefore it may be difficult to rule out the impact of problematic or inconsistent 
culture conditions in our experimental observations. Furthermore others have pointed 
out differences in the behaviour of hypoxic fibroblasts  even from different regions of 
the dermis, different tissue (Modarressi et al., 2010), different culture conditions 
(Falanga and Kirsner, 1993, Boraldi et al., 2007, Oberringer et al., 2008) and therefore 
differentiation status of the cells are often used, making interpretation of data from 
fibroblast hypoxic cultures in the literature problematic. Additionally, most studies 
reporting effects of hypoxia on dermal fibroblasts have mostly being reported in adult 
human dermal fibroblasts with little evidence of similar effects on adult murine dermal 
fibroblast cultures as fur as we know. To examine the role of Siah proteins in human 
fibroblasts, we then used the drosophila protein phyllopod in cell culture experiments.  
Thus, in the next chapter the role of Siah was investigated in healthy adult human 
dermal fibroblasts which in contrast to mouse dermal cells appeared to thrive in 
normoxic and hypoxic cultures condition with low serum without any overt or 
reportable signs of stress or early senescence (Chapter 5).   
4.4. Conclusion  
In summary, this study confirms that Siah is a positive regulator of HIF-1α stabilisation in 
hypoxia (Nakayama et al., 2004). Reduced HIF-1α may therefore partly explain reduced 
COL1A1 and αSMA induction in the absence of Siah2 implying that Siah2 may in part 
regulate granulation formation and myofibroblast differentiation during tissue hypoxia. 
Siah2 may also have a regulatory role in TGFβ1-induced COL1A1 expression and cell 
migration beyond that observed in a hypoxic milieu. Siah2 deficiency does not appear to 
have a significant effect on cell proliferation and TGFβ1 induced Smad phosphorylation. 
Therefore the regulatory effects of Siah on dermal fibroblast cell functionality are likely 
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to occur downstream of Smad phosphorylation or via non Smad dependent pathways 
possibly through Ras mediated mechanisms or HIF-1-Smad cross talk as discussed 
above. Overall, Siah2 through HIF-1 and possibly other mechanisms appears to be a 
positive regulator of dermal fibroblast cell function which may in part explain why early 
wound healing is delayed in Siah2-/- mice (Chapter 3).   
4.5. Specific experimental methods in this chapter. 
Mentioned here are summarized methods including only relevant details pertaining to 
this chapter. For the specific of individual methods, please refer to the general and 
methods chapter (Chapter 2) 
 
4.5.1. Fibroblast isolation and culture 
Primary MDFs were isolated from the tails of age- (8-12 week) and sex- (male only) 
matched wild type (Wt) and Siah2 homozygous mutant (Siah2-/-) mice using previously 
described enzymatic digestion methods with minor modifications. Tails were collected 
and dermis was isolated using dispase (10mg/ml) (Gibco). Cells were isolated in 
collagenase solution (dispase (4mg/ml)/ collagenase (Gibco) (3mg/ml)) and cultured in 
Dulbecco Modified Eagle media (DMEM) supplemented with 5% Fetal calf serum (FBS) 
in standard culture conditions (5% CO2, 21% O2 in humidified chamber). MDFs were 
used between 2nd to 4th passages only, as viability, growth and normal morphology of 
cells dramatically declined after the 4th passage.  
4.5.2. Analysis of protein expression by western blotting 
Protein expression was determined by means of SDS-PAGE and western blot analysis. 
Briefly, Siah2-/- and Wt MDFs cells were seeded into flasks (25cm2) at normalized cell 
density and grown until 70-80 % confluent. Cells were subjected to experimental 
conditions after which protein from cells was extracted by detergent (Triton-x100) 
based cell lysis and protein content measured using a bicinchoninic acid assay (BCA 
assay) kit. Protein samples were mixed with loading buffer and reducing agent and then 
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denatured at 90°C for 10 minutes and cooled on ice before loading.  Denatured protein 
samples were loaded on SDS PAGE gels (10% acrylamide) and separated at 160 to 200 
Volts direct current for 45 to 50 minutes in ice-cold running buffer (0.025M Tris glycine 
and 0.1% SDS). Proteins were transferred on to either PVDF (Bio-Rad, Aus) or 
nitrocellulose (Bio-Rad, Aus) membranes that were electrolyte soaked (0.025M Tris & 
glycine and 20% methanol) using a semi-dry transfer cell (Bio-Rad laboratories, USA) at 
19 volts direct current for 75 minutes. Primary antibodies were added onto the 
membrane and incubated overnight (approximately 16 hours) at 4°C. Membranes were 
washed in TBST (0.01M Tris Base Saline buffer, 0.05% (v/v) Tween 20, pH 7.6) for 30 
minutes. HRP-conjugated secondary antibodies (1:1000) were added to membranes for 
60 minutes at room temperature and washed off thoroughly in TBST. Protein bands on 
membranes were visualised via peroxidase -catalysed chemiluminescence reaction 
detected using a Chem-Doc ® unit (Bio-Rad). Protein band density was analysed by 
densitometry.    
4.5.2.1. Preliminary hypoxia treatment   
To determine the effect of Siah2 on HIF-1α stabilisation and type I collagen over time in 
hypoxia, Wt and Siah2-/- MDFs at matching passages, confluence (80%) and normal 
serum (5% FBS) were incubated in hypoxia (1% O2, 5% CO2 humidified) for increasing 
length of time (0 to 48 hours). Protein from cells was extracted and proteins levels 
determined by western blot analysis using anti-COL1A1 (1:500) and anti-HIF-1α (1:500) 
in normalised amounts of loaded proteins (10µg and 20 µg per well, respectively). 
 
4.5.2.2.  Hypoxia and TGFβ1 treatment   
To determine whether Siah2 had any effect on TGFβ1 or hypoxia induced MDF 
functionality (extracellular matrix expression and TGFβ1 signalling transduction) MDFs 
were treated with TGFβ1 (5ng/ml), hypoxia (1% O2, 5% CO2 humidified) or the 
combination of hypoxia supplemented with TGFβ1 for a period of 48 hours. Protein 
from cells was extracted and protein levels determined by western blot analysis using 
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anti-COL1A1 (1:500), anti-Smad2 (1:1000) and anti-p-Smad (1:1000) using normalised 
amounts of loaded proteins (10µg per well).   
 
4.5.3. Analysis of protein expression by flow cytometry 
Protein expression was also determined by means of immuno-labelling and subsequent 
flow cytometry. Briefly, Siah2-/- and Wt MDFs cells were seeded into flasks (25cm2) at 
normalized cell density and grown until 70-80 % confluent. Cells were serum starved for 
6 hours and later supplemented with low serum media (2% FBS) with or without TGFβ1 
(5ng/ml). Cells were incubated in normoxia or hypoxia for 48 hours. Cells were detached 
by trypsin, fixed in formalin and permeabilized.  Immuno-labelling of cells with mouse 
monoclonal anti-αSMA-FITC conjugated (1:250) and mouse monoclonal anti-PCNA 
(1:200). Fluorescently conjugated secondary anti-rabbit and anti-mouse antibodies were 
used to probe their respective primary antibodies (collagen I and Smads). The 
fluorescence intensity of at least 2000-5000 cells per sample was measured using a flow 
cytometer and analyzed by weasel cytometry software (Walter and Eliza Hall Institute, 
Aus) 
 
4.5.4. Collagen lattice contraction assay 
To determine if Siah2 deficiency had any impact on fibroblast contractile properties 
Siah2-/- and Wt MDFs were counted and seeded into collagen (2.1mg/ml) at normalized 
density (2 x 105cell/ml). Lattices were allowed to polymerize and then recover for 24 
hours in normal cell culture conditions (5% FBS). Cells were serum starved (2% FBS) for 6 
hour and later supplemented with either with low serum media or TGFβ1 (5ng/ml). Cells 
were incubated in normoxia or hypoxia for up 24 hours. Lattices were released and 
returned to their respective experimental conditions for a further 24 hours. The area of 
lattices was measured and contraction calculated as change in area (pixels2).  
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4.5.5. Migration of murine dermal fibroblasts  
MDFs cells were seeded into 6 well plates at normalized cell density and grown until 80-
90% confluent. Cells were then serum starved for 6 hours and scratched using a 
micropipette tip (1 ml) and then supplemented either with low serum medium  or low 
serum medium with added TGFβ1 (1ng/ml). Cells were incubated in normoxia or 
hypoxia overnight (16 hours). Migration was determined by measuring the difference in 
the area of the gap at time 0 versus time post-wounding.  
 
Chapter 5 
a 
179
 
5. Chapter 5 
Transient inhibition of Siah and its effect on 
human fibroblast function  
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5.1.  Introduction 
 
It is now well established that during hypoxia, HIF-1α escapes proteosomal degradation 
through the inhibitory effects of Siah ubiquitin ligases on PHD and FIH activity 
(Nakayama et al., 2004, Fukuba et al., 2007). In this context, Siah deficiency thus results 
in reduced HIF-1α availability and transcription of HIF-1 inducible genes (Nakayama et 
al., 2004). Previous chapters (3 and 4) have investigated the role of Siah2 in wound 
healing in vivo and in vitro, using a murine Siah2-/- transgenic mouse model and cells 
derived from these animals. In this chapter human dermal fibroblasts were transiently 
transfected with phyllopod expressing vectors (PHYL) to investigate the potential effects 
of reduced Siah-HIF-1 mediated signalling on human dermal fibroblast function  in vitro. 
PHYL has the added advantaged of inhibiting both Siah 1 and 2, potentially giving a more 
complete inhibition of Hif-1α stabilization.  
 
Phyllopod is a drosophila melanogaster protein that controls drosophila photoreceptor 
cell fate via the ras activated pathway during development (Dickson et al., 1995). The 
protein binds with high affinity to the substrate binding domain (SBD) of SINA, a 
drosophila homologue of mammalian Siah (Li et al., 2002). PHYL promotes degradation 
of Tramtrack, through SINA-induced E3 ligase activity by acting as an adaptor protein 
between SINA and Tramtrack (Li et al., 2002). PHYL mammalian homologues do not, as 
far as we know, exist and therefore it can be introduced in mammalian cells systems to 
inhibit Siah activity and subsequent ubiquitination of its substrates including HIF-prolyl-
hydroxylases (Moller et al., 2008). Consequently, PHYL transfected mammalian cells 
show reduced HIF-1α stabilization and reduced transcription of HIF-1 inducible genes  
during hypoxia (Moller et al., 2008).  
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5.2. Results 
5.2.1. Phyllopod expression in transfected human dermal fibroblasts  
To verify successful transfection of cells with a plasmid containing Phyllopod, HA-
labelled Phyllopod (PHYL) transfected human dermal fibroblasts (HDFs) were stained by 
with an anti-HA antibody and detected by immunofluorescence. HA-labelled cells 
showed a perinuclear distribution of the stain when compared to control HDFs 
(transfected with empty pcDNA plasmid which showed only low background staining 
(Figure 5-1a).  
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Figure 5-1. Detection of phyllopod expression in human dermal fibroblasts by 
immunofluorescence. Visualisation of HDFs transfected with empty pcDNA vector (a) 
and PHYL-HA expressing pcDNA Vector (b) with rabbit anti-HA (1:300) and anti-rabbit 
IgG-Alexa-fluor 488®. White arrows show perinuclear staining of HA-labelled cells  
(Magnification, x40). 
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5.2.2.  Reduced HIF-1α in phyllopod transfected human dermal fibroblasts  
In mammalian cells, PHYL binds to the substrate binding domain of Siah proteins (both 
Siah1 and Siah2)  impairing their ability to tag HIF-hydroxylases (PHDs and FIH) for 
proteosomal degradation, thus preventing the stabilisation of HIF-1α during hypoxia 
(Moller et al., 2008, Khurana et al., 2006). To investigate whether downstream Siah 
activity had been inhibited following PHYL transfection, HIF-1α expression was 
determined in HDFs (Mock and PHYL transfected cells) by flow cytometry following 
treatment  cells with TGFβ1 (5ng/ml), hypoxia (1%O2) or the combination of the two 
(Figure 5-2). Forward and side scatter characteristics of HDFs were used for their 
preliminary identification and appropriate gates were further used to localise HDF cells 
and exclude cellular aggregates and debris. HIF-1α induction or stabilisation was 
evaluated by a stimulation index, which was the ratio of mean fluorescence intensity of 
HIF-1α in treated HDFs to that of untreated HDFs. HIF-1α stimulation index in control 
HDFs (Mock) remained relatively unchanged in TGFβ1 (5ng/ml) and hypoxia alone (1% 
02) treated cells (1.04 ± 0.02 and1.01 ± 0.07, respectively ) but decreased by 15% (0.85 ± 
0.10) in combined hypoxia and TGFβ1. In PHYL transfected HDFs, HIF-1α stimulation 
index decreased by 11% (0.892 ± 0.08) in TGFβ1 treatment alone, decreased by 48% 
(0.52 ± 0.07) in hypoxia and decreased by 54% (0.46 ± 0.12) in TGFβ1 plus hypoxia. The 
stimulation index of HIF-1α in PHYL transfected HDFs was significantly reduced in 
hypoxia (p<0.01) and in hypoxia plus TGFβ1 (P<0.05) conditions when compared the 
mock HDFs. These results demonstrate the inhibitory effect of PHYL on HIF-1α 
availability in hypoxia by virtue of impairing Siah ubiquitin ligase activity, as previously 
described (Khurana et al., 2006, Moller et al., 2008, Qi et al., 2008) and its implications 
on hypoxia-induced HDF function was further tested below.  
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Figure 5-2. Effect of Phyllopod on HIF-1α induction or stabilisation in human dermal 
fibroblasts in response to hypoxia. (a.) Flow cytometry histograms of HIF-1α expression 
in mock and PHYL transfected HDFs. Overlays; black (secondary antibody only) grey 
shaded (untreated group), red (5ng/ml TGFβ1), blue (hypoxia (1%O2) and yellow (TGFβ1 
and hypoxia combined). (b.) Dot plot of FSC versus SSC of HDFs and the cells gated for 
analysis are shown. (c.) Analysis of HIF-1 induction or stabilisation in Mock (dotted bars) 
and PHYL transfected cells using a stimulation index, representing the ratio of mean 
fluorescence intensity of HIF-1α in treated cells (TGFβ1 (N+), hypoxia (H) or combination 
of both (H+) after 48 hours) to that untreated (N) cells. Each point represents mean ± 
standard error of the mean of three separate experiments (c). Bonferroni’s two way 
ANOVA analysis performed to determine significance. ** P<0.01, *P<0.05  
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5.2.3. Reduced VEGF expression in Phyllopod transfected human dermal fibroblasts 
Activation of VEGF gene expression during hypoxia is transcriptionally regulated through 
HIF-1 (Forsythe et al., 1996). In HDF cells the production of VEGF in hypoxia has been 
reported to also require stimulation from TGFβ (Berse et al., 1999). To investigate the 
effects of Siah on TGFβ induced VEGF release by HDF, cell culture media was collected 
from PHYL and mock transfected cells and analysed using a human VEGF ELISA (Figure 5-
3). In comparison to the untreated group (0.13 ± 0.03ng/ml) VEGF release in mock 
transfected HDFs was increased by 46% (0.19 ± 0.02ng/ml) in TGFβ1 (5 ng/ml), 
decreased by 47% (0.07± 0.03 ng/ml) in hypoxia and increased by 261% (0.47 ± 0.04 
ng/ml) after combined treatment with both hypoxia and TGFβ1. In comparison to the 
respective untreated group (0.20 ± 0.02 ng/ml), VEGF release in PHYL transfected cells 
decreased by 30% (0.14 ± 0.05 ng/ml) in TGFβ1 treated cells, decreased by 65% (0.07 
ng/ml) in hypoxia and increased by only 50 % (0.30 ± 0.04 ng/ml) following  treatment 
with both TGFβ1 and hypoxia. In normoxia, VEGF release following TGFβ1 treatment 
was not significantly different between PHYL and mock transfected HDFs. However, 
following combined treatment with TGFβ1 and hypoxia, a significant reduction (p<0.01) 
in VEGF release was observed in PHYL transfected cells (versus mock transfected control 
HDFs). The results demonstrate that the Siah and HIF-1α axis is important for TGFβ 
induced VEGF release in hypoxic HDFs.          
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Figure 5-3: Effect of Phyllopod on TGFβ1 induced VEGF release by human dermal 
fibroblasts. Analysis of VEGF production and release in mock and phyllopod (PHYL) 
transfected human dermal fibroblasts (HDFs) after 48 hours treatment in TGFβ1 (N+), 
hypoxia (1% O2) (H) and hypoxia plus TGFβ1 (H+) as well untreated controls (N). Each 
point represents mean ± standard error mean of three separate experiments. 
Bonferroni’s Two way ANOVA analysis performed ** P<0.01. 
  
5.2.4. Reduced COL1A1 expression in phyllopod transfected human dermal 
fibroblasts 
Increased expression and release of type I collagen is a hallmark response of human 
dermal fibroblasts during acute hypoxia (Siddiqui et al., 1996, Steinbrech et al., 1999, 
Falanga et al., 2002). This response is reliant on the up-regulation of TGFβ which can 
also be regulated through HIF-1 (Falanga et al., 2002, Distler et al., 2007). To determine 
whether Siah-HIF-1 axis inhibition by PHYL alters extracellular matrix synthesis by HDFs, 
flow cytometry using an anti-COL1A1 antibody was completed (Figure 5-4). Forward and 
side scatter characteristics of HDFs were used for their preliminary identification and 
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appropriate gates were further used to localise HDF cells and exclude cellular aggregates 
and debris. COL1A1 induction was evaluated by a stimulation index, which was the ratio 
of mean fluorescence intensity of COL1A1 in treated HDFs to that of untreated HDFs. 
The stimulation index of COL1A1 in mock transfected HDFs was increased by 98% after 
TGFβ1 (5 ng/ml) (1.98 ± 0.28), increased by 50% after hypoxia (1.50 ± 0.17) and 
increased by 128% in TGFβ1 treatment plus hypoxia (2.28 ± 0.59). The stimulation index 
of COL1A1 in PHYL transfected fibroblasts was increased by 49% in TGFβ1 (1.49 ± 0.15), 
reduced by 22% in hypoxia (0.78 ± 0.15 ) and increased by 32% after TGFβ1 plus hypoxia 
(1.32 ± 0.15). TGFβ1 alone did not induce a significant change in the stimulation index of 
COL1A1 in PHYL transfected HDFs (compared to mock transfected fibroblasts). However 
significant reductions in stimulation index of COL1A1 were observed in hypoxia (p<0.01) 
and hypoxia plus TGFβ1 treated PHYL transfected HDFs (versus mock cells).  The results 
reflect the role of Siah-HIF-1 axis in the stimulation of collagenous matrix synthesis 
under hypoxia conditions, a process that is described to be TGFβ-dependent and 
important for angiogenesis and granulation tissue formation (Steinbrech et al., 1999, 
Falanga et al., 2002). The findings are also in line with other studies that have 
demonstrated the importance of HIF-1 in the regulation of TGFβ-induced matrix 
expression and synthesis by HDFs during hypoxia (Distler et al., 2007). 
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Figure 5-4. Effect of phyllopod on induction of COL1A1 in human dermal fibroblast. (a.) 
Flow cytometry histogram of COL1A1 expression in mock and PHYL transfected HDFs. 
Overlays; black (secondary antibody only), grey shaded (untreated group), red (5ng/ml 
TGFβ1), blue (hypoxia (1%O2)) and yellow (TGFβ1 and hypoxia combined). (b.) Dot plot 
of FSC versus SSC of HDFs and the cells gated for analysis are shown. (c.) Analysis of 
COL1A1 induction in Mock (dotted bars) and PHYL transfected cells (non dotted bars) 
using a stimulation index, representing the ratio of mean fluorescence intensity of 
COL1A1 in treated cells (TGFβ1 (N+), hypoxia (H) or combination of both (H+) after 48 
hours) to that untreated (N) cells.. Each point represents mean ± standard error of the 
mean of six separate experiments. Bonferroni’s two way ANOVA analysis was 
performed**P<0.01, *P<0.05 
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5.2.5. Normal αSMA expression and myofibroblast transformation in phyllopod 
transfected human dermal fibroblasts  
Transient expression of αSMA in the granulation tissue during fibroblast-myofibroblast 
transition is a hallmark of normal wound healing and is synonymous with wound 
contraction (Darby et al., 1990). TGFβ1 induces αSMA expression and myofibroblast 
transition in quiescent and growing cultured fibroblasts (Desmouliere et al., 1993). To 
investigate the impact of Siah-deficiency on fibroblast-myofibroblast transition in 
human skin fibroblasts during hypoxia, an anti αSMA antibody was used and flow 
cytometry analysis completed (Figure 5-5). Forward and side scatter characteristics of 
HDFs were used for their preliminary identification and appropriate gates were further 
used to localise HDF cells and exclude cellular aggregates and debris. αSMA induction 
was evaluated by a stimulation index, which was the ratio of mean fluorescence 
intensity of αSMA in treated HDFs to that of untreated HDFs. In the TGFβ1 (5 ng/ml) 
treated group, αSMA stimulation index was increased by 182% (2.82 ± 0.31) in mock and 
by 191% (2.91 ± 0.66) in PHYL transfected HDFs. In hypoxia alone, αSMA stimulation 
index in mock HDFs was increased by 47% (1.47 ± 0.81) but remained mostly unaffected 
in PHYL transfected cells (1.00 ± 0.301). In the hypoxia plus TGFβ1 group, the αSMA 
stimulation index increased by 65% (1.65 ± 0.26) in mock and by 32% (1.32 ± 0.18) in 
PHYL transfected cells. Overall, no significant differences in the pattern of αSMA 
induction were observed between the different treatment groups following PHYL 
transfection. Interestingly, hypoxia appeared to have an overall inhibitory effect on 
TGFβ-induced αSMA expression in both PHYL and mock transfected HDFs. The result 
demonstrates that Siah-HIF-1 axis may be dispensable in the regulation of αSMA 
expression in human skin fibroblasts. Furthermore, the findings are similar to those of 
recently published research which shows that hypoxia impairs human skin fibroblast to 
myofibroblast differentiation depending on the duration of hypoxia and the source of 
fibroblasts (Modarressi et al., 2010). 
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Figure 5-5. Effect of Phyllopod on αSMA induction in human dermal fibroblasts. 
(a.)Flow cytometry histograms of αSMA expression in mock and PHYL transfected HDFs 
are shown. Overlays; black (secondary antibody only), grey shaded (untreated group), 
red (5 ng/ml TGFβ1), blue (hypoxia 1%O2) and yellow (TGFβ1 and hypoxia combined). 
(b.) Dot plot of FSC versus SSC of HDFs and the cells gated for analysis are shown. 
Analysis of αSMA induction in Mock (dotted bars) and PHYL transfected cells using a 
stimulation index, representing the ratio of mean fluorescence intensity of αSMA in 
treated cells (TGFβ1 (N+), hypoxia (H) or combination of both (H+) after 48 hours) to 
that untreated (N) cells. Each point represents mean ± standard error mean of six 
separate samples. Bonferroni’s two way ANOVA analysis performed to determine 
significance.  
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5.2.6. Collagen lattice contraction by PHYL transfected human dermal fibroblasts 
Wound contraction is associated with the presence of modified fibroblasts in the 
granulation tissue and the transient expression of αSMA by these cells (Gabbiani et al., 
1971, Darby et al., 1990). TGFβ, extracellular matrix content and mechanical tension are 
also central to this contractile process (Montesano and Orci, 1988, Arora et al., 1999, 
Desmouliere et al., 1993). Hypoxia (chronic) has been associated with impaired αSMA 
expression and reduced dermal fibroblast contraction (Modarressi et al., 2010) (Figure 
5-5). The role of acute hypoxia and Siah-HIF-1 axis in HDF-mediated contraction of 
collagen lattices has not yet described. To investigate this PHYL-transfected HDFs were 
seeded into three dimensional collagen lattices and exposed to TGFβ1, hypoxia or a 
combination of both for 48 hours (Figure 5-6). Contraction was calculated as the change 
in area between time 0 and 48 hours. Untreated mock and PHYL transfected HDFs 
showed similar levels of contraction (60.8 ± 18.5 mm2 and 63.1 ± 15.6 mm2, 
respectively).  PHYL transfected HDFs showed some reduction in contractile response 
following treatment with TGFβ (77.9 ± 25.3 mm2), hypoxia (51.6 ± 14.03 mm2) and 
hypoxia plus TGFβ1 (72.4 ± 25.6mm2) when compared to mock transfected HDFs 
exposed to identical conditions (96.0± 16.4 mm2, 69.5 ± 9.75 mm2 and 96.9 ± 15.7 mm2, 
respectively) however the observations were not statistically significant  due to the high 
variability in results. Overall the results do not clearly support any role for Siah-HIF-1 
axis in the HDF contraction process.    
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Figure 5-6. Effect of phyllopod on TGFβ1-induced dermal fibroblast contraction.  (a.) 
Images of contracted collagen lattices (outline indicated by yellow dashed line) seeded 
with mock and PHYL transfected HDFs following 48 hours of normoxia alone (N) or 
treatment with either TGFβ1 (5ng/ml) (N+), hypoxia (1%O2) (H) or combined hypoxia 
and TGFβ1 (H+) are shown. (b.) Analysis of contraction in mock (black bars) and PHLY 
transfected HDFs(grey bars), where contraction was calculated as change in area 
(∆mm2) between time 0 and 48 hours. Each data point represents a mean ± standard 
error of the mean of six separate samples. Bonferroni’s two way ANOVA analysis was 
performed to determine significance. 
Chapter 5 
a 
193
 
5.2.7.  Normal HDF proliferation in hypoxic conditions  
Hypoxia has previously been demonstrated as a potent stimulus for the proliferation 
and expansion of human adult and neonatal dermal fibroblasts seeded as single cells 
(Falanga and Kirsner, 1993). To investigate the effect of acute hypoxia and Siah-HIF-1 
axis on HDF proliferation, PHYL transfected cells were exposed to TGFβ (5ng/ml), 
hypoxia (1% O2) or both for 48 hours and proliferative activity determined by an anti 
PCNA antibody and flow cytometry analysis (Figure 5-7). Forward and side scatter 
characteristics of HDFs were used for their preliminary identification and appropriate 
gates were further used to localise HDF cells and exclude cellular aggregates and debris. 
Proliferative activity was evaluated by a stimulation index, which was the ratio of mean 
fluorescence intensity of PCNA in treated HDFs to that of untreated HDFs PCNA 
stimulation index in both mock and PHYL transfected HDFs appeared not to be altered 
by TGFβ (0.91 ± 0.01 and 1.01 ± 0.10 respectively), hypoxia (1.03 ± 0.04 and 1.08 ± 0.16, 
respectively) or combined treatment with TGFβ1 and hypoxia (1.04 ± 0.09 and 1.37± 
0.02, respectively). Furthermore, no significant differences were observed between 
PHYL and mock transfected cells in all treatment groups. This study may support the 
findings of other groups who demonstrate little or no effect of hypoxia on the regulation 
of dermal fibroblast proliferation, an indication of their ability to survive and proliferate 
under hypoxic conditions (Boraldi et al., 2007). However an inability of PCNA to detect 
small proliferative differences following TGFβ treatment (where we have seen increases 
in mouse fibroblast proliferation) raises some questions about the sensitivity of the 
assay in determining proliferation activity in HDF monolayer cultures where cell 
doubling is perpetual until full confluence is achieved. To this end, another proliferation 
assay that detects fewer cells and is more strictly an S phase marker, such as 
bromodeoxyuridine incorporation might be more useful and more able to detect small 
changes in proliferation rate.          
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Figure 5-7. Effect of Phyllopod on proliferation activity of human dermal fibroblasts in 
hypoxic conditions. (a.) Flow cytometry histograms of typical PCNA expression in mock 
and PHYL transfected HDFs are shown. Overlays represent black (secondary antibody 
only), grey shaded (untreated group), red (5 ng/ml TGFβ1), blue (hypoxia (1%O2) and 
yellow (combined TGFβ and hypoxia). (b.) Dot plot of FSC versus SSC of HDFs and the 
cells gated for analysis are shown. (c.) Analysis of proliferative activity in Mock (dotted 
bars) and PHYL transfected cells (non dotted bars) using a stimulation index, 
representing the ratio of mean fluorescence intensity of PCNA in treated cells (TGFβ1 
(N+), hypoxia (H) or combination of both (H+) after 48 hours) to that of untreated (N) 
cells. Each point represents mean ± standard error of the mean of three separate 
experiments. Bonferroni’s two way ANOVA analysis was performed to determine 
significance.   
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5.2.8. Phyllopod impairs migration of human dermal fibroblasts   
Migration of fibroblasts during ischaemic conditions is considered to be essential during 
wound healing. Hypoxia increases the migratory index of human dermal fibroblasts 
compared to normoxia and has combined effects in the presence of TGFβ (Mogford et 
al., 2002). To investigate the role of Siah-HIF-1 axis on HDF migration, confluent PYHL 
transfected HDFs monolayer cultures were wounded by a scratch and allowed to 
migrate/heal in the presence of TGFβ (0.5 ng/ml) and/or hypoxic conditions overnight 
(16 hours) and compared to mock transfected HDFs exposed to the same conditions. 
Fibroblast migration was determined as the change in area (Pixels2 x 1000) of the 
original scratch to that of the remaining gap after exposure to experimental conditions 
(Figure 5-8). Under untreated normoxic culture conditions, PHYL and mock transfected 
HDFs showed no significant difference in migration (24.1 ± 0.98 and 20.0.± 2.38 Pixels2). 
However, PHYL transfected HDF showed a significantly reduced response to TGFβ1 
induced migration under normoxic culture conditions (15.2 ± 1.34 pixels2, P<0.01) 
compared to mock cells which showed increased migration (31.6 ± 2.36 pixels2). 
Furthermore, PHYL transfected cells showed significantly reduced migration under both 
hypoxia (15.2 ± 2.44 pixels2, P<0.05) and TGFβ supplemented hypoxia conditions (18.5 ± 
2.89 pixels2, P<0.01) compared to migration in mock transfected cells where increases in 
migration were observed (27.1 ± 3.48 pixels2 and 36.1 ± 4.25 pixels2 respectively). These 
results suggest that Siah plays an important role in hypoxia- induced migration, as well 
as in TGFβ-induced migration under both normoxic and hypoxic conditions.   
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Figure 5-8. Effect of Phyllopod on TGFβ- and hypoxia-induced human dermal fibroblast 
migration. (a.) Images of cell monolayer scratch migration assay were used to 
determine migration capabilities of PHYL transfected HDFs (versus mock transfected 
cells) in TGFβ (N+) and hypoxia (H) or hypoxic conditions supplemented with TGFβ (H+). 
Scratched untreated cells served as experimental controls (N). (b.) Analysis of migratory 
of mock (black bar) and PHYL (grey bars) transfected HDFs, where cell migration was 
determined through change in pixel area (Pixels2) of the original scratch at 0 hours(T0) 
and wound area post exposure to experimental or control conditions for 16 hours. Each 
point represents mean ± standard error of the mean of three separate experiments. 
Bonferroni’s two way ANOVA statistical analysis was performed to determine 
significance. *P<0.05, **P<0.01   
 
5.2.9. Effect of phyllopod on TGFβ1 signalling cascade  
Cellular responsiveness to TGFβ1 is reliant on the growth factor binding to its receptor 
TGFRII followed by recruitment of TGFRI leading to phosphorylation of receptor 
activated Smad proteins and subsequent induction of TGFβ regulated genes (Massague, 
1998, Piek et al., 1999, Massague and Chen, 2000, Massague and Wotton, 2000). TGFβ 
and its downstream signalling cascades induce important fibroblasts functions during 
hypoxic conditions including cell migration, extracellular matrix synthesis, and VEGF 
release (Berse et al., 1999, Mogford et al., 2002, Falanga et al., 2002). To investigate the 
potential role of Siah on TGFβ-signalling cascade TGFβR1 expression (Figure 5-9) and 
phosphorylation of Smad2 (Figure 5-10) in PHYL transfected HDFs was determined using 
respective primary antibodies (anti-TGFR1 and anti-Smad2 and anti-phospho Smad2), 
detection was then performed using flow cytometry. Forward and side scatter 
characteristics of HDFs were used for their preliminary identification and appropriate 
gates were further used to localise HDF cells and exclude cellular aggregates and debris. 
TGFR1, p-Smad2 and Smad2 induction was evaluated by a stimulation index, which was 
the ratio of mean fluorescence intensity of the respective proteins in treated HDFs to 
that of untreated HDFs. Under normoxic conditions, TGFβ induced a similar increase in 
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TGFR1 stimulation index in PHYL and mock transfected cells (1.21 ± 0.11 and 1.35 ± 0.13 
respectively). However in hypoxia alone, PHYL transfected cells (0.72 ± 0.10) showed a 
reduction in TGFR1 stimulation index compared to mock transfected HDFs (0.98 ± 0.09), 
albeit that the difference observed was not significant. Under hypoxic conditions 
supplemented with TGFβ, PHYL transfected cells showed a significant reduction in the 
TGFR1 stimulation index (1.11 ± 0.08, P<0.05) compared to mock transfected cells 
where TGFβ and hypoxia appeared to synergistically increase the TGFR1 stimulation 
index (1.50 ± 0.13). The result implies a slight impairment in TGFR1 induction in PHYL 
transfected cells during hypoxic conditions. Downstream of TGFR1, p-Smad2 stimulation 
index (Figure 5-10) appeared to be reduced in PHYL transfected HDFs following 
treatment of cells in TGFβ (1.22 ± 0.08), hypoxia (1.22 ± 0.10) and hypoxic conditions 
supplemented with TGFβ (0.85 ± 0.21) compared to mock transfected cells (1.60 ± 0.16, 
1.67 ± 0.19 and 1.33 ± 0.25 respectively).  The stimulation index of total Smad2 was also 
analysed and appeared to be unchanged between PHYL and mock transfected cells 
across all treatment groups (Figure 5-10). 
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Figure 5-9. Effect of phyllopod on TGFR1 induction in human dermal fibroblasts. (a.) 
Flow cytometry histograms of TGFR1 expression in mock and PHYL transfected HDFs. 
Overlays represent black (secondary antibody only), grey shaded (untreated), red 
(5ng/ml TGFβ1), blue (hypoxia (1%O2) and yellow (combined TGFβ1 and hypoxia). (b.) 
Dot plot of FSC versus SSC of HDFs and the cells gated for analysis are shown. (c.) 
Analysis of TGFR1 induction in Mock (dotted bars) and PHYL transfected cells (non 
dotted bars) using a stimulation index, representing the ratio of mean fluorescence 
intensity of TGFR1 in treated cells (TGFβ1 (N+), hypoxia (H) or combination of both (H+) 
after 48 hours) to that untreated (N) cells. Each point represents mean ± standard error 
of the mean of three separate experiments. Bonferroni’s two way ANOVA analysis was 
performed to determine significance. *P<0.05      
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Figure 5-10. Effect of phyllopod on phosphorylated Smad2 (phospho-Smad2) 
induction. (a) Flow cytometry histograms of phosphorylated Smad2 expression in mock 
and PHYL transfected HDFs are shown. Overlays represent black (secondary antibody 
only), grey shaded (untreated), red (5 ng/ml TGFβ1), blue (hypoxia (1%O2)) and yellow 
(combined TGFβ1 and hypoxia). (b) Dot plot of FSC versus SSC of HDFs and the cells 
gated for analysis are shown. (c.) Analysis of P-Smad2 and (d.) Smad2 induction in Mock  
and PHYL transfected cells using a stimulation index, representing the ratio of mean 
fluorescence intensity of P-Smad2 and Smad2 in treated cells (TGFβ1 (N+), hypoxia (H) 
or combination of both (H+) after 48 hours) to that untreated (N) cells. Each point 
represents mean ± standard error of the mean of three separate experiments. 
Bonferroni’s two way ANOVA analysis was performed to determine significance.      
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5.3.  Discussion  
5.3.1. Hypoxia through HIF-1 regulates human skin fibroblasts  
Hypoxic microenvironments stimulate chemotaxis and various functions of several cells 
types that modulate important events involved in healing including inflammation, re-
epithelialisation, formation of granulation tissue and angiogenesis (Knighton et al., 
1983, O'Toole et al., 1997, Knighton et al., 1981, Falanga et al., 2002). Dermal fibroblasts 
are central in the regulation of granulation tissue and its eventual remodelling and 
modulate the angiogenic process through the release of extracellular matrix and 
paracrine factors that are required for both endothelial adhesion and chemotaxis during 
wound healing. In addition to soluble factors and matrix proteins released during 
inflammation, hypoxia has emerged as an important regulator of dermal fibroblast 
functionality during wound healing with the prevailing view that hypoxia promotes 
fibroblast chemotaxis, production of autocrine and paracrine factors as well as 
extracellular matrix which ultimately accelerate wound healing, through the promotion 
of granulation tissue formation and angiogenesis. (Falanga and Kirsner, 1993, Falanga et 
al., 2002, Siddiqui et al., 1996, Steinbrech et al., 1999, Berse et al., 1999, Hong et al., 
2006). HIF-1 regulated pathways are essential for cellular adaptive responses to hypoxia 
and have important regulatory effects on HDF functionality.  
 
HIF-1 transcriptional activity is tightly regulated through several proteins which control 
post-translational availability of the HIF-1α subunit. Siah proteins are E3 ubiquitin ligases 
that tag HIF-prolyl hydroxylases for degradation during hypoxia and thus positively 
regulate HIF-1α availability and the expression of hypoxia inducible genes (Nakayama et 
al., 2004, Fukuba et al., 2007). In previous chapters (3 and 4) the relevance of the Siah-
HIF-1 axis in normal cutaneous wounding was demonstrated in both in vivo and in vitro 
models using Siah2 knockout transgenic murine models of wounds or cultured 
fibroblasts. The studies provided evidence that Siah is important in the regulation of 
angiogenesis and granulation tissue formation and possibly in the regulation of 
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fibroblast function during hypoxia. Here, the role of Siah in human fibroblast function is 
described for the first time by using transfection of Phyllopod (PHYL) to otherwise 
healthy human dermal fibroblasts (Figure 5-1). PHYL protein has the added advantaged 
of inhibiting both Siah 1 and 2 activity (Moller et al., 2008).   
5.3.2. Siah inhibition impairs important human dermal fibroblast function. 
In Chapter 3, HIF-1α protein stabilization in wild type dermal fibroblasts (Siah2+/+) 
appeared to be parabolic over time in hypoxia, peaking after about 8 hours in hypoxia 
and gradually returning to baseline levels with increasing time in hypoxia. In contrast 
Siah2-/- knockout cells showed reduced HIF-1α stabilization over time in hypoxia where 
expression remained below baseline levels (up to 48 hours), demonstrating that Siah2 
was required for increased stabilization and maintenance of HIF-1α abundance in 
hypoxia (Figure 4-1). Here, evidence is provided to show that PHYL abrogates HIF-1 
availability in hypoxia (Figure 5-2) and that this has important downstream effects on 
HDF cell functionality during hypoxic conditions. Importantly, Siah inhibition impairs 
TGFβ induced responsiveness in normoxic conditions, suggesting that Siah may also 
have an important role in regulation of fibroblast functionality beyond the hypoxic 
milieu. 
 
VEGF in arguably the most important angiogenic factor during wound healing. Its 
expression is up-regulated in hypoxic cells as part of feedback mechanisms that lead 
eventually to angiogenesis and restoration of oxygen levels. HIF-1 is essential in the 
regulation and activation of VEGF transcription in hypoxic cells (Forsythe et al., 1996). In 
addition to hypoxia, enhanced VEGF expression by endothelial cells, macrophages and 
fibroblasts requires simultaneous activation by cytokines particularly, TGFβ1 (Sanchez-
Elsner et al., 2001, Jeon et al., 2007, Berse et al., 1999). Evidence suggests that an 
important cross-talk between TGFβ and hypoxia induced pathways exist, likely  involving 
a physical interaction between Smad and HIF1α proteins at the promoter region of the 
VEGF gene, which is required to enhance VEGF expression and release by hypoxic cells 
(Sanchez-Elsner et al., 2001, Jeon et al., 2007).  
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Here, the role of Siah-HIF-1 axis on TGFβ induced VEGF release by HDFs was investigated 
(Figure 5-3). The results showed that VEGF release in response TGFβ is reduced in 
hypoxic PHYL transfected cells (versus mock HDFs). The finding demonstrates that Siah 
may be important in regulation of enhanced VEGF release in hypoxia, presumably 
through regulation of HIF-1α, which is central to the TGFβ and hypoxia pathway cross-
talk (Sanchez-Elsner et al., 2001). Additionally because VEGF release by hypoxic 
macrophages and endothelial cells requires induction by TGFβ in a similar fashion (Jeon 
et al., 2007, Sanchez-Elsner et al., 2001), it is conceivable that Siah-HIF-1 would have a 
similar regulatory role in VEGF secretion by these cells. The finding have important 
implications on the regulation of angiogenesis during early wound healing, a phase 
where TGFβ signalling by dermal fibroblasts (Denton et al., 2009) and hypoxic gradients 
are demonstrated to be mandatory for good angiogenesis (Knighton et al., 1981). 
Additionally, the evidence provided here may in part explain why wound angiogenesis 
appeared delayed in Siah2 knockout mice (Chapter 3). 
 
Fibroblasts rapidly migrate into the provisional matrix from local mesenchymal 
connective tissue cells and bone marrow derived circulating progenitor lineages in 
response to inflammatory released factors where they form and resolve the granulation 
tissue. (Leibovich and Ross, 1975, Abe et al., 2001)(Salo et al., 1994, Darby et al., 2002). 
Cell migration is the result of repeated cycles of cytoskeletal-mediated protrusion and 
polarization, formation of adhesive contacts, cell contraction and retraction at the 
trailing edge (Lauffenburger and Horwitz, 1996). While granulation tissue formation and 
wound resolution are the result of matrix deposition/remodelling and myofibroblast 
transition/contraction followed by loss of cells via apoptosis (Gabbiani et al., 1971, 
Darby et al., 1990, Tomasek et al., 2002, Hinz et al., 2003, Hinz and Gabbiani, 2003a, 
Hinz and Gabbiani, 2003b).  
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Acute hypoxic microenvironments are an important regulator of skin cell motility, 
granulation tissue formation and remodelling, mostly through its modulation of 
matrices, soluble factors and their respective receptors (cytokine receptors and 
integrins) ((Falanga et al., 2002)(Steinbrech et al., 1999, Falanga et al., 1991, Keely et al., 
2009). HDF cell motility in hypoxia is regulated mostly through HIF-1, which thus far has 
been demonstrated, through its regulation of heat shock protien-90, an intracellular 
molecular chaperone that can be released to induce autocrine and paracrine extra-
cellular migratory responses during oxidative stress (Li et al., 2007). It is also conceivable 
that HIF-1 regulates cell function in HDFs cells through the up-regulation of hypoxia 
inducible proteins that control glucose intake (Glut-1) and metabolism (PGK-1), proteins 
that are highly expressed during cutaneous wound healing (Elson et al., 2000). 
Moreover, HIF-1 regulates the production and the release of several growth factors 
including CTGF and TGFβ1 (Hong et al., 2006, Distler et al., 2007), which act in an 
autocrine and paracrine manner to promote chemotaxis of fibroblastic cells, matrix 
production and wound contraction. HIF-1 also transcriptionally regulates the integrin 
beta 1 subunit, an integrin subunit that is required for attachment to collagenous matrix 
playing a role in mechano-perception and contraction by fibroblastic cells (Keely et al., 
2009, Arora et al., 1999).  
   
The current study provides evidence of the importance of hypoxia signalling in TGFβ 
induced matrix production by HDF cells (Figure 5-4). Here, PHYL transfected cells, which 
are deficient in HIF-1α (Figure 5-2), show reduced ability to induce COL1A1 in hypoxia 
(versus mock transfected or control cells). This is consistent with the role of HIF-1 in the 
regulation of endogenous TGFβ and collagenous matrix production in hypoxic tissue 
(Distler et al., 2007). Furthermore HIF-1 also directly regulates transcription of pro-
collagen hydroxylases (Hofbauer et al., 2003), which may represent a mechanism which 
could modulate fibrillar collagen abundance secondary to collagen synthesis. 
Interestingly, exogenous TGFβ was unable to rescue COL1A1 induction in hypoxic PHYL 
transfected cells indicating that Siah-HIF-1α may in part be required to enhance TGFβ 
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induced expression of matrix proteins during hypoxia. These findings are supported by 
other research that has demonstrated synergetic effects of TGFβ and HIF-1α in the 
expression of matrix inducing genes such as CTGF, a gene which contains a HRE and SRE 
in the gene promoter region (Hong et al., 2006, Higgins et al., 2004). The current study 
suggests the possibility of cross-talk between TGFβ and hypoxia pathways in the 
production of matrix and provides evidence to support the potential role of Siah-HIF-1 
axis in this interaction. These findings combined with those from our mouse studies 
suggest the Siah-HIF-1 axis may play an important role in wound healing in vivo (Chapter 
3), where collagen production is important for angiogenesis and granulation tissue 
formation. Additionally, because endogenous collagen synthesis is required for 
attachment (Kleinman et al., 1982) and chemotaxis of HDF cells both in vitro and in vivo 
(Postlethwaite et al., 1978), the regulation of COL1A1 by Siah-HIF1 axis may also 
represent a mechanism by which HDF cell attachment and migration can be augmented 
or regulated by hypoxia. 
  
Our study also provides evidence of the relevance of Siah proteins in the regulation of 
HDF cell migration (Figure 5-8). PHYL transfected HDF cells showed a reduced migratory 
responses to hypoxia alone, which maybe in line the role HIF-1 in the transcription of 
genes, including Hsp90, CTGF and matrices, which regulate migration (Hong et al., 2006, 
Li et al., 2007, Distler et al., 2007). PHYL transfected HDFs also show reduced migratory 
responses in hypoxia condition supplemented with TGFβ1, suggesting once again that 
Siah-HIF-1 axis may be required for co-operative responses between hypoxia and TGFβ 
pathways. Interestingly, PHYL transfected cells showed a reduced migratory response to 
TGFβ in normoxia. The reason for this finding is not clear but is suggestive of a potential 
role of Siah in regulation of TGFβ induced responses in both hypoxic and non-hypoxic 
settings. The result provides evidence to support the role of Siah in the regulation of cell 
migration during wound healing. This would in part explain why Siah2-/- deficient mice 
show marked delays in macrophage invasion, angiogenesis, re-epithelialisation and 
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granulation tissue formation, events that a reliant on cellular responses to cytokines 
that  induce cell migration.   
 
Transient expression and in corporation of α-SMA into stress fibres significantly 
augments contractile ability of fibroblastic cells and hallmarks  the contraction phase of 
connective tissue remodelling (Darby et al., 1990, Hinz et al., 2001). Here, the role of 
Siah in myofibroblast transition and HDF cell contraction was tested (Figure 5-5 and 
Figure 5-6). The results suggest that the Siah-HIF-1 axis has no significant effect on the 
modulation of contraction and fibroblast to myofibroblast transition in HDFs cells in 
response to TGFβ or hypoxia. The results are in contrast to observations made using 
mouse dermal fibroblasts where Siah2 appeared to modulate αSMA induction in 
hypoxia (see Chapters 4) suggesting the possibility that Siah has differential regulatory 
effects in mouse versus human cells. Additionally, the results support recent research 
that show impaired αSMA expression in hypoxia (Modarressi et al., 2010), with the 
major difference being that reduced αSMA in our study did not impair lattice 
contraction in acute hypoxia. Although the reason(s) for this effect remain unclear, it is 
likely that monolayer cultures models fail to take into account other factors including 
cell-matrix interactions or applied tension which are required for cell contraction (Arora 
et al., 1999, Tomasek et al., 1992). Additionally, given that wound contraction can occur 
independently of αSMA dependent mechanisms, as seen in  IL-6 ko mice which show 
reduced wound contraction despite early augmentation of α-SMA expression compared 
to wild type littermates (Gallucci et al., 2000), it seems possible to have a physiological 
state where αSMA expression or induction does not correlate to contraction. 
Furthermore, because αSMA expression is not absolute during cell contraction, and can 
be substituted by other isoforms such γ-smooth muscle and α-skeletal actin as seen in 
αSMA null mice (Schildmeyer et al., 2000), it may be tempting to postulate that 
contraction where αSMA is reduced may occur via a non-αSMA induced mechanisms 
(Hinz, 2007).  
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Various studies have reported different proliferative outcomes after exposing HDF cells 
to hypoxia. Some studies report that hypoxia inhibits dermal fibroblast cell proliferation 
(Oberringer et al., 2008) while others have reported enhanced proliferation (Falanga 
and Kirsner, 1993). Observations of no significant change to HDF proliferation in hypoxia 
have also been described (Boraldi et al., 2007). In our study, cell proliferation was 
determined by PCNA analysis, which did not reveal any significant change to cell 
proliferation during  hypoxia in both control and PHYL transfected cells. Our results may 
support the finding of Boraldi et al, mentioned aboved. The lack of an increase in 
proliferation following treatment of HDFs with exogenous TGFβ1 raises some concerns 
about the sensitivity of PCNA to determine proliferative differences in culture conditions 
where proliferation may be perpetual and occurring at a high rate, as was apparent with 
the HDF cultures (data not shown). Therefore other proliferative assays such as 
Bromodeoxyuridine (BRDU) incorporation assays, which are more s-phase specific, may 
be required to draw a conclusion on the effect of Siah in dermal fibroblast proliferation 
in hypoxia.  
 
Cellular responsiveness to growth factor, such as TGFβ is reliant on the growth factor 
binding to the receptors (TGFRII) which leads to the recruitment of TGFR1 and  
activation of cytosolic signalling pathways and subsequent alteration of cellular 
processes important for wound healing including mitogenesis, migration and matrix 
production (Massague, 1998, Piek et al., 1999, Massague and Chen, 2000, Massague and 
Wotton, 2000). Hypoxia up-regulates TGFβ1 in HDF cells (Falanga et al., 1991) which 
activates downstream signalling cascades including p42/p44 MAPKs (Mogford et al., 
2002) and Smads (Falanga et al., 1991). HIF-1 has been suggested as the likely candidate 
in the regulation of TGFR1 expression in hypoxia, as supported by reduced TGFβR1 
expression and p42/p44 MAPK activation in aged dermal fibroblasts (Mogford et al., 
2002) which are reported to be HIF-1α deficient cells (Loh et al., 2009). Furthermore, 
the importance of HIF-1 in the regulation of TGFβ responses in hypoxia is also supported 
by studies that demonstrate reduced TGFβ augmentation and matrix synthesis in HIF-1α 
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inhibited HDF cells (Distler et al., 2007). However, the study did not establish the effect 
of HIF-1 on TGFβ signalling cascades. 
 
Here the effect of Siah-HIF-1 axis on TGFR1 expression (Figure 5-9) and downstream 
Smad cascades (Figure 5-10) were investigated in response to TGFβ and hypoxia stimuli. 
Here, a moderate correlation between HIF-1α and TGFR1 expression is seen in hypoxic 
dermal fibroblasts. PHYL transfect HDFs show downward trend (not significant) in TGFR1 
induction in hypoxia (versus mock) and failure to enhance TGFR1 in hypoxia when 
supplemented with exogenous TGFβ (P<0.05, versus mock). Furthermore, downstream 
of TGFR1, PHYL transfected cells showed a downward trend in phosphorylated Smad2 
following treatment with TGFβ and hypoxia (compared to mock cells) which might be 
suggestive a reduced response to TGFβ. However, it is likely that moderate reduction to 
TGFβ signalling cascades (TGFR1 and Smad) in PHYL transfected cells (compared to mock 
cells) only partially account for the significant reductions in cell migration, VEGF 
secretion and collagen induction. It is likely that reduced Siah activity (in PHYL 
transfected cells) affects other mechanisms such as cross-talks between TGFβ and 
hypoxia signalling pathways, that occur downstream of Smad phosphorylation.  
 
These cross-talks involve a physical interaction between HIF-1α, Smad and a co-activator 
protein (p300) at promoter region of genes containing HRE and SRE sequences 
(Sanchez-Elsner et al., 2001). Smad-HIF-1α complexes are demonstrated in the 
activation of angiogenic genes including VEGF, erythropoietin-1 and TGFβ co-receptor, 
endoglin (Sanchez-Elsner et al., 2001, Sanchez-Elsner et al., 2004, Sanchez-Elsner et al., 
2002).  Furthermore, a variety of genes contain active SRE and HRE sequences and may 
potentially be regulated through TGFβ-hypoxia cross-talks. Examples that are relevant 
to wound healing and to the function of dermal fibroblasts include CTGF and PAI (Fink et 
al., 2002, Hong et al., 2006, Higgins et al., 2004, Zhang et al., 2003b). Such an interaction 
would explain why TGFβ responsiveness in hypoxia is reduced in HIF-1 deficient cells 
(PHYL transfected cells) without much difference to TGFβ cascade proteins.  
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Additionally, TGFβ and hypoxia are both demonstrated to induce increased activation of 
MAPKs (p38, p42/ p44 MAPKs) (Mogford et al., 2002). MAPK pathways are also critical 
for activation of Siah and HIF-1α proteins by oxidative stress and possibly through 
cytokines (Richard et al., 1999, Khurana et al., 2006). Therefore the possibility of a TGFβ-
MAPK-Siah-HIF-axis would also explain the observations of reduced TGFβ 
responsiveness in hypoxia if Siah or HIF-1α were to be reduced. The existence of such an 
interaction has been demonstrated in human cytotrophoblast cells where TGF β-MAPK- 
HIF-1 interactions are required to induce VEGF expression (Qian et al., 2004). 
 
Furthermore, because TGFβ induced migratory responses are reduced in PHYL 
transfected cells in normoxia, it is conceivable that Siah has regulatory effects on TGFβ 
responses downstream of Smad or via non-Smad dependant pathways in a fashion 
independent of the hypoxia signalling machinery. The requirement of Ras signalling in 
the enhancement of TGFβ-Smad dependent responses is a potential explanation for this 
result. Siah proteins have important regulatory effects on Ras signalling pathways 
downstream of the RAF/MEK/MAPK signalling cascade and depletion or inactivation of 
Siah inhibits Ras activated pathways as demonstrated in transformation and 
carcinogenesis models (Schmidt et al., 2007, Ahmed et al., 2008). In fibroblasts, 
activation with exogenous TGFβ leads to transient activation of RAS/MEK/MAPK 
cascades and subsequent enhancement of TGFβ-Smad responses (Leask and Abraham, 
2004). Activation of Ras signalling by TGFβ induces genes including CTGF, a protein 
associated with cell migration, proliferation, matrix synthesis and angiogenesis (Phanish 
et al., 2005, Secker et al., 2008). It is therefore likely that reduced TGFβ-Smad responses 
in Siah deficient or inhibited cells could occur due to impairment in Ras signalling. 
 
5.3.3. Implications on wound healing in human skin 
This is the first study of its kind that demonstrates an important role for Siah proteins in 
regulation of cell function in human skin cells. The evidence provided here suggests that 
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Siah is required for important fibroblast functions during hypoxia including cell 
migration, matrix synthesis and the release of angiogenic factors such as VEGF. 
Furthermore, Siah appears to be important in the regulation of TGFβ-induced responses 
in both the normoxic and hypoxic milieu. Taken together the evidence implies that Siah 
may be an important positive regulator of wound healing in human skin via its role in 
Hif-1 stabilization and possibly through other mechanisms as discussed above. This is 
further supported in previous chapters (3 and 4) where the role of Siah2 is described in 
mouse cutaneous wound healing models in vitro and in vivo, with the main difference 
being that Siah does not appear to alter αSMA expression or thus contraction in HDF 
cells. The findings of this study also have important clinical implications in pathological 
states of wound healing associated with deficiency or excessive accumulation of HIF-1 
(Discussed in section 3.3.3)             
 
5.4.  Conclusion  
Transient inhibition of Siah 1 and 2 with PHYL reduced the availability of HIF-1α in 
hypoxic HDF cells. This had significant inhibitory effects on cell migration, extracellular 
matrix protein expression, VEGF release and TGFR1 induction during hypoxia. 
Additionally, PHYL transfected cells showed reduced cell migration in response to TGFβ 
in normoxic culture conditions. Overall, the results, in general, support the role of Siah 
as a positive regulator of wound healing in human skin cells.           
 
5.5. Specific experimental methods for this chapter 
 
Mentioned here are summarized methods including only relevant details pertaining to 
this chapter. For specific descriptions of individual methods, please refer to the general 
methods chapter (Chapter 2) 
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5.5.1.  Transfection of human dermal fibroblasts with phyllopod  
Briefly, E.coli cells were made competent and transformed with pcDNA using standard 
calcium chloride and heat shock methods. Transformed E.coli colonies were selected for 
using antibiotic resistance. Transformed colonies were propagated in selection medium 
containing antibiotic and pcDNA plasmid isolated and purified using plasmid mini-prep 
columns. Purity and concentration of plasmids were determined by spectrophotometry 
at 260/280nm in quartz cuvettes. Primary adult HDF cells were transfected with pcDNA 
(3.4μg) using Lipofectamine for 5-6 hours in serum free 106 media for fibroblasts culture 
(Invitrogen). Cells were allowed to recover under normal culture conditions for 24 
hours. Expression of PHYL protein was verified by detection of HA tagged PHYL using an 
anti-HA antibody and anti- rabbit IgG- Alexa-fluor 488®. HA detection was compared to 
that of HDFs transfected with an empty pcDNA or scrambled (nonsense) vector.  
 
5.5.2. Migration of human dermal fibroblasts  
Transfected HDF cells were seeded into 6 well plates at normalized cell density and 
grown until 80-90% confluent. Cells were then serum starved for 6 hours and scratched 
using a micropipette tip (1 ml) and then supplemented either with low serum medium  
or low serum medium with added TGFβ1 (0.5ng/ml). Cells were incubated in normoxia 
or hypoxia overnight (16 hours). Migration was determined by measuring the difference 
in the area of the gap at time 0 versus time post-wounding.  
 
5.5.3.  Collagen lattice contraction assay  
Transfected HDFs were counted and seeded into collagen I (2.1mg/ml) at normalized 
density (2 x 105cell/ml). Lattices were allowed to polymerize and then recover for 24 
hours in normal cell culture conditions. Cells were serum starved for 6 hours and later 
supplemented with either low serum media or medium containing TGFβ1 (2.5ng/ml). 
Cells were incubated in normoxia or hypoxia for up 24 hours. Lattices were released and 
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returned to their respective experimental conditions for a further 24 hours. Area of 
lattices was measured and contraction calculated as change in lattice area (pixels2).  
   
5.5.4.  Analysis of protein expression by flow cytometry 
Protein expression was determined by means of immuno-labelling and flow cytometry. 
Briefly, transfected HDF cells were seeded into flasks (25cm2) at normalized cell density 
and grown until 70-80 % confluent. Cells were serum starved for 6 hours and later 
supplemented with either low serum media or medium containing TGFβ1 (2.5ng/ml). 
Cells were incubated in normoxia or hypoxia for 48 hours. Cells were detached by 
trypsin, fixed in formalin and permeabilized using saponin.  Immuno-labelling of cells 
with mouse monoclonal Anti-HIF-1α (1:100), rabbit polyclonal anti-COL1A1 (1:100), 
mouse monoclonal anti-αSMA-FITC conjugated (1:250), mouse monoclonal anti-PCNA 
(1:200), rabbit polyclonal anti-HA (1;100,), rabbit polyclonal anti-phosphorylated-Smad2 
(1:100), rabbit polyclonal anti-transforming growth factor-β receptor type-1 (1:100), 
mouse monoclonal anti-SMAD2 (1;100) and mouse monoclonal anti-Siah2 (1:100) was 
done to probe for these respective antigens. Fluorescent conjugated secondary anti-
rabbit and anti-mouse antibodies were used to probe for respective primary antibodies 
(excepting αSMA which was conjugated). The fluorescence intensity of at least 2000-
5000 cells per sample was measured using a flow cytometer and analyzed by weasel 
flow cytometry software (Walter and Eliza Hall Institute, Aus).  
 
5.5.5. VEGF ELISA 
VEGF production and release from cultured fibroblasts into the medium was measured 
using a human VEGF ELISA (PeproTech, USA). Briefly, this involved binding a capture 
VEGF antibody onto a high binding ELISA plate and adding normalized amounts of 
sample culture medium. Captured VEGF was detected by colorimetric horseradish 
peroxidase reaction after the addition of a biotinylated VEGF detection antibody and 
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HRP-conjugated streptavidin. A standard curve constructed using purified VEGF was 
used to quantify unknown samples.  
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6. Chapter 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion and future directions 
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6.1. General discussion  
Wound healing relies on a complex and precise sequence of events that lead via 
inflammation, proliferation and resolution phases to a generally imperfect tissue repair 
(Clark, 1996). These events are regulated by complex cellular interactions involving 
cytokines, extracellular matrix proteins, adhesion proteins and their respective cellular 
receptors that induce signalling pathways and lead to the activation and suppression of 
multiple genes controlling inflammation, re-epithelialisation, angiogenesis and 
granulation tissue formation during wound healing, as reviewed extensively in Chapter 
1. Impairment of any of these processes results in delayed or aberrant healing. In adults, 
the generation of granulation tissue and its eventual remodelling as wound maturation 
occurs, results in a scar with reduced functionality compared to the original tissue 
(Darby and Hewitson, 2007). Because of the loss of function in scarring tissue and the 
difficulty in healing chronic wounds as well as the high cost of wound care (Sen et al., 
2009), there is considerable interest in the factors involved in the regulation of normal 
and potentially pathological healing. 
 
Following injury, vascular damage generally occurs resulting in low oxygen tension 
(hypoxia) which may be further sustained by the rapid influx of inflammatory and 
mesenchymal cells with high metabolic demands for oxygen. Slight changes in systemic 
and cellular oxygen concentrations induce tightly regulated response pathways that 
attempt to restore oxygen supply to cells and modulate cell function in hypoxic 
conditions. Tissue hypoxia is a common microenvironment during both normal and 
abnormal wound healing and has important regulatory effects on cell behaviours during 
inflammation, re-epithelialisation, granulation tissue formation and angiogenesis 
(Haroon et al., 2000, Lokmic et al., 2006, Remensnyder and Majno, 1968, Knighton et al., 
1983, Knighton et al., 1981, Steinbrech et al., 1999, Ridgway et al., 2005). Most of these 
responses occur through the induction of HIF-1 which regulates many processes needed 
to carry out tissue repair processes during tissue ischaemia and indeed wound healing 
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(Semenza, 2010, Zhang et al., 2010b). Over elaborate HIF-1 responses have been linked 
with fibrosis disorders of the skin and impaired HIF-1 signalling is thought to be an 
important mechanism contributing to impaired wound healing in diabetics and the aged 
(Botusan et al., 2008, Distler, 2003, Liu et al., 2008, Zhang et al., 2006, Zhang et al., 
2003b) . HIF-1 is thus an important therapeutic target for the treatment and 
management of abnormal wounds.  The use of HIF-hydroxylase (PHD) inhibitors to 
increase HIF-1 stabilisation and improve wound healing has been demonstrated in 
cutaneous wound healing models in animals (Botusan et al., 2008). PHD inhibitors are 
now in clinical trials for the treatment of several ischaemia-related pathologies such as 
chronic wounds, anaemia, ischaemic heart disease, stroke, cancer, and pulmonary 
hypertension (Smith and Talbot, 2010). 
 
It is now well established that during hypoxia, HIF-1α escapes proteosomal degradation 
through the inhibitory effects of Siah ubiquitin ligases on PHD and FIH activity 
(Nakayama et al., 2004, Fukuba et al., 2007), thus aim of this study was to investigate 
the relevance of Siah during wound healing. 
6.1.1. Effect of Siah-deficiency or inhibition on wound healing and its clinical 
implications 
We report here for the first time that cutaneous wound healing of Siah2-deficient mice 
results in delayed recruitments of macrophages, delayed migration of vessel cells, 
delayed fibroblast – myofibroblast transformation and reduced extracellular matrix 
deposition during the early phase of wound healing and that this delay is significant, 
albeit transient (Chapter 3). Furthermore, Siah2 knockout fibroblasts showed impaired 
functionality under hypoxic conditions and in interestingly showed an impaired 
response to exogenous TGFβ (Chapter 4), which may in part explain why wound healing 
is delayed in Siah2-deficient mice. Moreover, transient inhibition of Siah in human 
dermal fibroblasts using a transfected Siah1/2 inhibitor (phyllopod) reduced the 
functionality of otherwise healthy dermal cells (Chapter 5) through, we suggest, both 
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HIF-1 dependent and HIF-1 independent mechanisms. We propose that reduced TGFβ1 
responses in Siah deficient dermal fibroblasts beyond the hypoxic milieu may be due to 
impaired Ras signalling, given the importance of Ras signalling in TGFβ- Smad responses 
(Leask and Abraham, 2004) and regulatory effects of Siah in Ras mediated signalling 
(Ahmed et al., 2008). Furthermore, because of the importance of HIF-1 and Smad 
interactions in the synergystic expression of certain genes by hypoxia and TGFβ, specific 
examples including VEGF (Sanchez-Elsner et al., 2001) and possibly CTGF (Hong et al., 
2006), it is likely that in the absence of Siah such cross talk may be reduced or impaired 
in hypoxia.   
 
The results of this study may have several important clinical implications. Firstly, genetic 
or pharmacological strategies to increase Siah levels may be beneficial in increasing HIF-
1α levels in tissue where this may prove beneficial. Increased HIF-1α has been shown to 
promote vascularisation and improve healing in ischaemic, excisional and burn wounds 
(Botusan et al., 2008, Liu et al., 2008). This is especially important for specific groups 
such as the aged and diabetic subjects who may be prone to HIF-1 deficiency in hypoxia 
(Catrina et al., 2004, Botusan et al., 2008, Liu et al., 2008, Loh et al., 2009) The use of 
Siah or a pharmacological mimetic may therefore be beneficial in the treatment of 
ischaemic wounds where HIF-1 induction of genes may be beneficial to the repair 
process may enhance healing. 
 
Conversely, inhibition of Siah using specific pharmacological inhibitors may prove 
beneficial in the treatment of fibroproliferative disorders, where HIF-1α is over-
expressed or expressed chronically and is now thought to promote fibrosis (Distler et al., 
2007, Zhang et al., 2006). At present, menadione (a Vitamin K derivative) is the only 
pharmacological inhibitor of Siah2 (Shah et al., 2009). Based on the results of the 
current study, experiments to test the effect of menadione in a wound healing scenario 
would seem desirable.   
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6.1.2. Future Directions 
In addition to this study, it is reasonable to hypothesise that a future study investigating 
the role of Siah in models with complete Siah 1 and 2 deficiencies may yield a more 
elaborate phenotype and better define the role of Siah in wound healing. Siah 1 and 2 
have overlapping functions in vivo which may only result in partial HIF-1α deficiency in 
Siah2-/- (Nakayama et al., 2004) and thus the transient delay in wound healing observed 
in our study. Complete deletion of both Siah 1 and 2 genes results in more complete 
HIF-1α deficiency (Nakayama et al., 2004) but  also causes embryonic lethality (Frew et 
al., 2003) which has hindered the effective study of Siah in later development and 
adulthood. It may be possible to overcome this problem in vivo by adopting a model 
where both Siah 1 and 2 are conditionally deleted in adult mice and in specific cell 
populations. Cre-lox P recombination is a technique commonly used to generate 
conditional knockout animals, in which genes can be inactivated in specific tissue or at a 
specific time (Sauer, 1998). Cre-lox P systems has been used successfully to abrogate 
expression of genes in adults skin wound healing models, for example, CD11b gene 
which is required for macrophage specific invasion during inflammation and wound 
healing (Mirza et al., 2009). Recently, Cre-lox P models have been used to generate 
adult HIF-1α deficient liver mice models enabling the pathological effects of HIF-1α to be 
studied in liver cirrhosis in vivo (Moon et al., 2009). A similar model targeting both Siah 1 
and 2 in skin tissue or specific wound healing cells including macrophages, fibroblast, 
keratinocytes and endothelial cells would be desirable for further defining the role of 
Siah in wound healing with respect to both HIF-1 and or RAS signalling pathways. 
Adoptive transfer of immune cells from Siah2-/- mice into recipient mice with immune 
cells ablated could also allow further dissection of the relative roles of fibroblasts 
compared to immune/inflammatory cells in Siah2 deficient mice.  Our data and 
preliminary data from our collaborator’s laboratory (Dr Möller, Peter MacCallum Cancer 
Institute) are certainly suggestive of a prominent role for macrophages in the Siah2 
knockout phenotype. 
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As mentioned earlier establishing primary murine dermal fibroblasts cultures proved 
challenging and may have limited the ability to clearly define the role of Siah2 in these 
cells (see Chapter 4 section 4.3.2). This problem was mostly overcome by inhibiting Siah 
activity in healthy adult human dermal fibroblasts which had the additional advantage 
of becoming an in vitro model that was more relevant to adult human skin. Inhibition of 
Siah in the HDF study might also benefit from improving the transfection efficiency of 
Phyllopod into these cells. This might be achieved by using a cellular marker such as 
DAPI, along side Phyllopod TAG (HA) which could help to determine and improve the 
transfection co-efficient. Establishment of stable Phyllopod transfected HDF could also 
be attempted by incooperating  Additionally, MDF cell lines, although mostly embryonic, 
are readily available and well characterised in culture. The role of Siah in murine dermal 
cell functions could be further tested in such a model using Siah inhibitors such as 
Phyllopod or anti-sense Siah oligonucleotides, taking into account that some differences 
between embryonic and adult dermal cell behaviour are likely. Embryonic fibroblasts 
may produce different types of matrix proteins in hypoxia and may be less responsive to 
changes induced by TGFβ1 compared to adult dermal fibroblasts which predominately 
produce type I collagen in hypoxia and show high responsiveness to the growth factor 
(Scheid et al., 2000, Scheid et al., 2002, Rolfe et al., 2005). Additionally embryonic 
fibroblasts are generally less differentiated towards a myofibroblast phenotype (Rolfe et 
al., 2005). 
 
 
The results of this study indicate that Siah proteins may be important in the regulation 
of matrix synthesis during wound healing and indeed in dermal fibroblasts during 
hypoxia, which could have important implications in scarring and fibrosis, thus testing 
the role of Siah in cutaneous and non-cutaneous scarring or fibrosis models is an 
important future direction.  Ear models of hypertrophic scarring in the skin (Kryger et al., 
2007) and bile duct ligation or carbon tetrachloride models of liver fibrosis (Moon et al., 
2009) are specific examples models that could be employed to evaluate the effects of 
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Siah in scarring and fibrosis in vivo. Our hypothesis here would be that Siah inhibition 
may be protective against fibrosis either through regulation of fibroblast function or 
through dampening of macrophage activity and TGFβ sensitivity. Conversely, genetic or 
pharmacological strategies to increase Siah levels in ischaemic wound healing models 
such as diabetic cutaneous healing models may be desirable to further investigate the 
relevance of Siah as a positive regulator of wound healing during hypoxia. 
 
6.2.  Overall Conclusion 
 
In summary, hypoxia is an important part of the microenvironment in early wound 
healing. Adaptive responses to hypoxia are controlled by HIF-1, which is positively 
regulated by Siah. This study demonstrates for the first time a role for Siah2 in wound 
healing and an effect on healing of Siah2 deficiency. Cutaneous wound healing of Siah2-
deficient mice results in delayed early phase wound healing. Siah through HIF-1 and 
possibly other mechanisms appears to be a positive regulator of dermal fibroblast cell 
function which may in part explain why early wound healing is delayed in Siah2-/- mice. 
Modulation of Siah protein levels or activity may therefore have important clinical 
implications in the treatment of abnormal wounds and fibrotic conditions. 
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7. Chapter 7 
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